Expanded GCT. Screening of more than 3000 genetic diseases
Índice
- 1 We have the latest technology to study and avoid the main hereditary diseases
- 2 Instituto Bernabeu leads the latest genetic technology.Genetic Compatibility Test (GCT)
- 3 Incorporated into all our gamete donors screening
- 4 More than 3000 recessive disorders detected by the Genetic Compatibility Test (GCT)
We have the latest technology to study and avoid the main hereditary diseases
Preconceptional genetic studies (also called carrier studies) aim to prevent the birth of a child with recessive diseases. Recessive genetic diseases behave in such a way that individuals can be either completely healthy, carriers or affected. Affected individuals are sick and manifest the disease. Carriers, however, do not manifest any symptoms, but they are at high risk of transmitting the disease if the other parent is also a carrier.
The fact that carriers do not have symptoms prevents them from being identified. Only by analyzing the genes responsible for these diseases can we recognize them and establish the risk of having affected offspring. The same is the case with sex-linked disorders, since female carriers would not show symptoms, but would have a high risk of affected male offspring.
For years, studies of carriers of recessive diseases such as cystic fibrosis, thalassemia, Tay-sachs, etc. have been carried out in certain populations. However, these studies included a single disease. In recent years, a molecular biology and genetics technique (called massive sequencing or NGS) has been developed that allows cost-effective analysis of hundreds of genes in a single assay. Thus, carrier studies have moved to include more genes. Advances in this field are taking place exponentially, so new studies have recently been carried out that allow the analysis of thousands of genes, including all genes in the genome (genome or exome).
Instituto Bernabeu leads the latest genetic technology.Genetic Compatibility Test (GCT)
In line with these advances, Instituto Bernabeu has been incorporating in its molecular biology laboratories the technology necessary to carry out these studies of hundreds or thousands of genes. In 2016, it developed the most comprehensive carrier test that included 600 recessive diseases as well as those linked to sex chromosomes (GCT: genetic compatibility test), preventing thousands of couples from exposing themselves to the risk of having children affected by these diseases.
Currently, and thanks to new advances, a new test has been developed that allows the analysis of more than 3,000 diseases, and is currently the most comprehensive study available. In this way, recessive and sex-related diseases that can be transmitted to offspring are minimized as much as possible and makes available to patients all the scientific knowledge and technology available.
Incorporated into all our gamete donors screening
Due to the importance of the information obtained in these tests to avoid the transmission of genetic diseases, at Instituto Bernabeu it is routinely performed on all our gamete donors and is recommended in all those couples with reproductive wishes regardless of whether or not they require assisted reproduction techniques.
More than 3000 recessive disorders detected by the Genetic Compatibility Test (GCT)
GENE | CHROMOSOME | LOCUS | DISEASE | OMIM |
AAAS | chr12 | 12q13 | Achalasia-addisonianism-alacrimia syndrome | 231550 |
AARS2 | chr6 | 6p21.1 | Combined oxidative phosphorylation deficiency 8 | 614096 |
AARS2 | chr6 | 6p21.1 | Leukoencephalopathy progressive with ovarian failure | 615889 |
AASS | chr7 | 7q31.3 | Hyperlysinemia | 238700 |
ABAT | chr16 | 16p13.3 | GABA-transaminase deficiency | 613163 |
ABCA1 | chr9 | 9q22-q31 | Tangier disease | 205400 |
ABCA12 | chr2 | 2q34 | Ichthyosis congenital autosomal recessive 4B (harlequin) | 242500 |
ABCA12 | chr2 | 2q34 | Ichthyosis congenital autosomal recessive 4A | 601277 |
ABCA2 | chr9 | 9q34 | Intellectual developmental disorder with poor growth and with or without seizures or ataxia | 618808 |
ABCA3 | chr16 | 16p13.3 | Surfactant metabolism dysfunction pulmonary 3 | 610921 |
ABCA4 | chr1 | 1p22.1 | Retinal dystrophy early-onset severe | 248200 |
ABCA4 | chr1 | 1p22.1 | Stargardt disease 1 | 248200 |
ABCA4 | chr1 | 1p22.1 | Fundus flavimaculatus | 248200 |
ABCA4 | chr1 | 1p22.1 | Retinitis pigmentosa 19 | 601718 |
ABCA5 | chr17 | 17q24.2 | Hypertrichosis congenital generalized with gingival hyperplasia | 135400 |
ABCB11 | chr2 | 2q24 | Cholestasis progressive familial intrahepatic 2 | 601847 |
ABCB11 | chr2 | 2q24 | Cholestasis benign recurrent intrahepatic 2 | 605479 |
ABCB4 | chr7 | 7q21.1 | Gallbladder disease 1 | 600803 |
ABCB4 | chr7 | 7q21.1 | Cholestasis intrahepatic of pregnancy 3 | 614972 |
ABCB4 | chr7 | 7q21.1 | Cholestasis progressive familial intrahepatic 3 | 602347 |
ABCB7 | chrX | Xq13.1-q13.3 | Anemia sideroblastic with ataxia | 301310 |
ABCC2 | chr10 | 10q24 | Dubin-Johnson syndrome | 237500 |
ABCC6 | chr16 | 16p13.1 | Pseudoxanthoma elasticum | 264800 |
ABCC6 | chr16 | 16p13.1 | Arterial calcification generalized of infancy 2 | 614473 |
ABCC8 | chr11 | 11p15.1 | Diabetes mellitus permanent neonatal 3 with or without neurologic features | 618857 |
ABCC8 | chr11 | 11p15.1 | Hyperinsulinemic hypoglycemia familial 1 | 256450 |
ABCD1 | chrX | Xq28 | Adrenomyeloneuropathy adult | 300100 |
ABCD1 | chrX | Xq28 | Adrenoleukodystrophy | 300100 |
ABCD3 | chr1 | 1p22-p21 | Bile acid synthesis defect congenital 5 | 616278 |
ABCD4 | chr14 | 14q24.3 | Methylmalonic aciduria and homocystinuria cblJ type | 614857 |
ABCG8 | chr2 | 2p21 | Sitosterolemia 1 | 210250 |
ABHD12 | chr20 | 20p11.21 | Polyneuropathy hearing loss ataxia retinitis pigmentosa and cataract | 612674 |
ABHD5 | chr3 | 3p21 | Chanarin-Dorfman syndrome | 275630 |
ACACA | chr17 | 17q21 | Acetyl-CoA carboxylase deficiency | 613933 |
ACAD8 | chr11 | 11q25 | Isobutyryl-CoA dehydrogenase deficiency | 611283 |
ACAD9 | chr3 | 3q26 | Mitochondrial complex I deficiency nuclear type 20 | 611126 |
ACADM | chr1 | 1p31 | Acyl-CoA dehydrogenase medium chain deficiency of | 201450 |
ACADS | chr12 | 12q22-qter | Acyl-CoA dehydrogenase short-chain deficiency of | 201470 |
ACADSB | chr10 | 10q25-q26 | 2-methylbutyrylglycinuria | 610006 |
ACADVL | chr17 | 17p13 | VLCAD deficiency | 201475 |
ACAN | chr15 | 15q26.1 | Spondyloepimetaphyseal dysplasia aggrecan type | 612813 |
ACAT1 | chr11 | 11q22.3-q23.1 | Alpha-methylacetoacetic aciduria | 203750 |
ACBD5 | chr10 | 10p12.1 | Retinal dystrophy with leukodystrophy | 618863 |
ACE | chr17 | 17q23 | Renal tubular dysgenesis | 267430 |
ACKR1 | chr1 | 1q23.2 | Blood group Duffy system | 110700 |
ACKR1 | chr1 | 1q23.2 | White blood cell count QTL | 611862 |
ACO2 | chr22 | 22q13.2 | Infantile cerebellar-retinal degeneration | 614559 |
ACO2 | chr22 | 22q13.2 | Optic atrophy 9 | 616289 |
ACOX1 | chr17 | 17q25.1 | Peroxisomal acyl-CoA oxidase deficiency | 264470 |
ACP2 | chr11 | 11p11.2 | Lysosomal acid phosphatase deficiency | 200950 |
ACP5 | chr19 | 19p13.3-p13.1 | Spondyloenchondrodysplasia with immune dysregulation | 607944 |
ACTA1 | chr1 | 1q42.1 | Myopathy actin congenital with cores | 161800 |
ACTA1 | chr1 | 1q42.1 | Nemaline myopathy 3 autosomal dominant or recessive | 161800 |
ACTA1 | chr1 | 1q42.1 | Myopathy congenital with fiber-type disproportion 1 | 255310 |
ACTA1 | chr1 | 1q42.1 | Myopathy actin congenital with excess of thin myofilaments | 161800 |
ACY1 | chr3 | 3p21.1 | Aminoacylase 1 deficiency | 609924 |
ADA | chr20 | 20q13.11 | Adenosine deaminase deficiency partial | 102700 |
ADA | chr20 | 20q13.11 | Severe combined immunodeficiency due to ADA deficiency | 102700 |
ADA2 | chr22 | 22q11.2 | Vasculitis autoinflammation immunodeficiency and hematologic defects syndrome | 615688 |
ADA2 | chr22 | 22q11.2 | Sneddon syndrome | 182410 |
ADAM17 | chr2 | 2p25 | Inflammatory skin and bowel disease neonatal 1 | 614328 |
ADAM22 | chr7 | 7q21 | Epileptic encephalopathy early infantile 61 | 617933 |
ADAM9 | chr8 | 8p11.23 | Cone-rod dystrophy 9 | 612775 |
ADAMTS10 | chr19 | 19p13.3-p13.2 | Weill-Marchesani syndrome 1 recessive | 277600 |
ADAMTS13 | chr9 | 9q34 | Thrombotic thrombocytopenic purpura hereditary | 274150 |
ADAMTS17 | chr15 | 15q24 | Weill-Marchesani 4 syndrome recessive | 613195 |
ADAMTS18 | chr16 | 16q23 | Microcornea myopic chorioretinal atrophy and telecanthus | 615458 |
ADAMTS2 | chr5 | 5q23 | Ehlers-Danlos syndrome dermatosparaxis type | 225410 |
ADAMTSL2 | chr9 | 9q34.2 | Geleophysic dysplasia 1 | 231050 |
ADAMTSL4 | chr1 | 1q21 | Ectopia lentis et pupillae | 225200 |
ADAMTSL4 | chr1 | 1q21 | Ectopia lentis isolated autosomal recessive | 225100 |
ADAR | chr1 | 1q21.3 | Dyschromatosis symmetrica hereditaria | 127400 |
ADAR | chr1 | 1q21.3 | Aicardi-Goutieres syndrome 6 | 615010 |
ADARB1 | chr21 | 21q22.3 | Neurodevelopmental disorder with hypotonia microcephaly and seizures | 618862 |
ADCY1 | chr7 | 7p13-p12 | Deafness autosomal recessive 44 | 610154 |
ADCY3 | chr2 | 2p24-p22 | Obesity susceptibility to BMIQ19 | 617885 |
ADCY6 | chr12 | 12q12-q13 | Lethal congenital contracture syndrome 8 | 616287 |
ADGRG1 | chr16 | 16q13 | Polymicrogyria bilateral frontoparietal | 606854 |
ADGRV1 | chr5 | 5q14.3 | Usher syndrome type 2C | 605472 |
ADGRV1 | chr5 | 5q14.3 | Usher syndrome type 2C GPR98/PDZD7 digenic | 605472 |
ADK | chr10 | 10q11-q24 | Hypermethioninemia due to adenosine kinase deficiency | 614300 |
ADRB2 | chr5 | 5q32-q34 | Obesity susceptibility to | 601665 |
ADRB3 | chr8 | 8p12-p11.2 | Obesity susceptibility to | 601665 |
ADSL | chr22 | 22q13.1 | Adenylosuccinase deficiency | 103050 |
AEBP1 | chr7 | 7p13 | Ehlers-Danlos syndrome classic-like 2 | 618000 |
AFF2 | chrX | Xq28 | Mental retardation X-linked FRAXE type | 309548 |
AFG3L2 | chr18 | 18p11 | Spastic ataxia 5 autosomal recessive | 614487 |
AFP | chr4 | 4q11-q13 | Alpha-fetoprotein deficiency | 615969 |
AGA | chr4 | 4q32-q33 | Aspartylglucosaminuria | 208400 |
AGK | chr7 | 7q34 | Sengers syndrome | 212350 |
AGK | chr7 | 7q34 | Cataract 38 autosomal recessive | 614691 |
AGL | chr1 | 1p21 | Glycogen storage disease IIIb | 232400 |
AGL | chr1 | 1p21 | Glycogen storage disease IIIa | 232400 |
AGPAT2 | chr9 | 9q34.3 | Lipodystrophy congenital generalized type 1 | 608594 |
AGPS | chr2 | 2q31 | Rhizomelic chondrodysplasia punctata type 3 | 600121 |
AGRN | chr1 | 1pter-p32 | Myasthenic syndrome congenital 8 with pre- and postsynaptic defects | 615120 |
AGRP | chr16 | 16q22 | Obesity late-onset | 601665 |
AGRP | chr16 | 16q22 | Leanness inherited | 601665 |
AGT | chr1 | 1q42-q43 | Renal tubular dysgenesis | 267430 |
AGTPBP1 | chr9 | 9q21.33 | Neurodegeneration childhood-onset with cerebellar atrophy | 618276 |
AGTR1 | chr3 | 3q21-q25 | Renal tubular dysgenesis | 267430 |
AGXT | chr2 | 2q36-q37 | Hyperoxaluria primary type 1 | 259900 |
AGXT2 | chr5 | 5p13 | Beta-aminoisobutyric acid urinary excretion of | 210100 |
AHCY | chr20 | 20cen-q13.1 | Hypermethioninemia with deficiency of S- adenosylhomocysteine hydrolase | 613752 |
AHI1 | chr6 | 6q23.3 | Joubert syndrome 3 | 608629 |
AHR | chr7 | 7p15 | Retinitis pigmentosa 85 | 618345 |
AHSG | chr3 | 3q27 | Alopecia-mental retardation syndrome 1 | 203650 |
AICDA | chr12 | 12p13 | Immunodeficiency with hyper-IgM type 2 | 605258 |
AIFM1 | chrX | Xq26.1 | Cowchock syndrome | 310490 |
AIFM1 | chrX | Xq26.1 | Spondyloepimetaphyseal dysplasia X-linked with hypomyelinating leukodystrophy | 300232 |
AIFM1 | chrX | Xq26.1 | Combined oxidative phosphorylation deficiency 6 | 300816 |
AIFM1 | chrX | Xq26.1 | Deafness X-linked 5 | 300614 |
AIMP1 | chr4 | 4q24 | Leukodystrophy hypomyelinating 3 | 260600 |
AIPL1 | chr17 | 17p13.1 | Leber congenital amaurosis 4 | 604393 |
AIPL1 | chr17 | 17p13.1 | Retinitis pigmentosa juvenile | 604393 |
AIPL1 | chr17 | 17p13.1 | Cone-rod dystrophy | 604393 |
AIRE | chr21 | 21q22.3 | Autoimmune polyendocrinopathy syndrome type I with or without reversible metaphyseal dysplasia | 240300 |
AK1 | chr9 | 9q34.1 | Hemolytic anemia due to adenylate kinase deficiency | 612631 |
AK2 | chr1 | 1p34 | Reticular dysgenesis | 267500 |
AK7 | chr14 | 14q32.2 | Spermatogenic failure 27 | 617965 |
AKR1C2 | chr10 | 10p15-p14 | 46XY sex reversal 8 | 614279 |
AKR1C4 | chr10 | 10p15-p14 | 46XY sex reversal 8 modifier of | 614279 |
AKR1D1 | chr7 | 7q32-q33 | Bile acid synthesis defect congenital 2 | 235555 |
ALAD | chr9 | 9q34 | Porphyria acute hepatic | 612740 |
ALAD | chr9 | 9q34 | Lead poisoning susceptibility to | 612740 |
ALAS2 | chrX | Xp11.21 | Protoporphyria erythropoietic X-linked | 300752 |
ALAS2 | chrX | Xp11.21 | Anemia sideroblastic 1 | 300751 |
ALDH18A1 | chr10 | 10q24.3 | Cutis laxa autosomal recessive type IIIA | 219150 |
ALDH18A1 | chr10 | 10q24.3 | Spastic paraplegia 9B autosomal recessive | 616586 |
ALDH1A3 | chr15 | 15q26 | Microphthalmia isolated 8 | 615113 |
ALDH3A2 | chr17 | 17p11.2 | Sjogren-Larsson syndrome | 270200 |
ALDH4A1 | chr1 | 1p36 | Hyperprolinemia type II | 239510 |
ALDH5A1 | chr6 | 6p22 | Succinic semialdehyde dehydrogenase deficiency | 271980 |
ALDH6A1 | chr14 | 14q24.3 | Methylmalonate semialdehyde dehydrogenase deficiency | 614105 |
ALDH7A1 | chr5 | 5q31 | Epilepsy pyridoxine-dependent | 266100 |
ALDOA | chr16 | 16p11.2 | Glycogen storage disease XII | 611881 |
ALDOB | chr9 | 9q22.3 | Fructose intolerance hereditary | 229600 |
ALG1 | chr16 | 16p13.3 | Congenital disorder of glycosylation type Ik | 608540 |
ALG11 | chr13 | 13q14.3 | Congenital disorder of glycosylation type Ip | 613661 |
ALG12 | chr22 | 22q13.33 | Congenital disorder of glycosylation type Ig | 607143 |
ALG14 | chr1 | 1p21.3 | Myasthenic syndrome congenital 15 without tubular aggregates | 616227 |
ALG2 | chr9 | 9q22 | Myasthenic syndrome congenital 14 with tubular aggregates | 616228 |
ALG2 | chr9 | 9q22 | Congenital disorder of glycosylation type Ii | 607906 |
ALG3 | chr3 | 3q27 | Congenital disorder of glycosylation type Id | 601110 |
ALG6 | chr1 | 1p22.3 | Congenital disorder of glycosylation type Ic | 603147 |
ALG8 | chr11 | 11pter-p15.5 | Congenital disorder of glycosylation type Ih | 608104 |
ALG8 | chr11 | 11pter-p15.5 | Polycystic liver disease 3 with or without kidney cysts | 617874 |
ALG9 | chr11 | 11q23 | Gillessen-Kaesbach-Nishimura syndrome | 263210 |
ALG9 | chr11 | 11q23 | Congenital disorder of glycosylation type Il | 608776 |
ALMS1 | chr2 | 2p13 | Alstrom syndrome | 203800 |
ALOX12B | chr17 | 17p13.1 | Ichthyosis congenital autosomal recessive 2 | 242100 |
ALOXE3 | chr17 | 17p13.1 | Ichthyosis congenital autosomal recessive 3 | 606545 |
ALPL | chr1 | 1p36.1-p34 | Hypophosphatasia adult | 146300 |
ALPL | chr1 | 1p36.1-p34 | Odontohypophosphatasia | 146300 |
ALPL | chr1 | 1p36.1-p34 | Hypophosphatasia childhood | 241510 |
ALPL | chr1 | 1p36.1-p34 | Hypophosphatasia infantile | 241500 |
ALS2 | chr2 | 2q33 | Primary lateral sclerosis juvenile | 606353 |
ALS2 | chr2 | 2q33 | Amyotrophic lateral sclerosis 2 juvenile | 205100 |
ALS2 | chr2 | 2q33 | Spastic paralysis infantile onset ascending | 607225 |
ALX1 | chr12 | 12q21.3-q22 | Frontonasal dysplasia 3 | 613456 |
ALX3 | chr1 | 1p21-p13 | Frontonasal dysplasia 1 | 136760 |
ALX4 | chr11 | 11p11.2 | Frontonasal dysplasia 2 | 613451 |
AMACR | chr5 | 5p13.2-q11.1 | Bile acid synthesis defect congenital 4 | 214950 |
AMACR | chr5 | 5p13.2-q11.1 | Alpha-methylacyl-CoA racemase deficiency | 614307 |
AMBN | chr4 | 4q21 | Amelogenesis imperfecta type IF | 616270 |
AMH | chr19 | 19p13.3-p13.2 | Persistent Mullerian duct syndrome type I | 261550 |
AMHR2 | chr12 | 12q13 | Persistent Mullerian duct syndrome type II | 261550 |
AMN | chr14 | 14q32 | Imerslund-Grasbeck syndrome 2 | 618882 |
AMPD1 | chr1 | 1p21-p13 | Myopathy due to myoadenylate deaminase deficiency | 615511 |
AMPD2 | chr1 | 1p13.3 | Spastic paraplegia 63 | 615686 |
AMPD2 | chr1 | 1p13.3 | Pontocerebellar hypoplasia type 9 | 615809 |
AMPD3 | chr11 | 11pter-p13 | AMP deaminase deficiency erythrocytic | 612874 |
AMT | chr3 | 3p21.2-p21.1 | Glycine encephalopathy | 605899 |
ANAPC1 | chr2 | 2q13 | Rothmund-Thomson syndrome type 1 | 618625 |
ANGPTL3 | chr1 | 1p31 | Hypobetalipoproteinemia familial 2 | 605019 |
ANK1 | chr8 | 8p11.2 | Spherocytosis type 1 | 182900 |
ANK3 | chr10 | 10q21 | Mental retardation autosomal recessive 37 | 615493 |
ANKLE2 | chr12 | 12q24.33 | Microcephaly 16 primary autosomal recessive | 616681 |
ANKS6 | chr9 | 9q22.33 | Nephronophthisis 16 | 615382 |
ANO10 | chr3 | 3p22.1 | Spinocerebellar ataxia autosomal recessive 10 | 613728 |
ANO5 | chr11 | 11p14.3 | Miyoshi muscular dystrophy 3 | 613319 |
ANO5 | chr11 | 11p14.3 | Muscular dystrophy limb-girdle autosomal recessive 12 | 611307 |
ANO6 | chr12 | 12q12 | Scott syndrome | 262890 |
ANOS1 | chrX | Xp22.31 | Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1) | 308700 |
ANTXR1 | chr2 | 2p13.1 | GAPO syndrome | 230740 |
ANTXR2 | chr4 | 4q21 | Hyaline fibromatosis syndrome | 228600 |
AP1S1 | chr7 | 7q22.1 | MEDNIK syndrome | 609313 |
AP1S2 | chrX | Xp22 | Mental retardation X-linked syndromic 5 | 304340 |
AP3B1 | chr5 | 5q14.1 | Hermansky-Pudlak syndrome 2 | 608233 |
AP3B2 | chr15 | 15q25.2 | Epileptic encephalopathy early infantile 48 | 617276 |
AP3D1 | chr19 | 19p13.3 | Hermansky-Pudlak syndrome 10 | 617050 |
AP4B1 | chr1 | 1p13.2 | Spastic paraplegia 47 autosomal recessive | 614066 |
AP4E1 | chr15 | 15q21.2 | Spastic paraplegia 51 autosomal recessive | 613744 |
AP4M1 | chr7 | 7q22.1 | Spastic paraplegia 50 autosomal recessive | 612936 |
AP4S1 | chr14 | 14q12 | Spastic paraplegia 52 autosomal recessive | 614067 |
AP5Z1 | chr7 | 7p22.1 | Spastic paraplegia 48 autosomal recessive | 613647 |
APC2 | chr19 | 19p13.3 | Sotos syndrome 3 | 617169 |
APC2 | chr19 | 19p13.3 | Cortical dysplasia complex with other brain malformations 10 | 618677 |
APOB | chr2 | 2p24 | Hypobetalipoproteinemia | 615558 |
APOC2 | chr19 | 19q13.2 | Hyperlipoproteinemia type Ib | 207750 |
APOE | chr19 | 19q13.2 | Sea-blue histiocyte disease | 269600 |
APRT | chr16 | 16q24.3 | Adenine phosphoribosyltransferase deficiency | 614723 |
APTX | chr9 | 9p13.3 | Ataxia early-onset with oculomotor apraxia and hypoalbuminemia | 208920 |
AQP2 | chr12 | 12q13 | Diabetes insipidus nephrogenic | 125800 |
AQP7 | chr9 | 9p13 | Glycerol quantitative trait locus | 614411 |
AR | chrX | Xq11-q12 | Hypospadias 1 X-linked | 300633 |
AR | chrX | Xq11-q12 | Androgen insensitivity | 300068 |
AR | chrX | Xq11-q12 | Androgen insensitivity partial with or without breast cancer | 312300 |
AR | chrX | Xq11-q12 | Spinal and bulbar muscular atrophy of Kennedy | 313200 |
ARFGEF2 | chr20 | 20q13.13 | Periventricular heterotopia with microcephaly | 608097 |
ARG1 | chr6 | 6q23 | Argininemia | 207800 |
ARHGDIA | chr17 | 17q25.3 | Nephrotic syndrome type 8 | 615244 |
ARHGEF9 | chrX | Xq22.1 | Epileptic encephalopathy early infantile 8 | 300607 |
ARL13B | chr3 | 3q11.2 | Joubert syndrome 8 | 612291 |
ARL2BP | chr16 | 16q13 | Retinitis pigmentosa with or without situs inversus | 615434 |
ARL3 | chr10 | 10q23.3 | Joubert syndrome 35 | 618161 |
ARL6 | chr3 | 3p12-q13 | Bardet-Biedl syndrome 3 | 600151 |
ARL6 | chr3 | 3p12-q13 | Bardet-Biedl syndrome 1 modifier of | 209900 |
ARL6IP1 | chr16 | 16p12-p11.2 | Spastic paraplegia 61 autosomal recessive | 615685 |
ARMC4 | chr10 | 10p12.1 | Ciliary dyskinesia primary 23 | 615451 |
ARNT2 | chr15 | 15q24 | Webb-Dattani syndrome | 615926 |
ARSA | chr22 | 22q13.31-qter | Metachromatic leukodystrophy | 250100 |
ARSB | chr5 | 5q11-q13 | Mucopolysaccharidosis type VI (Maroteaux-Lamy) | 253200 |
ARV1 | chr1 | 1q42.2 | Epileptic encephalopathy early infantile 38 | 617020 |
ARX | chrX | Xp22.13 | Epileptic encephalopathy early infantile 1 | 308350 |
ARX | chrX | Xp22.13 | Lissencephaly X-linked 2 | 300215 |
ARX | chrX | Xp22.13 | Proud syndrome | 300004 |
ARX | chrX | Xp22.13 | Mental retardation X-linked 29 and others | 300419 |
ARX | chrX | Xp22.13 | Partington syndrome | 309510 |
ARX | chrX | Xp22.13 | Hydranencephaly with abnormal genitalia | 300215 |
ASAH1 | chr8 | 8p22-p21.3 | Farber lipogranulomatosis | 228000 |
ASAH1 | chr8 | 8p22-p21.3 | Spinal muscular atrophy with progressive myoclonic epilepsy | 159950 |
ASCC1 | chr10 | 10q22.1 | Spinal muscular atrophy with congenital bone fractures 2 | 616867 |
ASL | chr7 | 7cen-q11.2 | Argininosuccinic aciduria | 207900 |
ASNS | chr7 | 7q21-q31 | Asparagine synthetase deficiency | 615574 |
ASPA | chr17 | 17pter-p13 | Canavan disease | 271900 |
ASPH | chr8 | 8q12.1 | Traboulsi syndrome | 601552 |
ASPM | chr1 | 1q31 | Microcephaly 5 primary autosomal recessive | 608716 |
ASS1 | chr9 | 9q34.1 | Citrullinemia | 215700 |
ATAD3A | chr1 | 1p36.33 | Harel-Yoon syndrome | 617183 |
ATAD3A | chr1 | 1p36.33 | Pontocerebellar hypoplasia hypotonia and respiratory insufficiency syndrome neonatal lethal | 618810 |
ATCAY | chr19 | 19p13.3 | Ataxia cerebellar Cayman type | 601238 |
ATF6 | chr1 | 1q22-q23 | Achromatopsia 7 | 616517 |
ATIC | chr2 | 2q35 | AICA-ribosiduria due to ATIC deficiency | 608688 |
ATM | chr11 | 11q22.3 | Ataxia-telangiectasia | 208900 |
ATOH7 | chr10 | 10q21.3-q22.1 | Persistent hyperplastic primary vitreous autosomal recessive | 221900 |
ATP13A2 | chr1 | 1p36 | Kufor-Rakeb syndrome | 606693 |
ATP13A2 | chr1 | 1p36 | Spastic paraplegia 78 autosomal recessive | 617225 |
ATP2A1 | chr16 | 16p12 | Brody myopathy | 601003 |
ATP2B2 | chr3 | 3p26-p25 | Deafness autosomal recessive 12 modifier of | 601386 |
ATP2B3 | chrX | Xq28 | Spinocerebellar ataxia X-linked 1 | 302500 |
ATP6AP2 | chrX | Xp11.4 | Congenital disorder of glycosylation type IIr | 301045 |
ATP6AP2 | chrX | Xp11.4 | Mental retardation X-linked syndromic Hedera type | 300423 |
ATP6AP2 | chrX | Xp11.4 | Parkinsonism with spasticity X-linked | 300911 |
ATP6V0A2 | chr12 | 12q24.3 | Wrinkly skin syndrome | 278250 |
ATP6V0A2 | chr12 | 12q24.3 | Cutis laxa autosomal recessive type IIA | 219200 |
ATP6V1B1 | chr2 | 2cen-q13 | Renal tubular acidosis with deafness | 267300 |
ATP7A | chrX | Xq12-q13 | Occipital horn syndrome | 304150 |
ATP7A | chrX | Xq12-q13 | Menkes disease | 309400 |
ATP7A | chrX | Xq12-q13 | Spinal muscular atrophy distal X-linked 3 | 300489 |
ATP7B | chr13 | 13q14.3-q21.1 | Wilson disease | 277900 |
ATP8A2 | chr13 | 13q12 | Cerebellar ataxia mental retardation and dysequilibrium syndrome 4 | 615268 |
ATP8B1 | chr18 | 18q21 | Cholestasis progressive familial intrahepatic 1 | 211600 |
ATP8B1 | chr18 | 18q21 | Cholestasis benign recurrent intrahepatic | 243300 |
ATPAF2 | chr17 | 17p11.2 | Mitochondrial complex V (ATP synthase) deficiency nuclear type 1 | 604273 |
ATR | chr3 | 3q22-q24 | Seckel syndrome 1 | 210600 |
ATRX | chrX | Xq13 | Mental retardation-hypotonic facies syndrome X-linked | 309580 |
AUH | chr9 | 9q22.31 | 3-methylglutaconic aciduria type I | 250950 |
AURKC | chr19 | 19q13.43 | Spermatogenic failure 5 | 243060 |
AVPR2 | chrX | Xq28 | Nephrogenic syndrome of inappropriate antidiuresis | 300539 |
AVPR2 | chrX | Xq28 | Diabetes insipidus nephrogenic | 304800 |
B2M | chr15 | 15q21-q22 | Immunodeficiency 43 | 241600 |
B3GALNT2 | chr1 | 1q42.3 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies type A 11 | 615181 |
B3GALT6 | chr1 | 1p36.3 | Ehlers-Danlos syndrome spondylodysplastic type 2 | 615349 |
B3GALT6 | chr1 | 1p36.3 | Spondyloepimetaphyseal dysplasia with joint laxity type 1 with or without fractures | 271640 |
B3GAT3 | chr11 | 11q12-q13 | Multiple joint dislocations short stature craniofacial dysmorphism with or without congenital heart defects | 245600 |
B3GLCT | chr13 | 13q12.3 | Peters-plus syndrome | 261540 |
B4GALNT1 | chr12 | 12q13.3 | Spastic paraplegia 26 autosomal recessive | 609195 |
B4GALT1 | chr9 | 9p13 | Congenital disorder of glycosylation type IId | 607091 |
B4GALT7 | chr5 | 5q35.2-q35.3 | Ehlers-Danlos syndrome spondylodysplastic type 1 | 130070 |
B4GAT1 | chr11 | 11q13.2 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A 13 | 615287 |
B9D1 | chr17 | 17p11.2 | Meckel syndrome 9 | 614209 |
B9D1 | chr17 | 17p11.2 | Joubert syndrome 27 | 617120 |
B9D2 | chr19 | 19q13.2 | Joubert syndrome 34 | 614175 |
B9D2 | chr19 | 19q13.2 | Meckel syndrome 10 | 614175 |
BAAT | chr9 | 9q22.3 | Hypercholanemia familial | 607748 |
BANF1 | chr11 | 11q13.1 | Nestor-Guillermo progeria syndrome | 614008 |
BBIP1 | chr10 | 10q25.2 | Bardet-Biedl syndrome 18 | 615995 |
BBS1 | chr11 | 11q13 | Bardet-Biedl syndrome 1 | 209900 |
BBS10 | chr12 | 12q21.2 | Bardet-Biedl syndrome 10 | 615987 |
BBS12 | chr4 | 4q27 | Bardet-Biedl syndrome 12 | 615989 |
BBS2 | chr16 | 16q21 | Bardet-Biedl syndrome 2 | 615981 |
BBS2 | chr16 | 16q21 | Retinitis pigmentosa 74 | 616562 |
BBS4 | chr15 | 15q22.3-q23 | Bardet-Biedl syndrome 4 | 615982 |
BBS5 | chr2 | 2q31 | Bardet-Biedl syndrome 5 | 615983 |
BBS7 | chr4 | 4q27 | Bardet-Biedl syndrome 7 | 615984 |
BBS9 | chr7 | 7p14 | Bardet-Biedl syndrome 9 | 615986 |
BCAM | chr19 | 19q13.2 | Blood group Lutheran null | 247420 |
BCAP31 | chrX | Xq28 | Deafness dystonia and cerebral hypomyelination | 300475 |
BCAT2 | chr19 | 19q13 | Hypervalinemia or hyperleucine-isoleucinemia | 618850 |
BCKDHA | chr19 | 19q13.1-q13.2 | Maple syrup urine disease type Ia | 248600 |
BCKDHB | chr6 | 6q14 | Maple syrup urine disease type Ib | 248600 |
BCL10 | chr1 | 1p22 | Immunodeficiency 37 | 616098 |
BCORL1 | chrX | Xq25-q26.1 | Shukla-Vernon syndrome | 301029 |
BCS1L | chr2 | 2q33 | Leigh syndrome | 256000 |
BCS1L | chr2 | 2q33 | GRACILE syndrome | 603358 |
BCS1L | chr2 | 2q33 | Bjornstad syndrome | 262000 |
BCS1L | chr2 | 2q33 | Mitochondrial complex III deficiency nuclear type 1 | 124000 |
BDP1 | chr5 | 5q13 | Deafness autosomal recessive 112 | 618257 |
BEST1 | chr11 | 11q13 | Bestrophinopathy autosomal recessive | 611809 |
BFSP1 | chr20 | 20p12.1-p11.23 | Cataract 33 multiple types | 611391 |
BGN | chrX | Xq28 | Meester-Loeys syndrome | 300989 |
BGN | chrX | Xq28 | Spondyloepimetaphyseal dysplasia X-linked | 300106 |
BHLHA9 | chr17 | 17p13.3 | Syndactyly mesoaxial synostotic with phalangeal reduction | 609432 |
BHLHA9 | chr17 | 17p13.3 | Camptosynpolydactyly complex | 607539 |
BIN1 | chr2 | 2q14 | Centronuclear myopathy 2 | 255200 |
BLM | chr15 | 15q26.1 | Bloom syndrome | 210900 |
BLNK | chr10 | 10q23.2 | Agammaglobulinemia 4 | 613502 |
BLOC1S3 | chr19 | 19q13 | Hermansky-Pudlak syndrome 8 | 614077 |
BLOC1S6 | chr15 | 15q15 | Hermansky-pudlak syndrome 9 | 614171 |
BLVRA | chr7 | 7p13 | Hyperbiliverdinemia | 614156 |
BMP1 | chr8 | 8p21 | Osteogenesis imperfecta type XIII | 614856 |
BMP2 | chr20 | 20p12 | HFE hemochromatosis modifier of | 235200 |
BMPER | chr7 | 7p14.3 | Diaphanospondylodysostosis | 608022 |
BMPR1B | chr4 | 4q23-q24 | Acromesomelic dysplasia Demirhan type | 609441 |
BOLA3 | chr2 | 2p13.1 | Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia | 614299 |
BPGM | chr7 | 7q31-q34 | Erythrocytosis familial 8 | 222800 |
BRAT1 | chr7 | 7p22.3 | Rigidity and multifocal seizure syndrome lethal neonatal | 614498 |
BRAT1 | chr7 | 7p22.3 | Neurodevelopmental disorder with cerebellar atrophy and with or without seizures | 618056 |
BRF1 | chr14 | 14q32.33 | Cerebellofaciodental syndrome | 616202 |
BRWD3 | chrX | Xq13 | Mental retardation X-linked 93 | 300659 |
BSCL2 | chr11 | 11q13 | Lipodystrophy congenital generalized type 2 | 269700 |
BSCL2 | chr11 | 11q13 | Encephalopathy progressive with or without lipodystrophy | 615924 |
BSND | chr1 | 1p31 | Sensorineural deafness with mild renal dysfunction | 602522 |
BSND | chr1 | 1p31 | Bartter syndrome type 4a | 602522 |
BTD | chr3 | 3p25 | Biotinidase deficiency | 253260 |
BTK | chrX | Xq21.3-q22 | Isolated growth hormone deficiency type III with agammaglobulinemia | 307200 |
BTK | chrX | Xq21.3-q22 | Agammaglobulinemia X-linked 1 | 300755 |
BUB1B | chr15 | 15q15 | Mosaic variegated aneuploidy syndrome 1 | 257300 |
BVES | chr6 | 6q21 | Muscular dystrophy limb-girdle autosomal recessive 25 | 616812 |
C12orf4 | chr12 | 12p13.3 | Mental retardation autosomal recessive 66 | 618221 |
C12orf57 | chr12 | 12p13 | Temtamy syndrome | 218340 |
C12orf65 | chr12 | 12q24.31 | Spastic paraplegia 55 autosomal recessive | 615035 |
C12orf65 | chr12 | 12q24.31 | Combined oxidative phosphorylation deficiency 7 | 613559 |
C19orf12 | chr19 | 19q12 | Neurodegeneration with brain iron accumulation 4 | 614298 |
C19orf12 | chr19 | 19q12 | Spastic paraplegia 43 autosomal recessive | 615043 |
C1QA | chr1 | 1p36.3-p34.1 | C1q deficiency | 613652 |
C1QB | chr1 | 1p36.3-p34.1 | C1q deficiency | 613652 |
C1QC | chr1 | 1p36.3-p34.1 | C1q deficiency | 613652 |
C2 | chr6 | 6p21.3 | C2 deficiency | 217000 |
C2CD3 | chr11 | 11q13.4 | Orofaciodigital syndrome XIV | 615948 |
C3 | chr19 | 19p13.3-p13.2 | Hemolytic uremic syndrome atypical susceptibility to 5 | 612925 |
C3 | chr19 | 19p13.3-p13.2 | C3 deficiency | 613779 |
C4A | chr6 | 6p21.3 | C4a deficiency | 614380 |
C8A | chr1 | 1p32 | C8 deficiency type I | 613790 |
C8B | chr1 | 1p32 | C8 deficiency type II | 613789 |
C8orf37 | chr8 | 8q22.1 | Retinitis pigmentosa 64 | 614500 |
C8orf37 | chr8 | 8q22.1 | Bardet-Biedl syndrome 21 | 617406 |
C8orf37 | chr8 | 8q22.1 | Cone-rod dystrophy 16 | 614500 |
CA12 | chr15 | 15q22 | Hyperchlorhidrosis isolated | 143860 |
CA2 | chr8 | 8q22 | Osteopetrosis autosomal recessive 3 with renal tubular acidosis | 259730 |
CA5A | chr16 | 16q24.3 | Hyperammonemia due to carbonic anhydrase VA deficiency | 615751 |
CA8 | chr8 | 8q11-q12 | Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3 | 613227 |
CABP2 | chr11 | 11q13.1 | Deafness autosomal recessive 93 | 614899 |
CABP4 | chr11 | 11q13.1 | Cone-rod synaptic disorder congenital nonprogressive | 610427 |
CACNA1B | chr9 | 9q34 | Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements | 618497 |
CACNA1D | chr3 | 3p21.1 | Sinoatrial node dysfunction and deafness | 614896 |
CACNA1F | chrX | Xp11.23 | Cone-rod dystrophy X-linked 3 | 300476 |
CACNA1F | chrX | Xp11.23 | Night blindness congenital stationary (incomplete) 2A X-linked | 300071 |
CACNA1F | chrX | Xp11.23 | Aland Island eye disease | 300600 |
CACNA2D2 | chr3 | 3p21.3 | Cerebellar atrophy with seizures and variable developmental delay | 618501 |
CACNA2D4 | chr12 | 12p13.3 | Retinal cone dystrophy 4 | 610478 |
CALCRL | chr2 | 2q31-q32 | Lymphatic malformation 8 | 618773 |
CANT1 | chr17 | 17q25.3 | Desbuquois dysplasia 1 | 251450 |
CANT1 | chr17 | 17q25.3 | Epiphyseal dysplasia multiple 7 | 617719 |
CAPN1 | chr11 | 11q13 | Spastic paraplegia 76 autosomal recessive | 616907 |
CAPN3 | chr15 | 15q15.1-q21.1 | Muscular dystrophy limb-girdle autosomal recessive 1 | 253600 |
CARD11 | chr7 | 7p22 | Immunodeficiency 11A | 615206 |
CARD9 | chr9 | 9q34.3 | Candidiasis familial 2 autosomal recessive | 212050 |
CARS2 | chr13 | 13q34 | Combined oxidative phosphorylation deficiency 27 | 616672 |
CARTPT | chr5 | 5q13.2 | Obesity susceptibility to | 601665 |
CASP8 | chr2 | 2q33 | Autoimmune lymphoproliferative syndrome type IIB | 607271 |
CASQ2 | chr1 | 1p13.3-p11 | Ventricular tachycardia catecholaminergic polymorphic 2 | 611938 |
CASR | chr3 | 3q21.1 | Hyperparathyroidism neonatal | 239200 |
CAST | chr5 | 5q15-q21 | Peeling skin with leukonychia acral punctate keratoses cheilitis and knuckle pads | 616295 |
CATSPER1 | chr11 | 11q13.1 | Spermatogenic failure 7 | 612997 |
CAV1 | chr7 | 7q31.1 | Lipodystrophy congenital generalized type 3 | 612526 |
CAVIN1 | chr17 | 17q21 | Lipodystrophy congenital generalized type 4 | 613327 |
CBS | chr21 | 21q22.3 | Homocystinuria B6-responsive and nonresponsive types | 236200 |
CBS | chr21 | 21q22.3 | Thrombosis hyperhomocysteinemic | 236200 |
CBX2 | chr17 | 17q25 | 46XY sex reversal 5 | 613080 |
CC2D1A | chr19 | 19p13.12 | Mental retardation autosomal recessive 3 | 608443 |
CC2D2A | chr4 | 4p15.3 | Meckel syndrome 6 | 612284 |
CC2D2A | chr4 | 4p15.3 | Joubert syndrome 9 | 612285 |
CC2D2A | chr4 | 4p15.3 | COACH syndrome | 216360 |
CCBE1 | chr18 | 18q21.32 | Hennekam lymphangiectasia-lymphedema syndrome 1 | 235510 |
CCDC103 | chr17 | 17q21.31 | Ciliary dyskinesia primary 17 | 614679 |
CCDC114 | chr19 | 19q13.3 | Ciliary dyskinesia primary 20 | 615067 |
CCDC151 | chr19 | 19p13.2 | Ciliary dyskinesia primary 30 | 616037 |
CCDC22 | chrX | Xp11.23 | Ritscher-Schinzel syndrome 2 | 300963 |
CCDC28B | chr1 | 1p35.1 | Bardet-Biedl syndrome 1 modifier of | 209900 |
CCDC65 | chr12 | 12q13.12 | Ciliary dyskinesia primary 27 | 615504 |
CCDC8 | chr19 | 19q13.2-q13.32 | 3-M syndrome 3 | 614205 |
CCDC88C | chr14 | 14q32.11 | Hydrocephalus congenital 1 | 236600 |
CCNO | chr5 | 5q11.2 | Ciliary dyskinesia primary 29 | 615872 |
CCT5 | chr5 | 5p15.2 | Neuropathy hereditary sensory with spastic paraplegia | 256840 |
CD19 | chr16 | 16p11.2 | Immunodeficiency common variable 3 | 613493 |
CD247 | chr1 | 1q22-q23 | Immunodeficiency 25 | 610163 |
CD27 | chr12 | 12p13 | Lymphoproliferative syndrome 2 | 615122 |
CD36 | chr7 | 7q21.11 | Platelet glycoprotein IV deficiency | 608404 |
CD3D | chr11 | 11q23 | Immunodeficiency 19 | 615617 |
CD3E | chr11 | 11q23 | Immunodeficiency 18 SCID variant | 615615 |
CD3E | chr11 | 11q23 | Immunodeficiency 18 | 615615 |
CD3G | chr11 | 11q23 | Immunodeficiency 17 CD3 gamma deficient | 615607 |
CD40 | chr20 | 20q12-q13.2 | Immunodeficiency with hyper-IgM type 3 | 606843 |
CD40LG | chrX | Xq26 | Immunodeficiency X-linked with hyper-IgM | 308230 |
CD46 | chr1 | 1q32 | Hemolytic uremic syndrome atypical susceptibility to 2 | 612922 |
CD55 | chr1 | 1q32 | Blood group Cromer | 613793 |
CD55 | chr1 | 1q32 | Complement hyperactivation angiopathic thrombosis and protein-losing enteropathy | 226300 |
CD59 | chr11 | 11p13 | Hemolytic anemia CD59-mediated with or without immune-mediated polyneuropathy | 612300 |
CD79A | chr19 | 19q13.2 | Agammaglobulinemia 3 | 613501 |
CD79B | chr17 | 17q23 | Agammaglobulinemia 6 | 612692 |
CD81 | chr11 | 11p | Immunodeficiency common variable 6 | 613496 |
CD8A | chr2 | 2p12 | CD8 deficiency familial | 608957 |
CDAN1 | chr15 | 15q15 | Dyserythropoietic anemia congenital type Ia | 224120 |
CDC6 | chr17 | 17q21.2 | Meier-Gorlin syndrome 5 | 613805 |
CDH23 | chr10 | 10q21-q22 | Pituitary adenoma 5 multiple types | 617540 |
CDH23 | chr10 | 10q21-q22 | Deafness autosomal recessive 12 | 601386 |
CDH23 | chr10 | 10q21-q22 | Usher syndrome type 1D/F digenic | 601067 |
CDH23 | chr10 | 10q21-q22 | Usher syndrome type 1D | 601067 |
CDH3 | chr16 | 16q22.1 | Ectodermal dysplasia ectrodactyly and macular dystrophy | 225280 |
CDH3 | chr16 | 16q22.1 | Hypotrichosis congenital with juvenile macular dystrophy | 601553 |
CDHR1 | chr10 | 10q23.1 | Cone-rod dystrophy 15 | 613660 |
CDHR1 | chr10 | 10q23.1 | Retinitis pigmentosa 65 | 613660 |
CDK5 | chr7 | 7q36 | Lissencephaly 7 with cerebellar hypoplasia | 616342 |
CDK5RAP2 | chr9 | 9q33.3 | Microcephaly 3 primary autosomal recessive | 604804 |
CDK6 | chr7 | 7q21-q22 | Microcephaly 12 primary autosomal recessive | 616080 |
CDSN | chr6 | 6p21.3 | Peeling skin syndrome 1 | 270300 |
CDT1 | chr16 | 16q24.3 | Meier-Gorlin syndrome 4 | 613804 |
CEACAM16 | chr19 | 19q13.31 | Deafness autosomal recessive 113 | 618410 |
CEBPE | chr14 | 14q11.2 | Specific granule deficiency | 245480 |
CENPE | chr4 | 4q24-q25 | Microcephaly 13 primary autosomal recessive | 616051 |
CENPJ | chr13 | 13q12.2 | Microcephaly 6 primary autosomal recessive | 608393 |
CENPJ | chr13 | 13q12.2 | Seckel syndrome 4 | 613676 |
CEP120 | chr5 | 5q23.2 | Joubert syndrome 31 | 617761 |
CEP120 | chr5 | 5q23.2 | Short-rib thoracic dysplasia 13 with or without polydactyly | 616300 |
CEP135 | chr4 | 4q12 | Microcephaly 8 primary autosomal recessive | 614673 |
CEP152 | chr15 | 15q21.1 | Microcephaly 9 primary autosomal recessive | 614852 |
CEP152 | chr15 | 15q21.1 | Seckel syndrome 5 | 613823 |
CEP164 | chr11 | 11q23.3 | Nephronophthisis 15 | 614845 |
CEP19 | chr3 | 3q29 | Morbid obesity and spermatogenic failure | 615703 |
CEP250 | chr20 | 20q11.2 | Cone-rod dystrophy and hearing loss 2 | 618358 |
CEP290 | chr12 | 12q21.3 | Bardet-Biedl syndrome 14 | 615991 |
CEP290 | chr12 | 12q21.3 | Senior-Loken syndrome 6 | 610189 |
CEP290 | chr12 | 12q21.3 | Meckel syndrome 4 | 611134 |
CEP290 | chr12 | 12q21.3 | Joubert syndrome 5 | 610188 |
CEP41 | chr7 | 7q32 | Joubert syndrome 15 | 614464 |
CEP57 | chr11 | 11q21 | Mosaic variegated aneuploidy syndrome 2 | 614114 |
CEP63 | chr3 | 3q22.2 | Seckel syndrome 6 | 614728 |
CEP83 | chr12 | 12q22 | Nephronophthisis 18 | 615862 |
CERS3 | chr15 | 15q26.3 | Ichthyosis congenital autosomal recessive 9 | 615023 |
CFAP53 | chr18 | 18q21.1 | Heterotaxy visceral 6 autosomal recessive | 614779 |
CFB | chr6 | 6p21.3 | Complement factor B deficiency | 615561 |
CFD | chr19 | 19p13.3 | Complement factor D deficiency | 613912 |
CFH | chr1 | 1q32 | Complement factor H deficiency | 609814 |
CFH | chr1 | 1q32 | Hemolytic uremic syndrome atypical susceptibility to 1 | 235400 |
CFHR1 | chr1 | 1q31-q32.1 | Hemolytic uremic syndrome atypical susceptibility to | 235400 |
CFHR3 | chr1 | 1q31-q32.1 | Hemolytic uremic syndrome atypical susceptibility to | 235400 |
CFI | chr4 | 4q25 | Complement factor I deficiency | 610984 |
CFL2 | chr14 | 14q12 | Nemaline myopathy 7 autosomal recessive | 610687 |
CFP | chrX | Xp11.4-p11.23 | Properdin deficiency X-linked | 312060 |
CFTR | chr7 | 7q31.2 | Cystic fibrosis | 219700 |
CFTR | chr7 | 7q31.2 | Congenital bilateral absence of vas deferens | 277180 |
CHAT | chr10 | 10q11.2 | Myasthenic syndrome congenital 6 presynaptic | 254210 |
CHIT1 | chr1 | 1q31-q32 | Chitotriosidase deficiency | 614122 |
CHKB | chr22 | 22q13 | Muscular dystrophy congenital megaconial type | 602541 |
CHMP1A | chr16 | 16q24.3 | Pontocerebellar hypoplasia type 8 | 614961 |
CHRDL1 | chrX | Xq22.1-q23 | Megalocornea 1 X-linked | 309300 |
CHRM3 | chr1 | 1q43 | Prune belly syndrome | 100100 |
CHRNA1 | chr2 | 2q24-q32 | Myasthenic syndrome congenital 1B fast-channel | 608930 |
CHRNA1 | chr2 | 2q24-q32 | Multiple pterygium syndrome lethal type | 253290 |
CHRNA3 | chr15 | 15q25.1 | Bladder dysfunction autonomic with impaired pupillary reflex and secondary CAKUT | 191800 |
CHRNB1 | chr17 | 17p12-p11 | Myasthenic syndrome congenital 2C associated with acetylcholine receptor deficiency | 616314 |
CHRND | chr2 | 2q33-q34 | Myasthenic syndrome congenital 3C associated with acetylcholine receptor deficiency | 616323 |
CHRND | chr2 | 2q33-q34 | Myasthenic syndrome congenital 3B fast-channel | 616322 |
CHRND | chr2 | 2q33-q34 | Multiple pterygium syndrome lethal type | 253290 |
CHRNE | chr17 | 17p13-p12 | Myasthenic syndrome congenital 4A slow-channel | 605809 |
CHRNE | chr17 | 17p13-p12 | Myasthenic syndrome congenital 4C associated with acetylcholine receptor deficiency | 608931 |
CHRNE | chr17 | 17p13-p12 | Myasthenic syndrome congenital 4B fast-channel | 616324 |
CHRNG | chr2 | 2q33-q34 | Escobar syndrome | 265000 |
CHRNG | chr2 | 2q33-q34 | Multiple pterygium syndrome lethal type | 253290 |
CHST14 | chr15 | 15q14 | Ehlers-Danlos syndrome musculocontractural type 1 | 601776 |
CHST3 | chr10 | 10q22.1 | Spondyloepiphyseal dysplasia with congenital joint dislocations | 143095 |
CHST6 | chr16 | 16q22 | Macular corneal dystrophy | 217800 |
CHST8 | chr19 | 19q13.1 | Peeling skin syndrome 3 | 616265 |
CHSY1 | chr15 | 15q26.3 | Temtamy preaxial brachydactyly syndrome | 605282 |
CIB2 | chr15 | 15q24 | Deafness autosomal recessive 48 | 609439 |
CIB2 | chr15 | 15q24 | Usher syndrome type IJ | 614869 |
CIDEC | chr3 | 3p25 | Lipodystrophy familial partial type 5 | 615238 |
CIITA | chr16 | 16p13 | Bare lymphocyte syndrome type II complementation group A | 209920 |
CISD2 | chr4 | 4q22-q24 | Wolfram syndrome 2 | 604928 |
CKAP2L | chr2 | 2q13 | Filippi syndrome | 272440 |
CLCF1 | chr11 | 11q13.3 | Cold-induced sweating syndrome 2 | 610313 |
CLCN1 | chr7 | 7q35 | Myotonia congenita recessive | 255700 |
CLCN2 | chr3 | 3q26 | Leukoencephalopathy with ataxia | 615651 |
CLCN5 | chrX | Xp11.22 | Proteinuria low molecular weight with hypercalciuric nephrocalcinosis | 308990 |
CLCN5 | chrX | Xp11.22 | Dent disease | 300009 |
CLCN5 | chrX | Xp11.22 | Hypophosphatemic rickets | 300554 |
CLCN5 | chrX | Xp11.22 | Nephrolithiasis type I | 310468 |
CLCN7 | chr16 | 16p13 | Osteopetrosis autosomal recessive 4 | 611490 |
CLCNKA | chr1 | 1p36 | Bartter syndrome type 4b digenic | 613090 |
CLCNKB | chr1 | 1p36 | Bartter syndrome type 3 | 607364 |
CLCNKB | chr1 | 1p36 | Bartter syndrome type 4b digenic | 613090 |
CLDN1 | chr3 | 3q28-q29 | Ichthyosis leukocyte vacuoles alopecia and sclerosing cholangitis | 607626 |
CLDN14 | chr21 | 21q22.3 | Deafness autosomal recessive 29 | 614035 |
CLDN16 | chr3 | 3q27 | Hypomagnesemia 3 renal | 248250 |
CLDN19 | chr1 | 1p34.2 | Hypomagnesemia 5 renal with ocular involvement | 248190 |
CLEC7A | chr12 | 12p13.2-p12.3 | Candidiasis familial 4 autosomal recessive | 613108 |
CLIC2 | chrX | Xq28 | Mental retardation X-linked syndromic 32 | 300886 |
CLIC5 | chr6 | 6p21.1-p12.1 | Deafness autosomal recessive 103 | 616042 |
CLMP | chr11 | 11q24.1 | Congenital short bowel syndrome | 615237 |
CLN3 | chr16 | 16p12.1 | Ceroid lipofuscinosis neuronal 3 | 204200 |
CLN5 | chr13 | 13q22.3 | Ceroid lipofuscinosis neuronal 5 | 256731 |
CLN6 | chr15 | 15q21-q23 | Ceroid lipofuscinosis neuronal Kufs type adult onset | 204300 |
CLN6 | chr15 | 15q21-q23 | Ceroid lipofuscinosis neuronal 6 | 601780 |
CLN8 | chr8 | 8p23 | Ceroid lipofuscinosis neuronal 8 | 600143 |
CLN8 | chr8 | 8p23 | Ceroid lipofuscinosis neuronal 8 Northern epilepsy variant | 610003 |
CLP1 | chr11 | 11q12.1 | Pontocerebellar hypoplasia type 10 | 615803 |
CLPB | chr11 | 11q13.4 | 3-methylglutaconic aciduria type VII with cataracts neurologic involvement and neutropenia | 616271 |
CLPP | chr19 | 19p13.3 | Perrault syndrome 3 | 614129 |
CLRN1 | chr3 | 3q21-q25 | Usher syndrome type 3A | 276902 |
CNGA3 | chr2 | 2q11 | Achromatopsia 2 | 216900 |
CNGB1 | chr16 | 16q21 | Retinitis pigmentosa 45 | 613767 |
CNGB3 | chr8 | 8q21-q22 | Achromatopsia 3 | 262300 |
CNNM2 | chr10 | 10q24.33 | Hypomagnesemia seizures and mental retardation | 616418 |
CNNM4 | chr2 | 2q11.2 | Jalili syndrome | 217080 |
CNPY3 | chr6 | 6pter-p12 | Epileptic encephalopathy early infantile 60 | 617929 |
CNTN1 | chr12 | 12q11-q12 | Myopathy congenital Compton-North | 612540 |
CNTN2 | chr1 | 1q32.1 | Epilepsy myoclonic familial adult 5 | 615400 |
CNTNAP1 | chr17 | 17q21 | Lethal congenital contracture syndrome 7 | 616286 |
CNTNAP1 | chr17 | 17q21 | Hypomyelinating neuropathy congenital 3 | 618186 |
CNTNAP2 | chr7 | 7q35-q36 | Pitt-Hopkins like syndrome 1 | 610042 |
CNTNAP2 | chr7 | 7q35-q36 | Cortical dysplasia-focal epilepsy syndrome | 610042 |
COA5 | chr2 | 2q11.2 | Cardioencephalomyopathy fatal infantile due to cytochrome c oxidase deficiency 3 | 616500 |
COA6 | chr1 | 1q42.2 | Cardioencephalomyopathy fatal infantile due to cytochrome c oxidase deficiency 4 | 616501 |
COASY | chr17 | 17q12-q21 | Neurodegeneration with brain iron accumulation 6 | 615643 |
COASY | chr17 | 17q12-q21 | Pontocerebellar hypoplasia type 12 | 618266 |
COCH | chr14 | 14q12-q13 | Deafness autosomal recessive 110 | 618094 |
COG1 | chr17 | 17q25.1 | Congenital disorder of glycosylation type IIg | 611209 |
COG2 | chr1 | 1q42.2 | Congenital disorder of glycosylation type IIq | 617395 |
COG4 | chr16 | 16q22.1 | Congenital disorder of glycosylation type IIj | 613489 |
COG5 | chr7 | 7q31 | Congenital disorder of glycosylation type IIi | 613612 |
COG6 | chr13 | 13q13.3 | Congenital disorder of glycosylation type IIl | 614576 |
COG6 | chr13 | 13q13.3 | Shaheen syndrome | 615328 |
COG7 | chr16 | 16p | Congenital disorder of glycosylation type IIe | 608779 |
COL11A1 | chr1 | 1p21 | Fibrochondrogenesis 1 | 228520 |
COL11A2 | chr6 | 6p21.3 | Otospondylomegaepiphyseal dysplasia autosomal recessive | 215150 |
COL11A2 | chr6 | 6p21.3 | Fibrochondrogenesis 2 | 614524 |
COL11A2 | chr6 | 6p21.3 | Deafness autosomal recessive 53 | 609706 |
COL17A1 | chr10 | 10q24.3 | Epidermolysis bullosa junctional non-Herlitz type | 226650 |
COL17A1 | chr10 | 10q24.3 | Epidermolysis bullosa junctional localisata variant | 226650 |
COL18A1 | chr21 | 21q22.3 | Knobloch syndrome type 1 | 267750 |
COL1A2 | chr7 | 7q22.1 | Ehlers-Danlos syndrome cardiac valvular type | 225320 |
COL25A1 | chr4 | 4q25 | Fibrosis of extraocular muscles congenital 5 | 616219 |
COL27A1 | chr9 | 9q32 | Steel syndrome | 615155 |
COL3A1 | chr2 | 2q32.2 | Ehlers-Danlos syndrome vascular type | 130050 |
COL3A1 | chr2 | 2q32.2 | Polymicrogyria with or without vascular-type EDS | 618343 |
COL4A3 | chr2 | 2q36-q37 | Alport syndrome 2 autosomal recessive | 203780 |
COL4A4 | chr2 | 2q36-q37 | Alport syndrome 2 autosomal recessive | 203780 |
COL4A6 | chrX | Xq22.3 | Deafness X-linked 6 | 300914 |
COL6A1 | chr21 | 21q22.3 | Ullrich congenital muscular dystrophy 1 | 254090 |
COL6A1 | chr21 | 21q22.3 | Bethlem myopathy 1 | 158810 |
COL6A2 | chr21 | 21q22.3 | Bethlem myopathy 1 | 158810 |
COL6A2 | chr21 | 21q22.3 | Ullrich congenital muscular dystrophy 1 | 254090 |
COL6A2 | chr21 | 21q22.3 | Myosclerosis congenital | 255600 |
COL6A3 | chr2 | 2q37 | Bethlem myopathy 1 | 158810 |
COL6A3 | chr2 | 2q37 | Dystonia 27 | 616411 |
COL6A3 | chr2 | 2q37 | Ullrich congenital muscular dystrophy 1 | 254090 |
COL7A1 | chr3 | 3p21.3 | EBD inversa | 226600 |
COL7A1 | chr3 | 3p21.3 | Epidermolysis bullosa dystrophica AR | 226600 |
COL7A1 | chr3 | 3p21.3 | Transient bullous of the newborn | 131705 |
COL7A1 | chr3 | 3p21.3 | Epidermolysis bullosa pruriginosa | 604129 |
COL7A1 | chr3 | 3p21.3 | Epidermolysis bullosa pretibial | 131850 |
COL9A2 | chr1 | 1p34.2 | Stickler syndrome type V | 614284 |
COLEC11 | chr2 | 2p25.3 | 3MC syndrome 2 | 265050 |
COLQ | chr3 | 3p25 | Myasthenic syndrome congenital 5 | 603034 |
COQ2 | chr4 | 4q21-q22 | Multiple system atrophy susceptibility to | 146500 |
COQ2 | chr4 | 4q21-q22 | Coenzyme Q10 deficiency primary 1 | 607426 |
COQ4 | chr9 | 9q34.13 | Coenzyme Q10 deficiency primary 7 | 616276 |
COQ6 | chr14 | 14q24.3 | Coenzyme Q10 deficiency primary 6 | 614650 |
COQ8A | chr1 | 1q42.2 | Coenzyme Q10 deficiency primary 4 | 612016 |
COQ8B | chr19 | 19q13.1 | Nephrotic syndrome type 9 | 615573 |
COQ9 | chr16 | 16q13 | Coenzyme Q10 deficiency primary 5 | 614654 |
CORO1A | chr16 | 16p11.2 | Immunodeficiency 8 | 615401 |
COX10 | chr17 | 17p12-p11.2 | Mitochondrial complex IV deficiency | 220110 |
COX10 | chr17 | 17p12-p11.2 | Leigh syndrome due to mitochondrial COX4 deficiency | 256000 |
COX14 | chr12 | 12q13.12 | Mitochondrial complex IV deficiency | 220110 |
COX15 | chr10 | 10q24 | Cardioencephalomyopathy fatal infantile due to cytochrome c oxidase deficiency 2 | 615119 |
COX15 | chr10 | 10q24 | Leigh syndrome due to cytochrome c oxidase deficiency | 256000 |
COX20 | chr1 | 1q44 | Mitochondrial complex IV deficiency | 220110 |
COX4I2 | chr20 | 20q11.21 | Exocrine pancreatic insufficiency dyserythropoietic anemia and calvarial hyperostosis | 612714 |
COX6A1 | chr12 | 12q24.2 | Charcot-Marie-Tooth disease recessive intermediate D | 616039 |
COX6B1 | chr19 | 19q13.1 | Mitochondrial complex IV deficiency | 220110 |
CP | chr3 | 3q23-q24 | Hypoceruloplasminemia hereditary | 604290 |
CP | chr3 | 3q23-q24 | Hemosiderosis systemic due to aceruloplasminemia | 604290 |
CP | chr3 | 3q23-q24 | Cerebellar ataxia | 604290 |
CPA6 | chr8 | 8q13 | Febrile seizures familial 11 | 614418 |
CPA6 | chr8 | 8q13 | Epilepsy familial temporal lobe 5 | 614417 |
CPN1 | chr10 | 10q24.2 | Carboxypeptidase N deficiency | 212070 |
CPOX | chr3 | 3q12 | Harderoporphyria | 618892 |
CPOX | chr3 | 3q12 | Coproporphyria | 121300 |
CPS1 | chr2 | 2q35 | Carbamoylphosphate synthetase I deficiency | 237300 |
CPT1A | chr11 | 11q13 | CPT deficiency hepatic type IA | 255120 |
CPT2 | chr1 | 1p32 | CPT II deficiency myopathic stress-induced | 255110 |
CPT2 | chr1 | 1p32 | CPT II deficiency infantile | 600649 |
CPT2 | chr1 | 1p32 | CPT II deficiency lethal neonatal | 608836 |
CPT2 | chr1 | 1p32 | Encephalopathy acute infection-induced 4 susceptibility to | 614212 |
CR2 | chr1 | 1q32 | Immunodeficiency common variable 7 | 614699 |
CRADD | chr12 | 12q21.33-q23.1 | Mental retardation autosomal recessive 34 with variant lissencephaly | 614499 |
CRAT | chr9 | 9q34.1 | Neurodegeneration with brain iron accumulation 8 | 617917 |
CRB1 | chr1 | 1q31-q32.1 | Retinitis pigmentosa-12 | 600105 |
CRB1 | chr1 | 1q31-q32.1 | Leber congenital amaurosis 8 | 613835 |
CRB2 | chr9 | 9q33.3 | Ventriculomegaly with cystic kidney disease | 219730 |
CRB2 | chr9 | 9q33.3 | Focal segmental glomerulosclerosis 9 | 616220 |
CRBN | chr3 | 3p26.2 | Mental retardation autosomal recessive 2 | 607417 |
CREB3L1 | chr11 | 11p11.2 | Osteogenesis imperfecta type XVI | 616229 |
CRIPT | chr2 | 2p21 | Short stature with microcephaly and distinctive facies | 615789 |
CRLF1 | chr19 | 19p12 | Cold-induced sweating syndrome 1 | 272430 |
CRTAP | chr3 | 3p22 | Osteogenesis imperfecta type VII | 610682 |
CRYAA | chr21 | 21q22.3 | Cataract 9 multiple types | 604219 |
CRYAB | chr11 | 11q22.3-q23.1 | Myopathy myofibrillar 2 | 608810 |
CRYAB | chr11 | 11q22.3-q23.1 | Cardiomyopathy dilated 1II | 615184 |
CRYAB | chr11 | 11q22.3-q23.1 | Myopathy myofibrillar fatal infantile hypertonic alpha-B crystallin-related | 613869 |
CRYAB | chr11 | 11q22.3-q23.1 | Cataract 16 multiple types | 613763 |
CRYBB1 | chr22 | 22q11.2-q12.1 | Cataract 17 multiple types | 611544 |
CRYBB3 | chr22 | 22q11.2-q12.2 | Cataract 22 | 609741 |
CSF1R | chr5 | 5q32 | Brain abnormalities neurodegeneration and dysosteosclerosis | 618476 |
CSF2RB | chr22 | 22q12.2-q13.1 | Surfactant metabolism dysfunction pulmonary 5 | 614370 |
CSF3R | chr1 | 1p35-p34.3 | Neutropenia severe congenital 7 autosomal recessive | 617014 |
CSGALNAC T1 | chr8 | 8p21.3 | Skeletal dysplasia mild with joint laxity and advanced bone age | 618870 |
CSPP1 | chr8 | 8q13.2 | Joubert syndrome 21 | 615636 |
CST6 | chr11 | 11q13 | Ectodermal dysplasia 15 hypohidrotic/hair type | 618535 |
CSTA | chr3 | 3q21 | Peeling skin syndrome 4 | 607936 |
CSTB | chr21 | 21q22.3 | Epilepsy progressive myoclonic 1A (Unverricht and Lundborg) | 254800 |
CTC1 | chr17 | 17p13.1 | Cerebroretinal microangiopathy with calcifications and cysts | 612199 |
CTDP1 | chr18 | 18q23 | Congenital cataracts facial dysmorphism and neuropathy | 604168 |
CTH | chr1 | 1p31.1 | Cystathioninuria | 219500 |
CTNNA2 | chr2 | 2p12-p11.1 | Cortical dysplasia complex with other brain malformations 9 | 618174 |
CTNS | chr17 | 17p13 | Cystinosis nephropathic | 219800 |
CTNS | chr17 | 17p13 | Cystinosis ocular nonnephropathic | 219750 |
CTNS | chr17 | 17p13 | Cystinosis late-onset juvenile or adolescent nephropathic | 219900 |
CTNS | chr17 | 17p13 | Cystinosis atypical nephropathic | 219800 |
CTPS1 | chr1 | 1p34.1 | Immunodeficiency 24 | 615897 |
CTSA | chr20 | 20q13.1 | Galactosialidosis | 256540 |
CTSC | chr11 | 11q14.1-q14.3 | Periodontitis 1 juvenile | 170650 |
CTSC | chr11 | 11q14.1-q14.3 | Papillon-Lefevre syndrome | 245000 |
CTSC | chr11 | 11q14.1-q14.3 | Haim-Munk syndrome | 245010 |
CTSD | chr11 | 11p15.5 | Ceroid lipofuscinosis neuronal 10 | 610127 |
CTSF | chr11 | 11q13.1 | Ceroid lipofuscinosis neuronal 13 Kufs type | 615362 |
CTSK | chr1 | 1q21 | Pycnodysostosis | 265800 |
CUBN | chr10 | 10p12.1 | Proteinuria chronic benign | 618884 |
CUBN | chr10 | 10p12.1 | Imerslund-Grasbeck syndrome 1 | 261100 |
CUL4B | chrX | Xq23 | Mental retardation X-linked syndromic 15 (Cabezas type) | 300354 |
CUL7 | chr6 | 6p21.1 | 3-M syndrome 1 | 273750 |
CWF19L1 | chr10 | 10q24.31 | Spinocerebellar ataxia autosomal recessive 17 | 616127 |
CYB5A | chr18 | 18q23 | Methemoglobinemia and ambiguous genitalia | 250790 |
CYB5R3 | chr22 | 22q13.31-qter | Methemoglobinemia type I | 250800 |
CYB5R3 | chr22 | 22q13.31-qter | Methemoglobinemia type II | 250800 |
CYBA | chr16 | 16q24 | Chronic granulomatous disease 4 autosomal recessive | 233690 |
CYBB | chrX | Xp21.1 | Immunodeficiency 34 mycobacteriosis X-linked | 300645 |
CYBB | chrX | Xp21.1 | Chronic granulomatous disease X-linked | 306400 |
CYC1 | chr8 | 8q24.3 | Mitochondrial complex III deficiency nuclear type 6 | 615453 |
CYP11B1 | chr8 | 8q21 | Adrenal hyperplasia congenital due to 11-beta- hydroxylase deficiency | 202010 |
CYP11B2 | chr8 | 8q21 | Hypoaldosteronism congenital due to CMO II deficiency | 610600 |
CYP11B2 | chr8 | 8q21 | Hypoaldosteronism congenital due to CMO I deficiency | 203400 |
CYP17A1 | chr10 | 10q24.3 | 17-alpha-hydroxylase/1720-lyase deficiency | 202110 |
CYP17A1 | chr10 | 10q24.3 | 1720-lyase deficiency isolated | 202110 |
CYP1B1 | chr2 | 2p22-p21 | Glaucoma 3A primary open angle congenital juvenile or adult onset | 231300 |
CYP21A2 | chr6 | 6p21.3 | Adrenal hyperplasia congenital due to 21-hydroxylase deficiency | 201910 |
CYP21A2 | chr6 | 6p21.3 | Hyperandrogenism nonclassic type due to 21- hydroxylase deficiency | 201910 |
CYP24A1 | chr20 | 20q13.2-q13.3 | Hypercalcemia infantile 1 | 143880 |
CYP26C1 | chr10 | 10q23.3 | Focal facial dermal dysplasia 4 | 614974 |
CYP27A1 | chr2 | 2q33-qter | Cerebrotendinous xanthomatosis | 213700 |
CYP27B1 | chr12 | 12q13.1-q13.3 | Vitamin D-dependent rickets type I | 264700 |
CYP2C19 | chr10 | 10q24.1-q24.3 | Clopidogrel impaired responsiveness to | 609535 |
CYP2C19 | chr10 | 10q24.1-q24.3 | Mephenytoin poor metabolizer | 609535 |
CYP2C19 | chr10 | 10q24.1-q24.3 | Proguanil poor metabolizer | 609535 |
CYP2C19 | chr10 | 10q24.1-q24.3 | Omeprazole poor metabolizer | 609535 |
CYP2D6 | chr22 | 22q13.1 | Debrisoquine sensitivity | 608902 |
CYP2D6 | chr22 | 22q13.1 | Codeine sensitivity | 608902 |
CYP2R1 | chr11 | 11p15.2 | Rickets due to defect in vitamin D 25-hydroxylation | 600081 |
CYP2U1 | chr4 | 4q25 | Spastic paraplegia 56 autosomal recessive | 615030 |
CYP4F22 | chr19 | 19p13.12 | Ichthyosis congenital autosomal recessive 5 | 604777 |
CYP4V2 | chr4 | 4q35.1 | Bietti crystalline corneoretinal dystrophy | 210370 |
CYP7B1 | chr8 | 8q21.3 | Spastic paraplegia 5A autosomal recessive | 270800 |
CYP7B1 | chr8 | 8q21.3 | Bile acid synthesis defect congenital 3 | 613812 |
D2HGDH | chr2 | 2q37.3 | D-2-hydroxyglutaric aciduria | 600721 |
DAG1 | chr3 | 3p21 | Muscular dystrophy-dystroglycanopathy (limb-girdle) type C 9 | 613818 |
DAG1 | chr3 | 3p21 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A 9 | 616538 |
DARS2 | chr1 | 1q25.1 | Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation | 611105 |
DBH | chr9 | 9q34 | Orthostatic hypotension 1 due to DBH deficiency | 223360 |
DBT | chr1 | 1p31 | Maple syrup urine disease type II | 248600 |
DCAF17 | chr2 | 2q22.3-q35 | Woodhouse-Sakati syndrome | 241080 |
DCC | chr18 | 18q21.3 | Gaze palsy familial horizontal with progressive scoliosis 2 | 617542 |
DCDC2 | chr6 | 6p22.1 | Sclerosing cholangitis neonatal | 617394 |
DCDC2 | chr6 | 6p22.1 | Nephronophthisis 19 | 616217 |
DCDC2 | chr6 | 6p22.1 | Deafness autosomal recessive 66 | 610212 |
DCHS1 | chr11 | 11p15.4 | Van Maldergem syndrome 1 | 601390 |
DCLRE1C | chr10 | 10p | Omenn syndrome | 603554 |
DCLRE1C | chr10 | 10p | Severe combined immunodeficiency Athabascan type | 602450 |
DCPS | chr11 | 11q24.2 | Al-Raqad syndrome | 616459 |
DCTN1 | chr2 | 2p13 | Amyotrophic lateral sclerosis susceptibility to | 105400 |
DCXR | chr17 | 17q25.3 | Pentosuria | 260800 |
DDB2 | chr11 | 11p12-p11 | Xeroderma pigmentosum group E DDB-negative subtype | 278740 |
DDC | chr7 | 7p11 | Aromatic L-amino acid decarboxylase deficiency | 608643 |
DDHD1 | chr14 | 14q22.1 | Spastic paraplegia 28 autosomal recessive | 609340 |
DDHD2 | chr8 | 8p11.23 | Spastic paraplegia 54 autosomal recessive | 615033 |
DDOST | chr1 | 1p36.1 | Congenital disorder of glycosylation type Ir | 614507 |
DDR2 | chr1 | 1q12-qter | Spondylometaepiphyseal dysplasia short limb-hand type | 271665 |
DDRGK1 | chr20 | 20p13 | Spondyloepimetaphyseal dysplasia Shohat type | 602557 |
DDX11 | chr12 | 12p11 | Warsaw breakage syndrome | 613398 |
DDX3X | chrX | Xp11.3-p11.23 | Intellectual developmental disorder X-linked syndrome Snijders Blok type | 300958 |
DDX59 | chr1 | 1q32.1 | Orofaciodigital syndrome V | 174300 |
DEAF1 | chr11 | 11p15.5 | Neurodevelopmental disorder with hypotonia impaired expressive language and with or without seizures | 617171 |
DENND5A | chr11 | 11p15.4 | Epileptic encephalopathy early infantile 49 | 617281 |
DES | chr2 | 2q35 | Myopathy myofibrillar 1 | 601419 |
DGAT1 | chr8 | 8q24.3 | Diarrhea 7 protein-losing enteropathy type | 615863 |
DGKE | chr17 | 17q22 | Hemolytic uremic syndrome atypical susceptibility to 7 | 615008 |
DGKE | chr17 | 17q22 | Nephrotic syndrome type 7 | 615008 |
DGUOK | chr2 | 2p13 | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive 4 | 617070 |
DGUOK | chr2 | 2p13 | Portal hypertension noncirrhotic | 617068 |
DGUOK | chr2 | 2p13 | Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) | 251880 |
DHCR24 | chr1 | 1p33-p31.1 | Desmosterolosis | 602398 |
DHCR7 | chr11 | 11q12-q13 | Smith-Lemli-Opitz syndrome | 270400 |
DHDDS | chr1 | 1p36.11 | Retinitis pigmentosa 59 | 613861 |
DHDDS | chr1 | 1p36.11 | Congenital disorder of glycosylation type 1bb | 613861 |
DHFR | chr5 | 5q11.2-q13.2 | Megaloblastic anemia due to dihydrofolate reductase deficiency | 613839 |
DHH | chr12 | 12q13.1 | 46XY sex reversal 7 | 233420 |
DHODH | chr16 | 16q22 | Miller syndrome | 263750 |
DHTKD1 | chr10 | 10p14 | 2-aminoadipic 2-oxoadipic aciduria | 204750 |
DHX37 | chr12 | 12q24.31 | Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies | 618731 |
DHX38 | chr16 | 16q21-q22 | Retinitis pigmentosa 84 | 618220 |
DIAPH1 | chr5 | 5q31 | Seizures cortical blindness microcephaly syndrome | 616632 |
DIS3L2 | chr2 | 2q37.2 | Perlman syndrome | 267000 |
DKC1 | chrX | Xq28 | Dyskeratosis congenita X-linked | 305000 |
DLAT | chr11 | 11q23.1 | Pyruvate dehydrogenase E2 deficiency | 245348 |
DLD | chr7 | 7q31-q32 | Dihydrolipoamide dehydrogenase deficiency | 246900 |
DLG3 | chrX | Xq13.1 | Mental retardation X-linked 90 | 300850 |
DLL3 | chr19 | 19q13 | Spondylocostal dysostosis 1 autosomal recessive | 277300 |
DLX5 | chr7 | 7q22 | Split-hand/foot malformation 1 with sensorineural hearing loss | 220600 |
DMD | chrX | Xp21.2 | Cardiomyopathy dilated 3B | 302045 |
DMD | chrX | Xp21.2 | Becker muscular dystrophy | 300376 |
DMD | chrX | Xp21.2 | Duchenne muscular dystrophy | 310200 |
DMGDH | chr5 | 5q12.2-q12.3 | Dimethylglycine dehydrogenase deficiency | 605850 |
DMP1 | chr4 | 4q21 | Hypophosphatemic rickets AR | 241520 |
DMXL2 | chr15 | 15q21.2 | Polyendocrine-polyneuropathy syndrome | 616113 |
DMXL2 | chr15 | 15q21.2 | Epileptic encephalopathy early infantile 81 | 618663 |
DNA2 | chr10 | 10q21.3-q22.1 | Seckel syndrome 8 | 615807 |
DNAAF1 | chr16 | 16q24.1 | Ciliary dyskinesia primary 13 | 613193 |
DNAAF3 | chr19 | 19q13.4 | Ciliary dyskinesia primary 2 | 606763 |
DNAAF4 | chr15 | 15q21 | Ciliary dyskinesia primary 25 | 615482 |
DNAAF5 | chr7 | 7p22.3 | Ciliary dyskinesia primary 18 | 614874 |
DNAH1 | chr3 | 3p21.3 | Ciliary dyskinesia primary 37 | 617577 |
DNAH1 | chr3 | 3p21.3 | Spermatogenic failure 18 | 617576 |
DNAH11 | chr7 | 7p21 | Ciliary dyskinesia primary 7 with or without situs inversus | 611884 |
DNAH9 | chr17 | 17p12 | Ciliary dyskinesia primary 40 | 618300 |
DNAI1 | chr9 | 9p13.3 | Ciliary dyskinesia primary 1 with or without situs inversus | 244400 |
DNAJB2 | chr2 | 2q35 | Spinal muscular atrophy distal autosomal recessive 5 | 614881 |
DNAJC19 | chr3 | 3q26.3 | 3-methylglutaconic aciduria type V | 610198 |
DNAJC3 | chr13 | 13q32 | Ataxia combined cerebellar and peripheral with hearing loss and diabetes mellitus | 616192 |
DNAJC6 | chr1 | 1p32.1-p31.3 | Parkinson disease 19b early-onset | 615528 |
DNAJC6 | chr1 | 1p32.1-p31.3 | Parkinson disease 19a juvenile-onset | 615528 |
DNAL1 | chr14 | 14q24.3 | Ciliary dyskinesia primary 16 | 614017 |
DNAL4 | chr22 | 22q13.1 | Mirror movements 3 | 616059 |
DNASE1L3 | chr3 | 3p21.1-p14.3 | Systemic lupus erythematosus 16 | 614420 |
DNM1L | chr12 | 12p11.21 | Encephalopathy lethal due to defective mitochondrial peroxisomal fission 1 | 614388 |
DNM2 | chr19 | 19p13.2 | Lethal congenital contracture syndrome 5 | 615368 |
DNMT3B | chr20 | 20q11.2 | Immunodeficiency-centromeric instability-facial anomalies syndrome 1 | 242860 |
DOCK3 | chr3 | 3p14 | Neurodevelopmental disorder with impaired intellectual development hypotonia and ataxia | 618292 |
DOCK6 | chr19 | 19p13.2 | Adams-Oliver syndrome 2 | 614219 |
DOCK7 | chr1 | 1p31.3 | Epileptic encephalopathy early infantile 23 | 615859 |
DOCK8 | chr9 | 9p24 | Hyper-IgE recurrent infection syndrome autosomal recessive | 243700 |
DOK7 | chr4 | 4p16.2 | Fetal akinesia deformation sequence 3 | 618389 |
DOK7 | chr4 | 4p16.2 | Myasthenic syndrome congenital 10 | 254300 |
DOLK | chr9 | 9q34.11 | Congenital disorder of glycosylation type Im | 610768 |
DPAGT1 | chr11 | 11q23.3 | Congenital disorder of glycosylation type Ij | 608093 |
DPAGT1 | chr11 | 11q23.3 | Myasthenic syndrome congenital 13 with tubular aggregates | 614750 |
DPH1 | chr17 | 17p13.3 | Developmental delay with short stature dysmorphic facial features and sparse hair | 616901 |
DPM1 | chr20 | 20q13.13 | Congenital disorder of glycosylation type Ie | 608799 |
DPM2 | chr9 | 9q34.11 | Congenital disorder of glycosylation type Iu | 615042 |
DPM3 | chr1 | 1q12-q21 | Muscular dystrophy-dystroglycanopathy (limb-girdle) type C 15 | 612937 |
DPY19L2 | chr12 | 12q14.2 | Spermatogenic failure 9 | 613958 |
DPYD | chr1 | 1p22 | Dihydropyrimidine dehydrogenase deficiency | 274270 |
DPYD | chr1 | 1p22 | 5-fluorouracil toxicity | 274270 |
DPYS | chr8 | 8q22 | Dihydropyrimidinuria | 222748 |
DRC1 | chr2 | 2p23.3 | Ciliary dyskinesia primary 21 | 615294 |
DSC2 | chr18 | 18q12.1 | Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair | 610476 |
DSC2 | chr18 | 18q12.1 | Arrhythmogenic right ventricular dysplasia 11 | 610476 |
DSC3 | chr18 | 18q12.1 | Hypotrichosis and recurrent skin vesicles | 613102 |
DSE | chr6 | 6q22 | Ehlers-Danlos syndrome musculocontractural type 2 | 615539 |
DSG1 | chr18 | 18q12.1-q12.2 | Erythroderma congenital with palmoplantar keratoderma hypotrichosis and hyper IgE | 615508 |
DSG4 | chr18 | 18q12 | Hypotrichosis 6 | 607903 |
DSP | chr6 | 6p24 | Epidermolysis bullosa lethal acantholytic | 609638 |
DSP | chr6 | 6p24 | Cardiomyopathy dilated with woolly hair and keratoderma | 605676 |
DSP | chr6 | 6p24 | Skin fragility-woolly hair syndrome | 607655 |
DST | chr6 | 6p12-p11 | Neuropathy hereditary sensory and autonomic type VI | 614653 |
DST | chr6 | 6p12-p11 | Epidermolysis bullosa simplex autosomal recessive 2 | 615425 |
DSTYK | chr1 | 1q32.1 | Spastic paraplegia 23 | 270750 |
DTNBP1 | chr6 | 6p22.3 | Hermansky-Pudlak syndrome 7 | 614076 |
DUOX2 | chr15 | 15q15.3 | Thyroid dyshormonogenesis 6 | 607200 |
DUOXA2 | chr15 | 15q15 | Thyroid dyshormonogenesis 5 | 274900 |
DYM | chr18 | 18q12-q21.1 | Smith-McCort dysplasia | 607326 |
DYM | chr18 | 18q12-q21.1 | Dyggve-Melchior-Clausen disease | 223800 |
DYNC2H1 | chr11 | 11q22.3 | Short-rib thoracic dysplasia 3 with or without polydactyly | 613091 |
DYSF | chr2 | 2p13.3-p13.1 | Miyoshi muscular dystrophy 1 | 254130 |
DYSF | chr2 | 2p13.3-p13.1 | Muscular dystrophy limb-girdle autosomal recessive 2 | 253601 |
DYSF | chr2 | 2p13.3-p13.1 | Myopathy distal with anterior tibial onset | 606768 |
EARS2 | chr16 | 16p13.1-p11.2 | Combined oxidative phosphorylation deficiency 12 | 614924 |
EBP | chrX | Xp11.23-p11.22 | MEND syndrome | 300960 |
ECEL1 | chr2 | 2q36-q37 | Arthrogryposis distal type 5D | 615065 |
ECHS1 | chr10 | 10q26.2-q26.3 | Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency | 616277 |
ECM1 | chr1 | 1q21 | Urbach-Wiethe disease | 247100 |
EDA | chrX | Xq12-q13.1 | Ectodermal dysplasia 1 hypohidrotic X-linked | 305100 |
EDAR | chr2 | 2q11-q13 | Ectodermal dysplasia 10B hypohidrotic/hair/tooth type autosomal recessive | 224900 |
EDARADD | chr1 | 1q42.2-q43 | Ectodermal dysplasia 11B hypohidrotic/hair/tooth type autosomal recessive | 614941 |
EDN1 | chr6 | 6p24-p23 | Auriculocondylar syndrome 3 | 615706 |
EDN3 | chr20 | 20q13.2-q13.3 | Waardenburg syndrome type 4B | 613265 |
EDNRB | chr13 | 13q22 | Waardenburg syndrome type 4A | 277580 |
EDNRB | chr13 | 13q22 | ABCD syndrome | 600501 |
EFEMP2 | chr11 | 11q13 | Cutis laxa autosomal recessive type IB | 614437 |
EGFR | chr7 | 7p12.3-p12.1 | Inflammatory skin and bowel disease neonatal 2 | 616069 |
EGR2 | chr10 | 10q21.1-q22.1 | Dejerine-Sottas disease | 145900 |
EGR2 | chr10 | 10q21.1-q22.1 | Hypomyelinating neuropathy congenital 1 | 605253 |
EIF2AK3 | chr2 | 2p12 | Wolcott-Rallison syndrome | 226980 |
EIF2AK4 | chr15 | 15q15.1 | Pulmonary venoocclusive disease 2 | 234810 |
EIF2B1 | chr12 | 12q24.31 | Leukoencephalopathy with vanishing white matter | 603896 |
EIF2B2 | chr14 | 14q24 | Ovarioleukodystrophy | 603896 |
EIF2B2 | chr14 | 14q24 | Leukoencephalopathy with vanishing white matter | 603896 |
EIF2B3 | chr1 | 1p34.1 | Leukoencephalopathy with vanishing white matter | 603896 |
EIF2B4 | chr2 | 2p23.3 | Leukoencephalopathy with vanishing white matter | 603896 |
EIF2B4 | chr2 | 2p23.3 | Ovarioleukodystrophy | 603896 |
EIF2B5 | chr3 | 3q27 | Leukoencephalopathy with vanishing white matter | 603896 |
EIF2B5 | chr3 | 3q27 | Ovarioleukodystrophy | 603896 |
EIF2S3 | chrX | Xp22.2-p22.1 | MEHMO syndrome | 300148 |
EIF4A3 | chr17 | 17q25.3 | Robin sequence with cleft mandible and limb anomalies | 268305 |
ELAC2 | chr17 | 17p11 | Combined oxidative phosphorylation deficiency 17 | 615440 |
ELMOD3 | chr2 | 2p11.3 | Deafness autosomal recessive 88 | 615429 |
ELOVL4 | chr6 | 6q14 | Ichthyosis spastic quadriplegia and mental retardation | 614457 |
ELP1 | chr9 | 9q31 | Dysautonomia familial | 223900 |
ELP2 | chr18 | 18q12.2 | Mental retardation autosomal recessive 58 | 617270 |
EMC1 | chr1 | 1p36.13 | Cerebellar atrophy visual impairment and psychomotor retardation | 616875 |
EMD | chrX | Xq28 | Emery-Dreifuss muscular dystrophy 1 X-linked | 310300 |
EMG1 | chr12 | 12p13 | Bowen-Conradi syndrome | 211180 |
EML1 | chr14 | 14q32 | Band heterotopia | 600348 |
EMP2 | chr16 | 16p13.2 | Nephrotic syndrome type 10 | 615861 |
ENAM | chr4 | 4q21 | Amelogenesis imperfecta type IC | 204650 |
ENO3 | chr17 | 17pter-p12 | Glycogen storage disease XIII | 612932 |
ENPP1 | chr6 | 6q22-q23 | Hypophosphatemic rickets autosomal recessive 2 | 613312 |
ENPP1 | chr6 | 6q22-q23 | Obesity susceptibility to | 601665 |
ENPP1 | chr6 | 6q22-q23 | Arterial calcification generalized of infancy 1 | 208000 |
ENTPD1 | chr10 | 10q24 | Spastic paraplegia 64 autosomal recessive | 615683 |
EOGT | chr3 | 3p14.1 | Adams-Oliver syndrome 4 | 615297 |
EPB41 | chr1 | 1p36.2-p34 | Elliptocytosis-1 | 611804 |
EPCAM | chr2 | 2p21 | Diarrhea 5 with tufting enteropathy congenital | 613217 |
EPG5 | chr18 | 18q12.3-q21.1 | Vici syndrome | 242840 |
EPHB2 | chr1 | 1p36.1-p35 | Bleeding disorder platelet-type 22 | 618462 |
EPHX1 | chr1 | 1q42.1 | Hypercholanemia familial | 607748 |
EPM2A | chr6 | 6q24 | Epilepsy progressive myoclonic 2A (Lafora) | 254780 |
EPO | chr7 | 7q21 | Diamond-Blackfan anemia-like | 617911 |
EPS8 | chr12 | 12p12.3 | Deafness autosomal recessive 102 | 615974 |
EPX | chr17 | 17q23.1 | Eosinophil peroxidase deficiency | 261500 |
ERBB3 | chr12 | 12q13 | Lethal congenital contractural syndrome 2 | 607598 |
ERCC1 | chr19 | 19q13.2-q13.3 | Cerebrooculofacioskeletal syndrome 4 | 610758 |
ERCC2 | chr19 | 19q13.2-q13.3 | Trichothiodystrophy 1 photosensitive | 601675 |
ERCC2 | chr19 | 19q13.2-q13.3 | Cerebrooculofacioskeletal syndrome 2 | 610756 |
ERCC2 | chr19 | 19q13.2-q13.3 | Xeroderma pigmentosum group D | 278730 |
ERCC3 | chr2 | 2q21 | Xeroderma pigmentosum group B | 610651 |
ERCC3 | chr2 | 2q21 | Trichothiodystrophy 2 photosensitive | 616390 |
ERCC4 | chr16 | 16p13.3-p13.13 | Xeroderma pigmentosum type F/Cockayne syndrome | 278760 |
ERCC4 | chr16 | 16p13.3-p13.13 | Fanconi anemia complementation group Q | 615272 |
ERCC4 | chr16 | 16p13.3-p13.13 | XFE progeroid syndrome | 610965 |
ERCC4 | chr16 | 16p13.3-p13.13 | Xeroderma pigmentosum group F | 278760 |
ERCC5 | chr13 | 13q33 | Xeroderma pigmentosum group G/Cockayne syndrome | 278780 |
ERCC5 | chr13 | 13q33 | Xeroderma pigmentosum group G | 278780 |
ERCC5 | chr13 | 13q33 | Cerebrooculofacioskeletal syndrome 3 | 616570 |
ERCC6 | chr10 | 10q11 | Cerebrooculofacioskeletal syndrome 1 | 214150 |
ERCC6 | chr10 | 10q11 | Cockayne syndrome type B | 133540 |
ERCC6 | chr10 | 10q11 | UV-sensitive syndrome 1 | 600630 |
ERCC6 | chr10 | 10q11 | De Sanctis-Cacchione syndrome | 278800 |
ERCC6L2 | chr9 | 9q22.32 | Bone marrow failure syndrome 2 | 615715 |
ERCC8 | chr5 | 5q12 | Cockayne syndrome type A | 216400 |
ERCC8 | chr5 | 5q12 | UV-sensitive syndrome 2 | 614621 |
ERLIN1 | chr10 | 10q24.31 | Spastic paraplegia 62 | 615681 |
ERLIN2 | chr8 | 8p11.2 | Spastic paraplegia 18 autosomal recessive | 611225 |
ESCO2 | chr8 | 8p21.1 | Roberts syndrome | 268300 |
ESCO2 | chr8 | 8p21.1 | SC phocomelia syndrome | 269000 |
ESPN | chr1 | 1p36.3-p36.1 | Usher syndrome type 1M | 618632 |
ESPN | chr1 | 1p36.3-p36.1 | Deafness autosomal recessive 36 | 609006 |
ESPN | chr1 | 1p36.3-p36.1 | Deafness neurosensory without vestibular involvement autosomal dominant | 609006 |
ESR1 | chr6 | 6q25.1 | Estrogen resistance | 615363 |
ESRRB | chr14 | 14q24.3 | Deafness autosomal recessive 35 | 608565 |
ETFA | chr15 | 15q23-q25 | Glutaric acidemia IIA | 231680 |
ETFB | chr19 | 19q13.3 | Glutaric acidemia IIB | 231680 |
ETFDH | chr4 | 4q32-qter | Glutaric acidemia IIC | 231680 |
ETHE1 | chr19 | 19q13.32 | Ethylmalonic encephalopathy | 602473 |
EVC | chr4 | 4p16 | Ellis-van Creveld syndrome | 225500 |
EVC2 | chr4 | 4p16 | Ellis-van Creveld syndrome | 225500 |
EXOC6B | chr2 | 2p13.2 | Spondyloepimetaphyseal dysplasia with joint laxity type 3 | 618395 |
EXOSC3 | chr9 | 9p13.2 | Pontocerebellar hypoplasia type 1B | 614678 |
EXOSC8 | chr13 | 13q13.1 | Pontocerebellar hypoplasia type 1C | 616081 |
EXPH5 | chr11 | 11q22.3 | Epidermolysis bullosa nonspecific autosomal recessive | 615028 |
EXT2 | chr11 | 11p12-p11 | Seizures scoliosis and macrocephaly syndrome | 616682 |
EXTL3 | chr8 | 8p21 | Immunoskeletal dysplasia with neurodevelopmental abnormalities | 617425 |
EYS | chr6 | 6q12 | Retinitis pigmentosa 25 | 602772 |
F10 | chr13 | 13q34 | Factor X deficiency | 227600 |
F11 | chr4 | 4q35 | Factor XI deficiency autosomal recessive | 612416 |
F12 | chr5 | 5q33-qter | Factor XII deficiency | 234000 |
F13A1 | chr6 | 6p25-p24 | Factor XIIIA deficiency | 613225 |
F13B | chr1 | 1q31-q32.1 | Factor XIIIB deficiency | 613235 |
F2 | chr11 | 11p11-q12 | Hypoprothrombinemia | 613679 |
F2 | chr11 | 11p11-q12 | Dysprothrombinemia | 613679 |
F5 | chr1 | 1q23 | Factor V deficiency | 227400 |
F5 | chr1 | 1q23 | Budd-Chiari syndrome | 600880 |
F7 | chr13 | 13q34 | Factor VII deficiency | 227500 |
F8 | chrX | Xq28 | Hemophilia A | 306700 |
F9 | chrX | Xq27.1-q27.2 | Hemophilia B | 306900 |
F9 | chrX | Xq27.1-q27.2 | Warfarin sensitivity | 301052 |
FA2H | chr16 | 16q23 | Spastic paraplegia 35 autosomal recessive | 612319 |
FADD | chr11 | 11q13.3 | Infections recurrent with encephalopathy hepatic dysfunction and cardiovascular malformations | 613759 |
FAH | chr15 | 15q23-q25 | Tyrosinemia type I | 276700 |
FAM126A | chr7 | 7p15.3 | Leukodystrophy hypomyelinating 5 | 610532 |
FAM20A | chr17 | 17q24.2 | Amelogenesis imperfecta type IG (enamel-renal syndrome) | 204690 |
FAM20C | chr7 | 7p22 | Raine syndrome | 259775 |
FAN1 | chr15 | 15q13.2-q13.3 | Interstitial nephritis karyomegalic | 614817 |
FANCA | chr16 | 16q24.3 | Fanconi anemia complementation group A | 227650 |
FANCB | chrX | Xp22.31 | Fanconi anemia complementation group B | 300514 |
FANCC | chr9 | 9q22.3 | Fanconi anemia complementation group C | 227645 |
FANCD2 | chr3 | 3p25.3 | Fanconi anemia complementation group D2 | 227646 |
FANCE | chr6 | 6p22-p21 | Fanconi anemia complementation group E | 600901 |
FANCI | chr15 | 15q25-q26 | Fanconi anemia complementation group I | 609053 |
FANCL | chr2 | 2p16.1 | Fanconi anemia complementation group L | 614083 |
FANCM | chr14 | 14q21.3 | Spermatogenic failure 28 | 618086 |
FANCM | chr14 | 14q21.3 | Premature ovarian failure 15 | 618096 |
FAR1 | chr11 | 11p15.2 | Peroxisomal fatty acyl-CoA reductase 1 disorder | 616154 |
FARS2 | chr6 | 6p25.1 | Spastic paraplegia 77 autosomal recessive | 617046 |
FARS2 | chr6 | 6p25.1 | Combined oxidative phosphorylation deficiency 14 | 614946 |
FASTKD2 | chr2 | 2q33.3 | Combined oxidative phosphorylation deficiency 44 | 618855 |
FAT4 | chr4 | 4q28.1 | Van Maldergem syndrome 2 | 615546 |
FAT4 | chr4 | 4q28.1 | Hennekam lymphangiectasia-lymphedema syndrome 2 | 616006 |
FBLN5 | chr14 | 14q32.1 | Macular degeneration age-related 3 | 608895 |
FBLN5 | chr14 | 14q32.1 | Cutis laxa autosomal dominant 2 | 614434 |
FBLN5 | chr14 | 14q32.1 | Neuropathy hereditary with or without age-related macular degeneration | 608895 |
FBLN5 | chr14 | 14q32.1 | Cutis laxa autosomal recessive type IA | 219100 |
FBP1 | chr9 | 9q22.2-q22.3 | Fructose-16-bisphosphatase deficiency | 229700 |
FBXL4 | chr6 | 6q16.1-q16.3 | Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type) | 615471 |
FBXO31 | chr16 | 16q24.3 | Mental retardation autosomal recessive 45 | 615979 |
FBXO7 | chr22 | 22q12-q13 | Parkinson disease 15 autosomal recessive | 260300 |
FCGR2A | chr1 | 1q21-q23 | Pseudomonas aeruginosa susceptibility to chronic infection by in cystic fibrosis | 219700 |
FCGR3A | chr1 | 1q23 | Immunodeficiency 20 | 615707 |
FCN3 | chr1 | 1p36.11 | Immunodeficiency due to ficolin 3 deficiency | 613860 |
FDFT1 | chr8 | 8p23.1-p22 | Squalene synthase deficiency | 618156 |
FECH | chr18 | 18q21.3 | Protoporphyria erythropoietic 1 | 177000 |
FERMT1 | chr20 | 20p13 | Kindler syndrome | 173650 |
FERMT3 | chr11 | 11q12 | Leukocyte adhesion deficiency type III | 612840 |
FEZF1 | chr7 | 7q31.32 | Hypogonadotropic hypogonadism 22 with or without anosmia | 616030 |
FGA | chr4 | 4q28 | Afibrinogenemia congenital | 202400 |
FGB | chr4 | 4q28 | Afibrinogenemia congenital | 202400 |
FGB | chr4 | 4q28 | Hypofibrinogenemia congenital | 202400 |
FGD1 | chrX | Xp11.21 | Mental retardation X-linked syndromic 16 | 305400 |
FGD1 | chrX | Xp11.21 | Aarskog-Scott syndrome | 305400 |
FGD4 | chr12 | 12p11.2 | Charcot-Marie-Tooth disease type 4H | 609311 |
FGF16 | chrX | Xq21.1 | Metacarpal 4-5 fusion | 309630 |
FGF20 | chr8 | 8p22-p21.3 | Renal hypodysplasia/aplasia 2 | 615721 |
FGF23 | chr12 | 12p13.3 | Tumoral calcinosis hyperphosphatemic familial 2 | 617993 |
FGF3 | chr11 | 11q13 | Deafness congenital with inner ear agenesis microtia and microdontia | 610706 |
FGF5 | chr4 | 4q21 | Trichomegaly | 190330 |
FGFR3 | chr4 | 4p16.3 | CATSHL syndrome | 610474 |
FGG | chr4 | 4q28 | Hypofibrinogenemia congenital | 202400 |
FH | chr1 | 1q42.1 | Fumarase deficiency | 606812 |
FHL1 | chrX | Xq27.2 | Reducing body myopathy X-linked 1b with late childhood or adult onset | 300718 |
FHL1 | chrX | Xq27.2 | Uruguay faciocardiomusculoskeletal syndrome | 300280 |
FHL1 | chrX | Xq27.2 | Emery-Dreifuss muscular dystrophy 6 X-linked | 300696 |
FHL1 | chrX | Xq27.2 | Myopathy X-linked with postural muscle atrophy | 300696 |
FIG4 | chr6 | 6q21 | Yunis-Varon syndrome | 216340 |
FIG4 | chr6 | 6q21 | Polymicrogyria bilateral temporooccipital | 612691 |
FIG4 | chr6 | 6q21 | Charcot-Marie-Tooth disease type 4J | 611228 |
FKBP10 | chr17 | 17q21.2 | Bruck syndrome 1 | 259450 |
FKBP10 | chr17 | 17q21.2 | Osteogenesis imperfecta type XI | 610968 |
FKBP14 | chr7 | 7p15.1 | Ehlers-Danlos syndrome kyphoscoliotic type 2 | 614557 |
FKRP | chr19 | 19q13.3 | Muscular dystrophy-dystroglycanopathy (limb-girdle) type C 5 | 607155 |
FKRP | chr19 | 19q13.3 | Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation) type B 5 | 606612 |
FKRP | chr19 | 19q13.3 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A 5 | 613153 |
FKTN | chr9 | 9q31 | Muscular dystrophy-dystroglycanopathy (limb-girdle) type C 4 | 611588 |
FKTN | chr9 | 9q31 | Cardiomyopathy dilated 1X | 611615 |
FKTN | chr9 | 9q31 | Muscular dystrophy-dystroglycanopathy (congenital without mental retardation) type B 4 | 613152 |
FKTN | chr9 | 9q31 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A 4 | 253800 |
FLG | chr1 | 1q21 | Ichthyosis vulgaris | 146700 |
FLI1 | chr11 | 11q24 | Bleeding disorder platelet-type 21 | 617443 |
FLNA | chrX | Xq28 | Congenital short bowel syndrome | 300048 |
FLNA | chrX | Xq28 | Intestinal pseudoobstruction neuronal | 300048 |
FLNA | chrX | Xq28 | Cardiac valvular dysplasia X-linked | 314400 |
FLNA | chrX | Xq28 | FG syndrome 2 | 300321 |
FLNA | chrX | Xq28 | Frontometaphyseal dysplasia 1 | 305620 |
FLNB | chr3 | 3p14.3 | Spondylocarpotarsal synostosis syndrome | 272460 |
FLVCR1 | chr1 | 1q31.3 | Ataxia posterior column with retinitis pigmentosa | 609033 |
FLVCR2 | chr14 | 14q24.3 | Proliferative vasculopathy and hydranencephaly- hydrocephaly syndrome | 225790 |
FMN2 | chr1 | 1q43 | Mental retardation autosomal recessive 47 | 616193 |
FMO3 | chr1 | 1q23-q25 | Trimethylaminuria | 602079 |
FOLR1 | chr11 | 11q13.3-q13.5 | Neurodegeneration due to cerebral folate transport deficiency | 613068 |
FOXE1 | chr9 | 9q22 | Bamforth-Lazarus syndrome | 241850 |
FOXE3 | chr1 | 1p32 | Anterior segment dysgenesis 2 multiple subtypes | 610256 |
FOXI1 | chr5 | 5q34 | Enlarged vestibular aqueduct | 600791 |
FOXL2 | chr3 | 3q23 | Blepharophimosis epicanthus inversus and ptosis type 2 | 110100 |
FOXL2 | chr3 | 3q23 | Blepharophimosis epicanthus inversus and ptosis type 1 | 110100 |
FOXN1 | chr17 | 17q11-q12 | T-cell immunodeficiency congenital alopecia and nail dystrophy | 601705 |
FOXP3 | chrX | Xp11.23-q13.3 | Immunodysregulation polyendocrinopathy and enteropathy X-linked | 304790 |
FOXRED1 | chr11 | 11q24.2 | Mitochondrial complex I deficiency nuclear type 19 | 618241 |
FRAS1 | chr4 | 4q21 | Fraser syndrome 1 | 219000 |
FREM1 | chr9 | 9p22.3 | Manitoba oculotrichoanal syndrome | 248450 |
FREM2 | chr13 | 13q13.3 | Fraser syndrome 2 | 617666 |
FREM2 | chr13 | 13q13.3 | Cryptophthalmos unilateral or bilateral isolated | 123570 |
FRRS1L | chr9 | 9q31.3 | Epileptic encephalopathy early infantile 37 | 616981 |
FSHB | chr11 | 11p13 | Hypogonadotropic hypogonadism 24 without anosmia | 229070 |
FSHR | chr2 | 2p21-p16 | Ovarian dysgenesis 1 | 233300 |
FSHR | chr2 | 2p21-p16 | Ovarian response to FSH stimulation | 276400 |
FTCD | chr21 | 21q22.3 | Glutamate formiminotransferase deficiency | 229100 |
FTL | chr19 | 19q13.3-q13.4 | Hyperferritinemia-cataract syndrome | 600886 |
FTL | chr19 | 19q13.3-q13.4 | Neurodegeneration with brain iron accumulation 3 | 606159 |
FTL | chr19 | 19q13.3-q13.4 | L-ferritin deficiency dominant and recessive | 615604 |
FTO | chr16 | 16q12.2 | Growth retardation developmental delay facial dysmorphism | 612938 |
FTO | chr16 | 16q12.2 | Obesity susceptibility to BMIQ14 | 612460 |
FTSJ1 | chrX | Xp11.23 | Mental retardation X-linked 9/44 | 309549 |
FUCA1 | chr1 | 1p34 | Fucosidosis | 230000 |
FUT1 | chr19 | 19q13.3 | Bombay phenotype | 616754 |
FUT2 | chr19 | 19q13.3 | Bombay phenotype digenic | 616754 |
FUT8 | chr14 | 14q23 | Congenital disorder of glycosylation with defective fucosylation 1 | 618005 |
FXN | chr9 | 9q13 | Friedreich ataxia with retained reflexes | 229300 |
FXN | chr9 | 9q13 | Friedreich ataxia | 229300 |
FYCO1 | chr3 | 3p21.3 | Cataract 18 autosomal recessive | 610019 |
FZD6 | chr8 | 8q22.3-q23.1 | Nail disorder nonsyndromic congenital 1 | 161050 |
G6PC | chr17 | 17q21 | Glycogen storage disease Ia | 232200 |
G6PC3 | chr17 | 17q21 | Dursun syndrome | 612541 |
G6PC3 | chr17 | 17q21 | Neutropenia severe congenital 4 autosomal recessive | 612541 |
GAA | chr17 | 17q25.2-q25.3 | Glycogen storage disease II | 232300 |
GAD1 | chr2 | 2q31 | Cerebral palsy spastic quadriplegic 1 | 603513 |
GALC | chr14 | 14q31 | Krabbe disease | 245200 |
GALE | chr1 | 1p36-p35 | Galactose epimerase deficiency | 230350 |
GALK1 | chr17 | 17q24 | Galactokinase deficiency with cataracts | 230200 |
GALNS | chr16 | 16q24.3 | Mucopolysaccharidosis IVA | 253000 |
GALNT2 | chr1 | 1q41-q42 | Congenital disorder of glycosylation type IIt | 618885 |
GALNT3 | chr2 | 2q24-q31 | Tumoral calcinosis hyperphosphatemic familial 1 | 211900 |
GALT | chr9 | 9p13 | Galactosemia | 230400 |
GAMT | chr19 | 19p13.3 | Cerebral creatine deficiency syndrome 2 | 612736 |
GAN | chr16 | 16q24.1 | Giant axonal neuropathy-1 | 256850 |
GAS2L2 | chr17 | 17q12 | Ciliary dyskinesia primary 41 | 618449 |
GATA1 | chrX | Xp11.23 | Anemia X-linked with/without neutropenia and/or platelet abnormalities | 300835 |
GATA1 | chrX | Xp11.23 | Thrombocytopenia X-linked with or without dyserythropoietic anemia | 300367 |
GATA1 | chrX | Xp11.23 | Thrombocytopenia with beta-thalassemia X-linked | 314050 |
GATA5 | chr20 | 20q13.2-q13.3 | Congenital heart defects multiple types 5 | 617912 |
GATAD1 | chr7 | 7q21.2 | Cardiomyopathy dilated 2B | 614672 |
GATM | chr15 | 15q21.1 | Cerebral creatine deficiency syndrome 3 | 612718 |
GBA | chr1 | 1q21 | Gaucher disease type III | 231000 |
GBA | chr1 | 1q21 | Gaucher disease type IIIC | 231005 |
GBA | chr1 | 1q21 | Gaucher disease type I | 230800 |
GBA | chr1 | 1q21 | Gaucher disease perinatal lethal | 608013 |
GBA | chr1 | 1q21 | Gaucher disease type II | 230900 |
GBA2 | chr9 | 9p13.3 | Spastic paraplegia 46 autosomal recessive | 614409 |
GBE1 | chr3 | 3p12 | Polyglucosan body disease adult form | 263570 |
GBE1 | chr3 | 3p12 | Glycogen storage disease IV | 232500 |
GCDH | chr19 | 19p13.2 | Glutaricaciduria type I | 231670 |
GCH1 | chr14 | 14q22.1-q22.2 | Hyperphenylalaninemia BH4-deficient B | 233910 |
GCH1 | chr14 | 14q22.1-q22.2 | Dystonia DOPA-responsive with or without hyperphenylalaninemia | 128230 |
GCK | chr7 | 7p15-p13 | Diabetes mellitus permanent neonatal 1 | 606176 |
GCLC | chr6 | 6p12 | Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency | 230450 |
GCNT2 | chr6 | 6p24-p23 | Cataract 13 with adult i phenotype | 116700 |
GCSH | chr16 | 16q24 | Glycine encephalopathy | 605899 |
GDAP1 | chr8 | 8q21.11 | Charcot-Marie-Tooth disease recessive intermediate A | 608340 |
GDAP1 | chr8 | 8q21.11 | Charcot-Marie-Tooth disease type 4A | 214400 |
GDAP1 | chr8 | 8q21.11 | Charcot-Marie-Tooth disease axonal type 2K | 607831 |
GDAP1 | chr8 | 8q21.11 | Charcot-Marie-Tooth disease axonal with vocal cord paresis | 607706 |
GDF1 | chr19 | 19p12 | Right atrial isomerism (Ivemark) | 208530 |
GDF5 | chr20 | 20q11.2 | Acromesomelic dysplasia Hunter-Thompson type | 201250 |
GDF5 | chr20 | 20q11.2 | Brachydactyly type A1 C | 615072 |
GDF5 | chr20 | 20q11.2 | Chondrodysplasia Grebe type | 200700 |
GDF5 | chr20 | 20q11.2 | Du Pan syndrome | 228900 |
GDF6 | chr8 | 8q22.1 | Leber congenital amaurosis 17 | 615360 |
GDF9 | chr5 | 5q31.1 | Premature ovarian failure 14 | 618014 |
GEMIN4 | chr17 | 17p13.3 | Neurodevelopmental disorder with microcephaly cataracts and renal abnormalities | 617913 |
GFI1B | chr9 | 9q34.13 | Bleeding disorder platelet-type 17 | 187900 |
GFM1 | chr3 | 3q25.32 | Combined oxidative phosphorylation deficiency 1 | 609060 |
GFM2 | chr5 | 5q13 | Combined oxidative phosphorylation deficiency 39 | 618397 |
GFPT1 | chr2 | 2p13 | Myasthenia congenital 12 with tubular aggregates | 610542 |
GGCX | chr2 | 2p12 | Vitamin K-dependent clotting factors combined deficiency of 1 | 277450 |
GH1 | chr17 | 17q22-q24 | Kowarski syndrome | 262650 |
GH1 | chr17 | 17q22-q24 | Growth hormone deficiency isolated type IA | 262400 |
GHR | chr5 | 5p13-p12 | Laron dwarfism | 262500 |
GHRHR | chr7 | 7p15-p14 | Growth hormone deficiency isolated type IV | 618157 |
GHRL | chr3 | 3p26-p25 | Obesity susceptibility to | 601665 |
GHSR | chr3 | 3q26.3 | Growth hormone deficiency isolated partial | 615925 |
GIPC3 | chr19 | 19p13.3 | Deafness autosomal recessive 15 | 601869 |
GJA1 | chr6 | 5q22.31 | Craniometaphyseal dysplasia autosomal recessive | 218400 |
GJA1 | chr6 | 5q22.31 | Oculodentodigital dysplasia autosomal recessive | 257850 |
GJA1 | chr6 | 5q22.31 | Hypoplastic left heart syndrome 1 | 241550 |
GJB2 | chr13 | 13q11-q12 | Deafness autosomal recessive 1A | 220290 |
GJB3 | chr1 | 1p35.1 | Deafness autosomal recessive | |
GJB3 | chr1 | 1p35.1 | Deafness digenic GJB2/GJB3 | 220290 |
GJB3 | chr1 | 1p35.1 | Erythrokeratodermia variabilis et progressiva 1 | 133200 |
GJB6 | chr13 | 13q12 | Deafness autosomal recessive 1B | 612645 |
GJB6 | chr13 | 13q12 | Deafness digenic GJB2/GJB6 | 220290 |
GJC2 | chr1 | 1q42.13 | Spastic paraplegia 44 autosomal recessive | 613206 |
GJC2 | chr1 | 1q42.13 | Leukodystrophy hypomyelinating 2 | 608804 |
GK | chrX | Xp21.3-p21.2 | Glycerol kinase deficiency | 307030 |
GLB1 | chr3 | 3p21.33 | GM1-gangliosidosis type III | 230650 |
GLB1 | chr3 | 3p21.33 | GM1-gangliosidosis type I | 230500 |
GLB1 | chr3 | 3p21.33 | Mucopolysaccharidosis type IVB (Morquio) | 253010 |
GLB1 | chr3 | 3p21.33 | GM1-gangliosidosis type II | 230600 |
GLDC | chr9 | 9p22 | Glycine encephalopathy | 605899 |
GLE1 | chr9 | 9q34 | Congenital arthrogryposis with anterior horn cell disease | 611890 |
GLE1 | chr9 | 9q34 | Lethal congenital contracture syndrome 1 | 253310 |
GLI1 | chr12 | 12q13.2-q13.3 | Polydactyly postaxial type A8 | 618123 |
GLI1 | chr12 | 12q13.2-q13.3 | Polydactyly preaxial I | 174400 |
GLIS3 | chr9 | 9p24.3-p23 | Diabetes mellitus neonatal with congenital hypothyroidism | 610199 |
GLRA1 | chr5 | 5q32 | Hyperekplexia 1 | 149400 |
GLRB | chr4 | 4q31.3 | Hyperekplexia 2 | 614619 |
GLRX5 | chr14 | 14q32 | Anemia sideroblastic 3 pyridoxine-refractory | 616860 |
GLRX5 | chr14 | 14q32 | Spasticity childhood-onset with hyperglycinemia | 616859 |
GLS | chr2 | 2q32-q34 | Global developmental delay progressive ataxia and elevated glutamine | 618412 |
GLS | chr2 | 2q32-q34 | Epileptic encephalopathy early infantile 71 | 618328 |
GLUL | chr1 | 1q31 | Glutamine deficiency congenital | 610015 |
GLYCTK | chr3 | 3p21 | D-glyceric aciduria | 220120 |
GM2A | chr5 | 5q31.3-q33.1 | GM2-gangliosidosis AB variant | 272750 |
GMPPA | chr2 | 2q35 | Alacrima achalasia and mental retardation syndrome | 615510 |
GMPPB | chr3 | 3p21.31 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A 14 | 615350 |
GMPPB | chr3 | 3p21.31 | Muscular dystrophy-dystroglycanopathy (congenital with mental retardation) type B 14 | 615351 |
GMPPB | chr3 | 3p21.31 | Muscular dystrophy-dystroglycanopathy (limb-girdle) type C 14 | 615352 |
GNAT1 | chr3 | 3p21 | Night blindness congenital stationary type 1G | 616389 |
GNB3 | chr12 | 12p13 | Night blindness congenital stationary type 1H | 617024 |
GNB5 | chr15 | 15q21.2 | Intellectual developmental disorder with cardiac arrhythmia | 617173 |
GNB5 | chr15 | 15q21.2 | Language delay and ADHD/cognitive impairment with or without cardiac arrhythmia | 617182 |
GNE | chr9 | 9p13.3 | Nonaka myopathy | 605820 |
GNMT | chr6 | 6p12 | Glycine N-methyltransferase deficiency | 606664 |
GNPAT | chr1 | 1q42 | Rhizomelic chondrodysplasia punctata type 2 | 222765 |
GNPTAB | chr12 | 12q23.3 | Mucolipidosis II alpha/beta | 252500 |
GNPTAB | chr12 | 12q23.3 | Mucolipidosis III alpha/beta | 252600 |
GNPTG | chr16 | 16p | Mucolipidosis III gamma | 252605 |
GNRH1 | chr8 | 8p21-p11.2 | Hypogonadotropic hypogonadism 12 with or without anosmia | 614841 |
GNRHR | chr4 | 4q21.2 | Hypogonadotropic hypogonadism 7 without anosmia | 146110 |
GNS | chr12 | 12q14 | Mucopolysaccharidosis type IIID | 252940 |
GORAB | chr1 | 1q24.2 | Geroderma osteodysplasticum | 231070 |
GOSR2 | chr17 | 17q21 | Epilepsy progressive myoclonic 6 | 614018 |
GP1BA | chr17 | 17pter-p12 | Bernard-Soulier syndrome type A1 (recessive) | 231200 |
GP1BA | chr17 | 17pter-p12 | Nonarteritic anterior ischemic optic neuropathy susceptibility to | 258660 |
GP1BB | chr22 | 22q11.2 | Giant platelet disorder isolated | 231200 |
GP1BB | chr22 | 22q11.2 | Bernard-Soulier syndrome type B | 231200 |
GP6 | chr19 | 19q13.4 | Bleeding disorder platelet-type 11 | 614201 |
GP9 | chr3 | 3q21 | Bernard-Soulier syndrome type C | 231200 |
GPC3 | chrX | Xq26 | Simpson-Golabi-Behmel syndrome type 1 | 312870 |
GPC4 | chrX | Xq26 | Keipert syndrome | 301026 |
GPC6 | chr13 | 13q32 | Omodysplasia 1 | 258315 |
GPD1 | chr12 | 12q12-q13 | Hypertriglyceridemia transient infantile | 614480 |
GPHN | chr14 | 14q24 | Molybdenum cofactor deficiency C | 615501 |
GPI | chr19 | 19q13.1 | Hemolytic anemia nonspherocytic due to glucose phosphate isomerase deficiency | 613470 |
GPIHBP1 | chr8 | 8q24.3 | Hyperlipoproteinemia type 1D | 615947 |
GPNMB | chr7 | 7p15.3 | Amyloidosis primary localized cutaneous 3 | 617920 |
GPR143 | chrX | Xp22.3 | Ocular albinism type I Nettleship-Falls type | 300500 |
GPR143 | chrX | Xp22.3 | Nystagmus 6 congenital X-linked | 300814 |
GPR179 | chr17 | 17q12 | Night blindness congenital stationary (complete) 1E autosomal recessive | 614565 |
GPR68 | chr14 | 14q31 | Amelogenesis imperfecta hypomaturation type IIA6 | 617217 |
GPSM2 | chr1 | 1p13.1 | Chudley-McCullough syndrome | 604213 |
GPT2 | chr16 | 16q12.1 | Mental retardation autosomal recessive 49 | 616281 |
GPX1 | chr3 | 3p21.3 | Hemolytic anemia due to glutathione peroxidase deficiency | 614164 |
GPX4 | chr19 | 19p13.3 | Spondylometaphyseal dysplasia Sedaghatian type | 250220 |
GRHL2 | chr8 | 8q22 | Ectodermal dysplasia/short stature syndrome | 616029 |
GRHPR | chr9 | 9cen | Hyperoxaluria primary type II | 260000 |
GRIA3 | chrX | Xq25-q26 | Mental retardation X-linked 94 | 300699 |
GRID2 | chr4 | 4q22 | Spinocerebellar ataxia autosomal recessive 18 | 616204 |
GRIK2 | chr6 | 6q21 | Mental retardation autosomal recessive 6 | 611092 |
GRIN1 | chr9 | 9q34.3 | Neurodevelopmental disorder with or without hyperkinetic movements and seizures autosomal recessive | 617820 |
GRIP1 | chr12 | 12q14.3 | Fraser syndrome 3 | 617667 |
GRM1 | chr6 | 6q24 | Spinocerebellar ataxia autosomal recessive 13 | 614831 |
GRM6 | chr5 | 5q35 | Night blindness congenital stationary (complete) 1B autosomal recessive | 257270 |
GRM7 | chr3 | 3p26.1 | Neurodevelopmental disorder with seizures hypotonia and brain imaging abnormalities | 618922 |
GRN | chr17 | 17q21.32 | Ceroid lipofuscinosis neuronal 11 | 614706 |
GRXCR1 | chr4 | 4p13 | Deafness autosomal recessive 25 | 613285 |
GRXCR2 | chr5 | 5q32 | Deafness autosomal recessive 101 | 615837 |
GSC | chr14 | 14q32.1 | Short stature auditory canal atresia mandibular hypoplasia skeletal abnormalities | 602471 |
GSR | chr8 | 8p21.1 | Hemolytic anemia due to glutathione reductase deficiency | 618660 |
GSS | chr20 | 20q11.2 | Glutathione synthetase deficiency | 266130 |
GSS | chr20 | 20q11.2 | Hemolytic anemia due to glutathione synthetase deficiency | 231900 |
GSTZ1 | chr14 | 14q24.3 | Maleylacetoacetate isomerase deficiency | 617596 |
GTPBP3 | chr19 | 19p13.11 | Combined oxidative phosphorylation deficiency 23 | 616198 |
GUCY2C | chr12 | 12p12 | Meconium ileus | 614665 |
GUCY2D | chr17 | 17p13.1 | Cone-rod dystrophy 6 | 601777 |
GUCY2D | chr17 | 17p13.1 | Leber congenital amaurosis 1 | 204000 |
GUCY2D | chr17 | 17p13.1 | Night blindness congenital stationary type 1I | 618555 |
GUSB | chr7 | 7q21.11 | Mucopolysaccharidosis VII | 253220 |
GYG1 | chr3 | 3q24-q25.1 | Glycogen storage disease XV | 613507 |
GYG1 | chr3 | 3q24-q25.1 | Polyglucosan body myopathy 2 | 616199 |
GYS1 | chr19 | 19q13.3 | Glycogen storage disease 0 muscle | 611556 |
GYS2 | chr12 | 12p12.2 | Glycogen storage disease 0 liver | 240600 |
H6PD | chr1 | 1p36 | Cortisone reductase deficiency 1 | 604931 |
HACE1 | chr6 | 6q21 | Spastic paraplegia and psychomotor retardation with or without seizures | 616756 |
HADH | chr4 | 4q22-q26 | 3-hydroxyacyl-CoA dehydrogenase deficiency | 231530 |
HADH | chr4 | 4q22-q26 | Hyperinsulinemic hypoglycemia familial 4 | 609975 |
HADHA | chr2 | 2p23 | LCHAD deficiency | 609016 |
HADHA | chr2 | 2p23 | HELLP syndrome maternal of pregnancy | 609016 |
HADHA | chr2 | 2p23 | Mitochondrial trifunctional protein deficiency | 609015 |
HADHA | chr2 | 2p23 | Fatty liver acute of pregnancy | 609016 |
HADHB | chr2 | 2p23 | Trifunctional protein deficiency | 609015 |
HAL | chr12 | 12q22-q23 | Histidinemia | 235800 |
HAMP | chr19 | 19q13 | Hemochromatosis type 2B | 613313 |
HARS2 | chr5 | 5q31.3 | Perrault syndrome 2 | 614926 |
HAX1 | chr1 | 1q21.3 | Neutropenia severe congenital 3 autosomal recessive | 610738 |
HBB | chr11 | 11p15.5 | Thalassemia beta | 613985 |
HBB | chr11 | 11p15.5 | Sickle cell anemia | 603903 |
HCFC1 | chrX | Xq28 | Mental retardation X-linked 3 (methylmalonic acidemia and homocysteinemia cblX type ) | 309541 |
HEPACAM | chr11 | 11q24 | Megalencephalic leukoencephalopathy with subcortical cysts 2A | 613925 |
HERC1 | chr15 | 15q22.31 | Macrocephaly dysmorphic facies and psychomotor retardation | 617011 |
HERC2 | chr15 | 15q13.1 | Skin/hair/eye pigmentation 1 blue/nonblue eyes | 227220 |
HERC2 | chr15 | 15q13.1 | Mental retardation autosomal recessive 38 | 615516 |
HERC2 | chr15 | 15q13.1 | Skin/hair/eye pigmentation 1 blond/brown hair | 227220 |
HES7 | chr17 | 17p13.2 | Spondylocostal dysostosis 4 autosomal recessive | 613686 |
HESX1 | chr3 | 3p21.2-p21.1 | Pituitary hormone deficiency combined 5 | 182230 |
HESX1 | chr3 | 3p21.2-p21.1 | Septooptic dysplasia | 182230 |
HESX1 | chr3 | 3p21.2-p21.1 | Growth hormone deficiency with pituitary anomalies | 182230 |
HEXA | chr15 | 15q23-q24 | GM2-gangliosidosis several forms | 272800 |
HEXA | chr15 | 15q23-q24 | Tay-Sachs disease | 272800 |
HEXA | chr15 | 15q23-q24 | Hex A pseudodeficiency | 272800 |
HEXB | chr5 | 5q13 | Sandhoff disease infantile juvenile and adult forms | 268800 |
HFE | chr6 | 6p21.3 | Porphyria cutanea tarda susceptibility to | 176100 |
HFE | chr6 | 6p21.3 | Hemochromatosis | 235200 |
HFM1 | chr1 | 1p22.2 | Premature ovarian failure 9 | 615724 |
HGD | chr3 | 3q13.33 | Alkaptonuria | 203500 |
HGF | chr7 | 7q21.1 | Deafness autosomal recessive 39 | 608265 |
HGSNAT | chr8 | 8p11.1 | Retinitis pigmentosa 73 | 616544 |
HGSNAT | chr8 | 8p11.1 | Mucopolysaccharidosis type IIIC (Sanfilippo C) | 252930 |
HIBCH | chr2 | 2q32.2 | 3-hydroxyisobutryl-CoA hydrolase deficiency | 250620 |
HINT1 | chr5 | 5q31.2 | Neuromyotonia and axonal neuropathy autosomal recessive | 137200 |
HK1 | chr10 | 10q22 | Hemolytic anemia due to hexokinase deficiency | 235700 |
HK1 | chr10 | 10q22 | Neuropathy hereditary motor and sensory Russe type | 605285 |
HK1 | chr10 | 10q22 | Neurodevelopmental disorder with visual defects and brain anomalies | 618547 |
HK1 | chr10 | 10q22 | Retinitis pigmentosa 79 | 617460 |
HLA-DQA1 | chr6 | 6p21.3 | Celiac disease susceptibility to | 212750 |
HLA-DQB1 | chr6 | 6p21.3 | Celiac disease susceptibility to | 212750 |
HLCS | chr21 | 21q22.1 | Holocarboxylase synthetase deficiency | 253270 |
HMGCL | chr1 | 1pter-p33 | HMG-CoA lyase deficiency | 246450 |
HMGCS2 | chr1 | 1p13-p12 | HMG-CoA synthase-2 deficiency | 605911 |
HMX1 | chr4 | 4p16.1 | Oculoauricular syndrome | 612109 |
HNF1A | chr12 | 12q24.2 | Diabetes mellitus insulin-dependent | 222100 |
HNMT | chr2 | 2q22 | Mental retardation autosomal recessive 51 | 616739 |
HOGA1 | chr10 | 10q24.2 | Hyperoxaluria primary type III | 613616 |
HOXA2 | chr7 | 7p15-p14 | Microtia with or without hearing impairment (AD) | 612290 |
HOXA2 | chr7 | 7p15-p14 | Microtia hearing impairment and cleft palate (AR) | 612290 |
HOXB1 | chr17 | 17q21-q22 | Facial paresis hereditary congenital 3 | 614744 |
HOXC13 | chr12 | 12q13 | Ectodermal dysplasia 9 hair/nail type | 614931 |
HPCA | chr1 | 1p35-p34.2 | Dystonia 2 torsion autosomal recessive | 224500 |
HPD | chr12 | 12q24-qter | Tyrosinemia type III | 276710 |
HPGD | chr4 | 4q34-q35 | Hypertrophic osteoarthropathy primary autosomal recessive 1 | 259100 |
HPGD | chr4 | 4q34-q35 | Digital clubbing isolated congenital | 119900 |
HPGD | chr4 | 4q34-q35 | Cranioosteoarthropathy | 259100 |
HPRT1 | chrX | Xq26.2 | HPRT-related gout | 300323 |
HPRT1 | chrX | Xq26.2 | Lesch-Nyhan syndrome | 300322 |
HPS1 | chr10 | 10q23.1 | Hermansky-Pudlak syndrome 1 | 203300 |
HPS3 | chr3 | 3q24 | Hermansky-Pudlak syndrome 3 | 614072 |
HPS4 | chr22 | 22q11.2-q12.2 | Hermansky-Pudlak syndrome 4 | 614073 |
HPS5 | chr11 | 11p15-p13 | Hermansky-Pudlak syndrome 5 | 614074 |
HPS6 | chr10 | 10q24.32 | Hermansky-Pudlak syndrome 6 | 614075 |
HPSE2 | chr10 | 10q23-q24 | Urofacial syndrome 1 | 236730 |
HR | chr8 | 8p21.2 | Alopecia universalis | 203655 |
HR | chr8 | 8p21.2 | Atrichia with papular lesions | 209500 |
HSD11B2 | chr16 | 16q22 | Apparent mineralocorticoid excess | 218030 |
HSD17B3 | chr9 | 9q22 | Pseudohermaphroditism male with gynecomastia | 264300 |
HSD17B4 | chr5 | 5q23.1 | D-bifunctional protein deficiency | 261515 |
HSD17B4 | chr5 | 5q23.1 | Perrault syndrome 1 | 233400 |
HSD3B2 | chr1 | 1p13.1 | Adrenal hyperplasia congenital due to 3-beta- hydroxysteroid dehydrogenase 2 deficiency | 201810 |
HSD3B7 | chr16 | 16p12-p11.2 | Bile acid synthesis defect congenital 1 | 607765 |
HSPA9 | chr5 | 5q31.2 | Even-plus syndrome | 616854 |
HSPD1 | chr2 | 2q33.1 | Leukodystrophy hypomyelinating 4 | 612233 |
HSPG2 | chr1 | 1p36.1 | Dyssegmental dysplasia Silverman-Handmaker type | 224410 |
HTRA1 | chr10 | 10q25.3-q26.2 | CARASIL syndrome | 600142 |
HTRA2 | chr2 | 2p12 | 3-methylglutaconic aciduria type VIII | 617248 |
HTT | chr4 | 4p16.3 | Lopes-Maciel-Rodan syndrome | 617435 |
HYAL1 | chr3 | 3p21.3-p21.2 | Mucopolysaccharidosis type IX | 601492 |
HYDIN | chr16 | 16q22.2 | Ciliary dyskinesia primary 5 | 608647 |
HYLS1 | chr11 | 11q24.2 | Hydrolethalus syndrome | 236680 |
IARS2 | chr1 | 1q41 | Cataracts growth hormone deficiency sensory neuropathy sensorineural hearing loss and skeletal dysplasia | 616007 |
IBA57 | chr1 | 1q42.13 | Spastic paraplegia 74 autosomal recessive | 616451 |
IBA57 | chr1 | 1q42.13 | Multiple mitochondrial dysfunctions syndrome 3 | 615330 |
ICOS | chr2 | 2q33 | Immunodeficiency common variable 1 | 607594 |
IDS | chrX | Xq28 | Mucopolysaccharidosis II | 309900 |
IDUA | chr4 | 4p16.3 | Mucopolysaccharidosis Ih/s | 607015 |
IDUA | chr4 | 4p16.3 | Mucopolysaccharidosis Ih | 607014 |
IDUA | chr4 | 4p16.3 | Mucopolysaccharidosis Is | 607016 |
IER3IP1 | chr18 | 18q21.1 | Microcephaly epilepsy and diabetes syndrome | 614231 |
IFNAR2 | chr21 | 21q22.1 | Immunodeficiency 45 | 616669 |
IFNG | chr12 | 12q14 | Immunodeficiency 69 mycobacteriosis | 618963 |
IFNGR1 | chr6 | 6q23.3 | Immunodeficiency 27A mycobacteriosis AR | 209950 |
IFNGR2 | chr21 | 21q22.1-q22.2 | Immunodeficiency 28 mycobacteriosis | 614889 |
IFT122 | chr3 | 3q21 | Cranioectodermal dysplasia 1 | 218330 |
IFT140 | chr16 | 16p13.3 | Retinitis pigmentosa 80 | 617781 |
IFT140 | chr16 | 16p13.3 | Short-rib thoracic dysplasia 9 with or without polydactyly | 266920 |
IFT172 | chr2 | 2p23.3 | Retinitis pigmentosa 71 | 616394 |
IFT172 | chr2 | 2p23.3 | Short-rib thoracic dysplasia 10 with or without polydactyly | 615630 |
IFT27 | chr22 | 22q12.3 | Bardet-Biedl syndrome 19 | 615996 |
IFT43 | chr14 | 14q24.3 | Cranioectodermal dysplasia 3 | 614099 |
IFT43 | chr14 | 14q24.3 | Short-rib thoracic dysplasia 18 with polydactyly | 617866 |
IFT43 | chr14 | 14q24.3 | Retinitis pigmentosa 81 | 617871 |
IFT80 | chr3 | 3q25.33 | Short-rib thoracic dysplasia 2 with or without polydactyly | 611263 |
IGBP1 | chrX | Xq13.1-q13.3 | Corpus callosum agenesis of with mental retardation ocular coloboma and micrognathia | 300472 |
IGF1 | chr12 | 12q22-q24.1 | Growth retardation with deafness and mental retardation due to IGF1 deficiency | 608747 |
IGF1R | chr15 | 15q25-q26 | Insulin-like growth factor I resistance to | 270450 |
IGFBP7 | chr4 | 4q12 | Retinal arterial macroaneurysm with supravalvular pulmonic stenosis | 614224 |
IGHM | chr14 | 14q32.33 | Agammaglobulinemia 1 | 601495 |
IGHMBP2 | chr11 | 11q13.2-q13.4 | Neuronopathy distal hereditary motor type VI | 604320 |
IGHMBP2 | chr11 | 11q13.2-q13.4 | Charcot-Marie-Tooth disease axonal type 2S | 616155 |
IGLL1 | chr22 | 22q11.21 | Agammaglobulinemia 2 | 613500 |
IGSF1 | chrX | Xq25 | Hypothyroidism central and testicular enlargement | 300888 |
IGSF3 | chr1 | 1p13 | Lacrimal duct defect | 149700 |
IHH | chr2 | 2q33-q35 | Acrocapitofemoral dysplasia | 607778 |
IKBKB | chr8 | 8p11.2 | Immunodeficiency 15B | 615592 |
IKBKG | chrX | Xq28 | Immunodeficiency 33 | 300636 |
IKBKG | chrX | Xq28 | Ectodermal dysplasia and immunodeficiency 1 | 300291 |
IL10RA | chr11 | 11q23.3 | Inflammatory bowel disease 28 early onset autosomal recessive | 613148 |
IL10RB | chr21 | 21q22.1 | Inflammatory bowel disease 25 early onset autosomal recessive | 612567 |
IL11RA | chr9 | 9p13 | Craniosynostosis and dental anomalies | 614188 |
IL12B | chr5 | 5q33.3 | Immunodeficiency 29 mycobacteriosis | 614890 |
IL12RB1 | chr19 | 19p13.1 | Immunodeficiency 30 | 614891 |
IL17RA | chr22 | 22q11.22- q11.23 | Immunodeficiency 51 | 613953 |
IL17RD | chr3 | 3p14.3-p14.2 | Hypogonadotropic hypogonadism 18 with or without anosmia | 615267 |
IL1RAPL1 | chrX | Xp22.1-p21.3 | Mental retardation X-linked 21/34 | 300143 |
IL1RN | chr2 | 2q14.2 | Interleukin 1 receptor antagonist deficiency | 612852 |
IL21 | chr4 | 4q26-q27 | Immunodeficiency common variable 11 | 615767 |
IL21R | chr16 | 16p11 | Immunodeficiency 56 | 615207 |
IL2RA | chr10 | 10p15.1 | Immunodeficiency 41 with lymphoproliferation and autoimmunity | 606367 |
IL2RG | chrX | Xq13 | Severe combined immunodeficiency X-linked | 300400 |
IL2RG | chrX | Xq13 | Combined immunodeficiency X-linked moderate | 312863 |
IL36RN | chr2 | 2q13 | Psoriasis 14 pustular | 614204 |
IL6 | chr7 | 7p21 | Diabetes susceptibility to | 222100 |
IL6R | chr1 | 1q21.3 | Hyper-IgE recurrent infection syndrome 5 autosomal recessive | 618944 |
IL6ST | chr5 | 5q11 | Hyper-IgE recurrent infection syndrome 4 autosomal recessive | 618523 |
IL7 | chr8 | 8q21.13 | Epidermodysplasia verruciformis susceptibility to 5 | 618309 |
IL7R | chr5 | 5p13 | Severe combined immunodeficiency T-cell negative B- cell/natural killer cell-positive type | 608971 |
ILDR1 | chr3 | 3q21.1 | Deafness autosomal recessive 42 | 609646 |
IMPG2 | chr3 | 3q11.2 | Retinitis pigmentosa 56 | 613581 |
INPP5K | chr17 | 17p13.3 | Muscular dystrophy congenital with cataracts and intellectual disability | 617404 |
INPPL1 | chr11 | 11q23 | Opsismodysplasia | 258480 |
INS | chr11 | 11p15.5 | Maturity-onset diabetes of the young type 10 | 613370 |
INS | chr11 | 11p15.5 | Hyperproinsulinemia | 616214 |
INS | chr11 | 11p15.5 | Diabetes mellitus insulin-dependent 2 | 125852 |
INS | chr11 | 11p15.5 | Diabetes mellitus permanent neonatal | 618858 |
INSR | chr19 | 19p13.2 | Rabson-Mendenhall syndrome | 262190 |
INSR | chr19 | 19p13.2 | Leprechaunism | 246200 |
INTU | chr4 | 4q28 | Short-rib thoracic dysplasia 20 with polydactyly | 617925 |
INTU | chr4 | 4q28 | Orofaciodigital syndrome XVII | 617926 |
INVS | chr9 | 9q31 | Nephronophthisis 2 infantile | 602088 |
IQCB1 | chr3 | 3q13.33 | Senior-Loken syndrome 5 | 609254 |
IQCE | chr7 | 7p22.3 | Polydactyly postaxial type A7 | 617642 |
IRAK4 | chr12 | 12q12 | Immunodeficiency 67 | 607676 |
IRF7 | chr11 | 11p15.5 | Immunodeficiency 39 | 616345 |
IRF8 | chr16 | 16q24.1 | Immunodeficiency 32B monocyte and dendritic cell deficiency autosomal recessive | 226990 |
IRF9 | chr14 | 14q11.2 | Immunodeficiency 65 susceptibility to viral infections | 618648 |
IRS4 | chrX | Xq22.3 | Hypothyroidism congenital nongoitrous 9 | 301035 |
IRX5 | chr16 | 16q11.2-q13 | Hamamy syndrome | 611174 |
ISCA2 | chr14 | 14q24.3 | Multiple mitochondrial dysfunctions syndrome 4 | 616370 |
ISCU | chr12 | 12q24.1 | Myopathy with lactic acidosis hereditary | 255125 |
ISG15 | chr1 | 1p36.33 | Immunodeficiency 38 | 616126 |
ITCH | chr20 | 20q11.22- q11.23 | Autoimmune disease multisystem with facial dysmorphism | 613385 |
ITGA2B | chr17 | 17q21.32 | Glanzmann thrombasthenia | 273800 |
ITGA3 | chr17 | 17q21.33 | Interstitial lung disease nephrotic syndrome and epidermolysis bullosa congenital | 614748 |
ITGA6 | chr2 | 2q31.1 | Epidermolysis bullosa junctional with pyloric stenosis | 226730 |
ITGA7 | chr12 | 12q13 | Muscular dystrophy congenital due to ITGA7 deficiency | 613204 |
ITGA8 | chr10 | 10p13 | Renal hypodysplasia/aplasia 1 | 191830 |
ITGB2 | chr21 | 21q22.3 | Leukocyte adhesion deficiency | 116920 |
ITGB3 | chr17 | 17q21.32 | Glanzmann thrombasthenia | 273800 |
ITGB4 | chr17 | 17q11-qter | Epidermolysis bullosa junctional with pyloric atresia | 226730 |
ITGB4 | chr17 | 17q11-qter | Epidermolysis bullosa junctional non-Herlitz type | 226650 |
ITGB6 | chr2 | 2q24.2 | Amelogenesis imperfecta type IH | 616221 |
ITK | chr5 | 5q32 | Lymphoproliferative syndrome 1 | 613011 |
ITPA | chr20 | 20p | Epileptic encephalopathy early infantile 35 | 616647 |
ITPR1 | chr3 | 3p26.1 | Gillespie syndrome | 206700 |
ITPR2 | chr12 | 12p11 | Anhidrosis isolated with normal sweat glands | 106190 |
ITPR3 | chr6 | 6pter-p21 | Diabetes type 1 susceptibility to | 222100 |
IVD | chr15 | 15q14-q15 | Isovaleric acidemia | 243500 |
IYD | chr6 | 6q24-q25 | Thyroid dyshormonogenesis 4 | 274800 |
JAGN1 | chr3 | 3p25.3 | Neutropenia severe congenital 6 autosomal recessive | 616022 |
JAK3 | chr19 | 19p13.1 | SCID autosomal recessive T-negative/B-positive type | 600802 |
JAM3 | chr11 | 11q25 | Hemorrhagic destruction of the brain subependymal calcification and cataracts | 613730 |
JUP | chr17 | 17q21 | Naxos disease | 601214 |
KANK2 | chr19 | 19p13.2 | Palmoplantar keratoderma and woolly hair | 616099 |
KANK2 | chr19 | 19p13.2 | Nephrotic syndrome type 16 | 617783 |
KATNB1 | chr16 | 16q21 | Lissencephaly 6 with microcephaly | 616212 |
KCNA4 | chr11 | 11q13.4-q14.1 | Microcephaly cataracts impaired intellectual development and dystonia with abnormal striatum | 618284 |
KCNE1 | chr21 | 21q22.1-q22.2 | Jervell and Lange-Nielsen syndrome 2 | 612347 |
KCNJ1 | chr11 | 11q24 | Bartter syndrome type 2 | 241200 |
KCNJ10 | chr1 | 1q23.2 | Enlarged vestibular aqueduct digenic | 600791 |
KCNJ10 | chr1 | 1q23.2 | SESAME syndrome | 612780 |
KCNJ11 | chr11 | 11p15.1 | Hyperinsulinemic hypoglycemia familial 2 | 601820 |
KCNJ13 | chr2 | 2q37 | Leber congenital amaurosis 16 | 614186 |
KCNMA1 | chr10 | 10q22.3 | Cerebellar atrophy developmental delay and seizures | 617643 |
KCNQ1 | chr11 | 11p15.5 | Jervell and Lange-Nielsen syndrome | 220400 |
KCNV2 | chr9 | 9p24.2 | Retinal cone dystrophy 3B | 610356 |
KCTD7 | chr7 | 7q11.21 | Epilepsy progressive myoclonic 3 with or without intracellular inclusions | 611726 |
KDM5B | chr1 | 1q32 | Mental retardation autosomal recessive 65 | 618109 |
KDM5C | chrX | Xp11.22- p11.21 | Mental retardation X-linked syndromic Claes-Jensen type | 300534 |
KDSR | chr18 | 18q21.3 | Erythrokeratodermia variabilis et progressiva 4 | 617526 |
KERA | chr12 | 12q22 | Cornea plana 2 autosomal recessive | 217300 |
KHDC3L | chr6 | 6q13 | Hydatidiform mole recurrent 2 | 614293 |
KHK | chr2 | 2p23.3-p23.2 | Fructosuria | 229800 |
KIAA1109 | chr4 | 4q27 | Alkuraya-Kucinskas syndrome | 617822 |
KIAA1549 | chr7 | 7q34 | Retinitis pigmentosa 86 | 618613 |
KIF14 | chr1 | 1q31 | Microcephaly 20 primary autosomal recessive | 617914 |
KIF14 | chr1 | 1q31 | Meckel syndrome 12 | 616258 |
KIF1A | chr2 | 2q37 | Spastic paraplegia 30 autosomal dominant | 610357 |
KIF1A | chr2 | 2q37 | Neuropathy hereditary sensory type IIC | 614213 |
KIF1A | chr2 | 2q37 | Spastic paraplegia 30 autosomal recessive | 610357 |
KIF1C | chr17 | 17p13.2 | Spastic ataxia 2 autosomal recessive | 611302 |
KIF4A | chrX | Xq13.1 | Mental retardation X-linked 100 | 300923 |
KIF7 | chr15 | 15q26.1 | Hydrolethalus syndrome 2 | 614120 |
KIF7 | chr15 | 15q26.1 | Acrocallosal syndrome | 200990 |
KIF7 | chr15 | 15q26.1 | Joubert syndrome 12 | 200990 |
KIF7 | chr15 | 15q26.1 | Al-Gazali-Bakalinova syndrome | 607131 |
KISS1 | chr1 | 1q32 | Hypogonadotropic hypogonadism 13 with or without anosmia | 614842 |
KISS1R | chr19 | 19p13.3 | Hypogonadotropic hypogonadism 8 with or without anosmia | 614837 |
KIZ | chr20 | 20p11.23 | Retinitis pigmentosa 69 | 615780 |
KL | chr13 | 13q12 | Tumoral calcinosis hyperphosphatemic familial 3 | 617994 |
KLHDC8B | chr3 | 3p21.31 | Hodgkin lymphoma susceptibility to | 236000 |
KLHL15 | chrX | Xp22.1 | Mental retardation X-linked 103 | 300982 |
KLHL3 | chr5 | 5q31 | Pseudohypoaldosteronism type IID | 614495 |
KLHL40 | chr3 | 3p22.1 | Nemaline myopathy 8 autosomal recessive | 615348 |
KLHL41 | chr2 | 2q31.1 | Nemaline myopathy 9 | 615731 |
KLHL7 | chr7 | 7p15.3 | PERCHING syndrome | 617055 |
KLK4 | chr19 | 19q13.4 | Amelogenesis imperfecta type IIA1 | 204700 |
KLKB1 | chr4 | 4q35 | Fletcher factor (prekallikrein) deficiency | 612423 |
KNG1 | chr3 | 3q27 | Kininogen deficiency | 228960 |
KNG1 | chr3 | 3q27 | High molecular weight kininogen deficiency | 228960 |
KNL1 | chr15 | 15q15.1 | Microcephaly 4 primary autosomal recessive | 604321 |
KPTN | chr19 | 19q13.4 | Mental retardation autosomal recessive 41 | 615637 |
KRT1 | chr12 | 12q13 | Epidermolytic hyperkeratosis | 113800 |
KRT10 | chr17 | 17q21-q22 | Epidermolytic hyperkeratosis | 113800 |
KRT14 | chr17 | 17q12-q21 | Epidermolysis bullosa simplex recessive 1 | 601001 |
KRT18 | chr12 | 12q13 | Cirrhosis noncryptogenic susceptibility to | 215600 |
KRT18 | chr12 | 12q13 | Cirrhosis cryptogenic | 215600 |
KRT5 | chr12 | 12q13 | Epidermolysis bullosa simplex recessive 1 | 601001 |
KRT74 | chr12 | 12q13 | Ectodermal dysplasia 7 hair/nail type | 614929 |
KRT8 | chr12 | 12q13 | Cirrhosis noncryptogenic susceptibility to | 215600 |
KRT8 | chr12 | 12q13 | Cirrhosis cryptogenic | 215600 |
KRT83 | chr12 | 12q13 | Erythrokeratodermia variabilis et progressiva 5 | 617756 |
KRT85 | chr12 | 12q13 | Ectodermal dysplasia 4 hair/nail type | 602032 |
KYNU | chr2 | 2q22.2 | Vertebral cardiac renal and limb defects syndrome 2 | 617661 |
KYNU | chr2 | 2q22.2 | Hydroxykynureninuria | 236800 |
L1CAM | chrX | Xq28 | MASA syndrome | 303350 |
L1CAM | chrX | Xq28 | Hydrocephalus with Hirschsprung disease | 307000 |
L1CAM | chrX | Xq28 | Hydrocephalus with congenital idiopathic intestinal pseudoobstruction | 307000 |
L1CAM | chrX | Xq28 | Corpus callosum partial agenesis of | 304100 |
L1CAM | chrX | Xq28 | CRASH syndrome | 303350 |
L1CAM | chrX | Xq28 | Hydrocephalus due to aqueductal stenosis | 307000 |
L2HGDH | chr14 | 14q22.1 | L-2-hydroxyglutaric aciduria | 236792 |
LAMA1 | chr18 | 18p11.31 | Poretti-Boltshauser syndrome | 615960 |
LAMA2 | chr6 | 6q22-q23 | Muscular dystrophy limb-girdle autosomal recessive 23 | 618138 |
LAMA2 | chr6 | 6q22-q23 | Muscular dystrophy congenital merosin deficient or partially deficient | 607855 |
LAMA3 | chr18 | 18q11.2 | Epidermolysis bullosa junctional Herlitz type | 226700 |
LAMA3 | chr18 | 18q11.2 | Laryngoonychocutaneous syndrome | 245660 |
LAMA3 | chr18 | 18q11.2 | Epidermolysis bullosa generalized atrophic benign | 226650 |
LAMB1 | chr7 | 7q31.1-q31.3 | Lissencephaly 5 | 615191 |
LAMB2 | chr3 | 3p21 | Pierson syndrome | 609049 |
LAMB3 | chr1 | 1q32 | Epidermolysis bullosa junctional Herlitz type | 226700 |
LAMB3 | chr1 | 1q32 | Epidermolysis bullosa junctional non-Herlitz type | 226650 |
LAMC2 | chr1 | 1q25-q31 | Epidermolysis bullosa junctional non-Herlitz type | 226650 |
LAMC2 | chr1 | 1q25-q31 | Epidermolysis bullosa junctional Herlitz type | 226700 |
LAMC3 | chr9 | 9q33-q34 | Cortical malformations occipital | 614115 |
LAMTOR2 | chr1 | 1q22 | Immunodeficiency due to defect in MAPBP-interacting protein | 610798 |
LARGE1 | chr22 | 22q12.3-q13.1 | Muscular dystrophy-dystroglycanopathy (congenital with mental retardation) type B 6 | 608840 |
LARGE1 | chr22 | 22q12.3-q13.1 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A 6 | 613154 |
LARP7 | chr4 | 4q25 | Alazami syndrome | 615071 |
LARS2 | chr3 | 3p21.3 | Perrault syndrome 4 | 615300 |
LARS2 | chr3 | 3p21.3 | Hydrops lactic acidosis and sideroblastic anemia | 617021 |
LAS1L | chrX | Xq12 | Wilson-Turner syndrome | 309585 |
LBR | chr1 | 1q42.1 | Greenberg skeletal dysplasia | 215140 |
LCA5 | chr6 | 6q14.1 | Leber congenital amaurosis 5 | 604537 |
LCAT | chr16 | 16q22.1 | Norum disease | 245900 |
LCAT | chr16 | 16q22.1 | Fish-eye disease | 136120 |
LCK | chr1 | 1p35-p34.3 | Immunodeficiency 22 | 615758 |
LCT | chr2 | 2q21 | Lactase deficiency congenital | 223000 |
LDHA | chr11 | 11p15.4 | Glycogen storage disease XI | 612933 |
LDLRAP1 | chr1 | 1p36-p35 | Hypercholesterolemia familial 4 | 603813 |
LEP | chr7 | 7q31.3 | Obesity morbid due to leptin deficiency | 614962 |
LEPR | chr1 | 1p31 | Obesity morbid due to leptin receptor deficiency | 614963 |
P3H1 | chr1 | 1p34 | Osteogenesis imperfecta type VIII | 610915 |
LFNG | chr7 | 7p22 | Spondylocostal dysostosis 3 autosomal recessive | 609813 |
LGI4 | chr19 | 19q13.11 | Arthrogryposis multiplex congenita 1 neurogenic with myelin defect | 617468 |
LHB | chr19 | 19q13.32 | Hypogonadotropic hypogonadism 23 with or without anosmia | 228300 |
LHCGR | chr2 | 2p21 | Luteinizing hormone resistance female | 238320 |
LHCGR | chr2 | 2p21 | Leydig cell hypoplasia with pseudohermaphroditism | 238320 |
LHCGR | chr2 | 2p21 | Leydig cell hypoplasia with hypergonadotropic hypogonadism | 238320 |
LHFPL5 | chr6 | 6p21.3 | Deafness autosomal recessive 67 | 610265 |
LHX3 | chr9 | 9q34.3 | Pituitary hormone deficiency combined 3 | 221750 |
LIAS | chr4 | 4p14 | Hyperglycinemia lactic acidosis and seizures | 614462 |
LIFR | chr5 | 5p13.1 | Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome | 601559 |
LIG4 | chr13 | 13q22-q34 | LIG4 syndrome | 606593 |
LIM2 | chr19 | 19q13.4 | Cataract 19 multiple types | 615277 |
LIMS2 | chr2 | 2q14.3 | Muscular dystrophy autosomal recessive with cardiomyopathy and triangular tongue | 616827 |
LINS1 | chr15 | 15q26 | Mental retardation autosomal recessive 27 | 614340 |
LIPA | chr10 | 10q23.31 | Wolman disease | 278000 |
LIPA | chr10 | 10q23.31 | Cholesteryl ester storage disease | 278000 |
LIPC | chr15 | 15q21.3 | Hepatic lipase deficiency | 614025 |
LIPE | chr19 | 19q13.1-q13.2 | Lipodystrophy familial partial type 6 | 615980 |
LIPH | chr3 | 3q27-q28 | Woolly hair autosomal recessive 2 with or without hypotrichosis | 604379 |
LIPH | chr3 | 3q27-q28 | Hypotrichosis 7 | 604379 |
LIPN | chr10 | 10q23.31 | Ichthyosis congenital autosomal recessive 8 | 613943 |
LIPT1 | chr2 | 2q11.2 | Lipoyltransferase 1 deficiency | 616299 |
LMAN1 | chr18 | 18q21.3-q22 | Combined factor V and VIII deficiency | 227300 |
LMAN2L | chr2 | 2q11.2 | Mental retardation autosomal recessive 52 | 616887 |
LMBR1 | chr7 | 7q36 | Acheiropody | 200500 |
LMBRD1 | chr6 | 6q13 | Methylmalonic aciduria and homocystinuria cblF type | 277380 |
LMF1 | chr16 | 16p13.3 | Lipase deficiency combined | 246650 |
LMNA | chr1 | 1q21.2 | Charcot-Marie-Tooth disease type 2B1 | 605588 |
LMNA | chr1 | 1q21.2 | Hutchinson-Gilford progeria | 176670 |
LMNA | chr1 | 1q21.2 | Restrictive dermopathy lethal | 275210 |
LMNA | chr1 | 1q21.2 | Mandibuloacral dysplasia | 248370 |
LMNA | chr1 | 1q21.2 | Emery-Dreifuss muscular dystrophy 3 autosomal recessive | 616516 |
LMNB2 | chr19 | 19p13.3 | Epilepsy progressive myoclonic 9 | 616540 |
LMOD3 | chr3 | 3p14.1 | Nemaline myopathy 10 | 616165 |
LONP1 | chr19 | 19p13.2 | CODAS syndrome | 600373 |
LOXHD1 | chr18 | 18q12-q21 | Deafness autosomal recessive 77 | 613079 |
LPAR6 | chr13 | 13q14.12- q14.2 | Hypotrichosis 8 | 278150 |
LPAR6 | chr13 | 13q14.12- q14.2 | Woolly hair autosomal recessive 1 with or without hypotrichosis | 278150 |
LPIN1 | chr2 | 2p21 | Myoglobinuria acute recurrent autosomal recessive | 268200 |
LPL | chr8 | 8p22 | Lipoprotein lipase deficiency | 238600 |
LPL | chr8 | 8p22 | High density lipoprotein cholesterol level QTL 11 | 238600 |
LRAT | chr4 | 4q31 | Retinal dystrophy early-onset severe | 613341 |
LRAT | chr4 | 4q31 | Leber congenital amaurosis 14 | 613341 |
LRAT | chr4 | 4q31 | Retinitis pigmentosa juvenile | 613341 |
LRBA | chr4 | 4q31.3 | Immunodeficiency common variable 8 with autoimmunity | 614700 |
LRIG2 | chr1 | 1p13 | Urofacial syndrome 2 | 615112 |
LRIT3 | chr4 | 4q25 | Night blindness congenital stationary (complete) 1F autosomal recessive | 615058 |
LRMDA | chr10 | 10q22.3 | Albinism oculocutaneous type VII | 615179 |
LRP1 | chr12 | 12q13.1-q13.3 | Keratosis pilaris atrophicans | 604093 |
LRP2 | chr2 | 2q24-q31 | Donnai-Barrow syndrome | 222448 |
LRP4 | chr11 | 11p12-p11.2 | Myasthenic syndrome congenital 17 | 616304 |
LRP4 | chr11 | 11p12-p11.2 | Sclerosteosis 2 | 614305 |
LRP4 | chr11 | 11p12-p11.2 | Cenani-Lenz syndactyly syndrome | 212780 |
LRP5 | chr11 | 11q13.4 | Exudative vitreoretinopathy 4 | 601813 |
LRP5 | chr11 | 11q13.4 | Osteoporosis-pseudoglioma syndrome | 259770 |
LRPAP1 | chr4 | 4p16.3 | Myopia 23 autosomal recessive | 615431 |
LRPPRC | chr2 | 2p21 | Leigh syndrome French-Canadian type | 220111 |
LRRC6 | chr8 | 8q24.22 | Ciliary dyskinesia primary 19 | 614935 |
LRSAM1 | chr9 | 9q33.3-q34.11 | Charcot-Marie-Tooth disease axonal type 2P | 614436 |
LRTOMT | chr11 | 11q13.3-q13.4 | Deafness autosomal recessive 63 | 611451 |
LTBP2 | chr14 | 14q24 | Microspherophakia and/or megalocornea with ectopia lentis and with or without secondary glaucoma | 251750 |
LTBP2 | chr14 | 14q24 | Weill-Marchesani syndrome 3 recessive | 614819 |
LTBP3 | chr11 | 11q12 | Dental anomalies and short stature | 601216 |
LTBP4 | chr19 | 19q13.1-q13.2 | Cutis laxa autosomal recessive type IC | 613177 |
LTC4S | chr5 | 5q35 | Leukotriene C4 synthase deficiency | 614037 |
LYRM4 | chr6 | 6p25.1 | Combined oxidative phosphorylation deficiency 19 | 615595 |
LYRM7 | chr5 | 5q23.3 | Mitochondrial complex III deficiency nuclear type 8 | 615838 |
LYST | chr1 | 1q42.3 | Chediak-Higashi syndrome | 214500 |
LZTFL1 | chr3 | 3p21.3 | Bardet-Biedl syndrome 17 | 615994 |
LZTR1 | chr22 | 22q11.1-q11.2 | Noonan syndrome 2 | 605275 |
MAB21L2 | chr4 | 4q31.3 | Microphthalmia/coloboma and skeletal dysplasia syndrome | 615877 |
MAG | chr19 | 19q13.1 | Spastic paraplegia 75 autosomal recessive | 616680 |
MAGI2 | chr7 | 7q21 | Nephrotic syndrome type 15 | 617609 |
MAGT1 | chrX | Xq13.1-q13.2 | Immunodeficiency X-linked with magnesium defect Epstein-Barr virus infection and neoplasia | 300853 |
MAGT1 | chrX | Xq13.1-q13.2 | Congenital disorder of glycosylation type Icc | 301031 |
MAK | chr6 | 6p24.2 | Retinitis pigmentosa 62 | 614181 |
MALT1 | chr18 | 18q21 | Immunodeficiency 12 | 615468 |
MAMLD1 | chrX | Xq28 | Hypospadias 2 X-linked | 300758 |
MAN1B1 | chr9 | 9q34.3 | Mental retardation autosomal recessive 15 | 614202 |
MAN2B1 | chr19 | 19cen-q12 | Mannosidosis alpha- types I and II | 248500 |
MANBA | chr4 | 4q22-q25 | Mannosidosis beta | 248510 |
MAOA | chrX | Xp11.23 | Brunner syndrome | 300615 |
MAOA | chrX | Xp11.23 | Antisocial behavior | 300615 |
MAPT | chr17 | 17q21.1 | Supranuclear palsy progressive atypical | 260540 |
MARS2 | chr2 | 2q33.1 | Spastic ataxia 3 autosomal recessive | 611390 |
MARS2 | chr2 | 2q33.1 | Combined oxidative phosphorylation deficiency 25 | 616430 |
MARVELD2 | chr5 | 5q13.1 | Deafness autosomal recessive 49 | 610153 |
MASP1 | chr3 | 3q27-q28 | 3MC syndrome 1 | 257920 |
MASP2 | chr1 | 1p36.3-p36.2 | MASP2 deficiency | 613791 |
MAT1A | chr10 | 10q22 | Methionine adenosyltransferase deficiency autosomal recessive | 250850 |
MAT1A | chr10 | 10q22 | Hypermethioninemia persistent autosomal dominant due to methionine adenosyltransferase I/III deficiency | 250850 |
MATN3 | chr2 | 2p24-p23 | Spondyloepimetaphyseal dysplasia | 608728 |
MBOAT7 | chr19 | 19q13.4 | Mental retardation autosomal recessive 57 | 617188 |
MBTPS2 | chrX | Xp22.12- p22.11 | IFAP syndrome with or without BRESHECK syndrome | 308205 |
MBTPS2 | chrX | Xp22.12- p22.11 | Keratosis follicularis spinulosa decalvans X-linked | 308800 |
MBTPS2 | chrX | Xp22.12- p22.11 | Osteogenesis imperfecta type XIX | 301014 |
MBTPS2 | chrX | Xp22.12- p22.11 | ?Olmsted syndrome X-linked | 300918 |
MC1R | chr16 | 16q24.3 | Skin/hair/eye pigmentation 2 blond hair/fair skin | 266300 |
MC1R | chr16 | 16q24.3 | Albinism oculocutaneous type II modifier of | 203200 |
MC1R | chr16 | 16q24.3 | UV-induced skin damage | 266300 |
MC1R | chr16 | 16q24.3 | Skin/hair/eye pigmentation 2 red hair/fair skin | 266300 |
MC2R | chr18 | 18p11.2 | Glucocorticoid deficiency due to ACTH unresponsiveness | 202200 |
MC4R | chr18 | 18q22 | Obesity (BMIQ20) | 618406 |
MCCC1 | chr3 | 3q25-q27 | 3-Methylcrotonyl-CoA carboxylase 1 deficiency | 210200 |
MCCC2 | chr5 | 5q12-q13 | 3-Methylcrotonyl-CoA carboxylase 2 deficiency | 210210 |
MCEE | chr2 | 2p13.3 | Methylmalonyl-CoA epimerase deficiency | 251120 |
MCM3AP | chr21 | 21q22.3 | Peripheral neuropathy autosomal recessive with or without impaired intellectual development | 618124 |
MCM4 | chr8 | 8q11.2 | Immunodeficiency 54 | 609981 |
MCM5 | chr22 | 22q13.1 | Meier-Gorlin syndrome 8 | 617564 |
MCM8 | chr20 | 20p13-p12.3 | Premature ovarian failure 10 | 612885 |
MCM9 | chr6 | 6q22.1-q22.33 | Ovarian dysgenesis 4 | 616185 |
MCOLN1 | chr19 | 19p13.3-p13.2 | Mucolipidosis IV | 252650 |
MCPH1 | chr8 | 8p23 | Microcephaly 1 primary autosomal recessive | 251200 |
MDH2 | chr7 | 7q11.23 | Epileptic encephalopathy early infantile 51 | 617339 |
MDM2 | chr12 | 12q14.3-q15 | Lessel-Kubisch syndrome | 618681 |
MECP2 | chrX | Xq28 | Mental retardation X-linked syndromic Lubs type | 300260 |
MECP2 | chrX | Xq28 | Encephalopathy neonatal severe | 300673 |
MECP2 | chrX | Xq28 | Mental retardation X-linked syndromic 13 | 300055 |
MECP2 | chrX | Xq28 | Autism susceptibility X-linked 3 | 300496 |
MED12 | chrX | Xq13 | Ohdo syndrome X-linked | 300895 |
MED12 | chrX | Xq13 | Lujan-Fryns syndrome | 309520 |
MED12 | chrX | Xq13 | Opitz-Kaveggia syndrome | 305450 |
MED17 | chr11 | 11q21 | Microcephaly postnatal progressive with seizures and brain atrophy | 613668 |
MED23 | chr6 | 6q23.2 | Mental retardation autosomal recessive 18 | 614249 |
MED25 | chr19 | 19q13.3 | Basel-Vanagait-Smirin-Yosef syndrome | 616449 |
MEFV | chr16 | 16p13 | Familial Mediterranean fever AR | 249100 |
MEGF10 | chr5 | 5q23.2 | Myopathy areflexia respiratory distress and dysphagia early-onset mild variant | 614399 |
MEGF10 | chr5 | 5q23.2 | Myopathy areflexia respiratory distress and dysphagia early-onset | 614399 |
MEGF8 | chr19 | 19q12 | Carpenter syndrome 2 | 614976 |
MEOX1 | chr17 | 17q21 | Klippel-Feil syndrome 2 | 214300 |
MERTK | chr2 | 2q14.1 | Retinitis pigmentosa 38 | 613862 |
MESD | chr15 | 15q25.1 | Osteogenesis imperfecta type XX | 618644 |
MESP2 | chr15 | 15q26.1 | Spondylocostal dysostosis 2 autosomal recessive | 608681 |
MET | chr7 | 7q31 | Deafness autosomal recessive 97 | 616705 |
METTL23 | chr17 | 17q25.1 | Mental retardation autosomal recessive 44 | 615942 |
MFF | chr2 | 2q36.3 | Encephalopathy due to defective mitochondrial and peroxisomal fission 2 | 617086 |
MFN2 | chr1 | 1p36.2 | Charcot-Marie-Tooth disease axonal type 2A2B | 617087 |
MFRP | chr11 | 11q23 | Microphthalmia isolated 5 | 611040 |
MFSD2A | chr1 | 1p34.2 | Neurodevelopmental disorder with progressive microcephaly spasticity and brain imaging abnormalities | 616486 |
MFSD8 | chr4 | 4q28.1-q28.2 | Macular dystrophy with central cone involvement | 616170 |
MFSD8 | chr4 | 4q28.1-q28.2 | Ceroid lipofuscinosis neuronal 7 | 610951 |
MGAT2 | chr14 | 14q21 | Congenital disorder of glycosylation type IIa | 212066 |
MGME1 | chr20 | 20p11.23 | Mitochondrial DNA depletion syndrome 11 | 615084 |
MGP | chr12 | 12p13.1-p12.3 | Keutel syndrome | 245150 |
MICU1 | chr10 | 10q22.1 | Myopathy with extrapyramidal signs | 615673 |
MID1 | chrX | Xp22 | Opitz GBBB syndrome type I | 300000 |
MID2 | chrX | Xq22 | Mental retardation X-linked 101 | 300928 |
MIR2861 | chr9 | 9q34.11 | Bone mineral density QTL 15 | 613418 |
MITF | chr3 | 3p14.1-p12.3 | COMMAD syndrome | 617306 |
MKKS | chr20 | 20p12 | Bardet-Biedl syndrome 6 | 605231 |
MKKS | chr20 | 20p12 | McKusick-Kaufman syndrome | 236700 |
MKS1 | chr17 | 17q23 | Bardet-Biedl syndrome 13 | 615990 |
MKS1 | chr17 | 17q23 | Joubert syndrome 28 | 617121 |
MKS1 | chr17 | 17q23 | Meckel syndrome 1 | 249000 |
MLC1 | chr22 | 22q13.33 | Megalencephalic leukoencephalopathy with subcortical cysts | 604004 |
MLH1 | chr3 | 3p21.3 | Mismatch repair cancer syndrome | 276300 |
MLPH | chr2 | 2q37 | Griscelli syndrome type 3 | 609227 |
MLYCD | chr16 | 16q24 | Malonyl-CoA decarboxylase deficiency | 248360 |
MMAA | chr4 | 4q31.1-q31.2 | Methylmalonic aciduria vitamin B12-responsive | 251100 |
MMAB | chr12 | 12q24 | Methylmalonic aciduria vitamin B12-responsive due to defect in synthesis of adenosylcobalamin cblB complementation type | 251110 |
MMACHC | chr1 | 1p34.1 | Methylmalonic aciduria and homocystinuria cblC type | 277400 |
MMADHC | chr2 | 2q23.2 | Homocystinuria cblD type variant 1 | 277410 |
MMADHC | chr2 | 2q23.2 | Methylmalonic aciduria and homocystinuria cblD type | 277410 |
MMADHC | chr2 | 2q23.2 | Methylmalonic aciduria cblD type variant 2 | 277410 |
MME | chr3 | 3q21-q27 | Charcot-Marie-Tooth disease axonal type 2T | 617017 |
MMP1 | chr11 | 11q22-q23 | Epidermolysis bullosa dystrophica autosomal recessive modifier of | 226600 |
MMP13 | chr11 | 11q22.3 | Metaphyseal dysplasia Spahr type | 250400 |
MMP2 | chr16 | 16q13 | Multicentric osteolysis nodulosis and arthropathy | 259600 |
MMP20 | chr11 | 11q22.3-q23 | Amelogenesis imperfecta type IIA2 | 612529 |
MOCOS | chr18 | 18q12.2 | Xanthinuria type II | 603592 |
MOCS1 | chr6 | 6p21.3 | Molybdenum cofactor deficiency A | 252150 |
MOCS2 | chr5 | 5q11 | Molybdenum cofactor deficiency B | 252160 |
MOGS | chr2 | 2p13.1 | Congenital disorder of glycosylation type IIb | 606056 |
MPC1 | chr6 | 6q27 | Mitochondrial pyruvate carrier deficiency | 614741 |
MPDU1 | chr17 | 17p13.1-p12 | Congenital disorder of glycosylation type If | 609180 |
MPDZ | chr9 | 9p23 | Hydrocephalus congenital 2 with or without brain or eye anomalies | 615219 |
MPI | chr15 | 15q22-qter | Congenital disorder of glycosylation type Ib | 602579 |
MPL | chr1 | 1p34 | Thrombocytopenia congenital amegakaryocytic | 604498 |
MPLKIP | chr7 | 7p14 | Trichothiodystrophy 4 nonphotosensitive | 234050 |
MPO | chr17 | 17q23.1 | Myeloperoxidase deficiency | 254600 |
MPV17 | chr2 | 2p23-p21 | Charcot-Marie-Tooth disease axonal type 2EE | 618400 |
MPV17 | chr2 | 2p23-p21 | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) | 256810 |
MPZ | chr1 | 1q22 | Dejerine-Sottas disease | 145900 |
MRAP | chr21 | 21q22.1 | Glucocorticoid deficiency 2 | 607398 |
MRPL12 | chr17 | 17q25-qter | Combined oxidative phosphorylation deficiency 45 | 618951 |
MRPL3 | chr3 | 3q22.1 | Combined oxidative phosphorylation deficiency 9 | 614582 |
MRPL44 | chr2 | 2q36 | Combined oxidative phosphorylation deficiency 16 | 615395 |
MRPS16 | chr10 | 10q22.1 | Combined oxidative phosphorylation deficiency 2 | 610498 |
MRPS2 | chr9 | 9q34 | Combined oxidative phosphorylation deficiency 36 | 617950 |
MRPS22 | chr3 | 3q23 | Combined oxidative phosphorylation deficiency 5 | 611719 |
MRPS22 | chr3 | 3q23 | Ovarian dysgenesis 7 | 618117 |
MS4A1 | chr11 | 11q13 | Immunodeficiency common variable 5 | 613495 |
MSH2 | chr2 | 2p22-p21 | Mismatch repair cancer syndrome | 276300 |
MSH3 | chr5 | 5q11-q12 | Familial adenomatous polyposis 4 | 617100 |
MSH5 | chr6 | 6p21.33 | Premature ovarian failure 13 | 617442 |
MSH6 | chr2 | 2p16 | Mismatch repair cancer syndrome | 276300 |
MSMO1 | chr4 | 4q32-q34 | Microcephaly congenital cataract and psoriasiform dermatitis | 616834 |
MSRB3 | chr12 | 12q14.3 | Deafness autosomal recessive 74 | 613718 |
MTFMT | chr15 | 15q22.31 | Combined oxidative phosphorylation deficiency 15 | 614947 |
MTFMT | chr15 | 15q22.31 | Mitochondrial complex I deficiency nuclear type 27 | 618248 |
MTHFD1 | chr14 | 14q24 | Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia | 617780 |
MTHFD1 | chr14 | 14q24 | Neural tube defects folate-sensitive susceptibility to | 601634 |
MTHFR | chr1 | 1p36.3 | Homocystinuria due to MTHFR deficiency | 236250 |
MTHFR | chr1 | 1p36.3 | Neural tube defects susceptibility to | 601634 |
MTHFS | chr15 | 15q25.1 | Neurodevelopmental disorder with microcephaly epilepsy and hypomyelination | 618367 |
MTM1 | chrX | Xq28 | Myotubular myopathy X-linked | 310400 |
MTMR2 | chr11 | 11q22 | Charcot-Marie-Tooth disease type 4B1 | 601382 |
MTO1 | chr6 | 6q13 | Combined oxidative phosphorylation deficiency 10 | 614702 |
MTPAP | chr10 | 10p11.23 | Spastic ataxia 4 autosomal recessive | 613672 |
MTR | chr1 | 1q43 | Neural tube defects folate-sensitive susceptibility to | 601634 |
MTR | chr1 | 1q43 | Homocystinuria-megaloblastic anemia cblG complementation type | 250940 |
MTRR | chr5 | 5p15.3-p15.2 | Neural tube defects folate-sensitive susceptibility to | 601634 |
MTRR | chr5 | 5p15.3-p15.2 | Homocystinuria-megaloblastic anemia cbl E type | 236270 |
MTTP | chr4 | 4q22-q24 | Abetalipoproteinemia | 200100 |
MUSK | chr9 | 9q31.3-q32 | Fetal akinesia deformation sequence 1 | 208150 |
MUSK | chr9 | 9q31.3-q32 | Myasthenic syndrome congenital 9 associated with acetylcholine receptor deficiency | 616325 |
MUTYH | chr1 | 1p34.3-p32.1 | Adenomas multiple colorectal | 608456 |
MVK | chr12 | 12q24 | Hyper-IgD syndrome | 260920 |
MVK | chr12 | 12q24 | Mevalonic aciduria | 610377 |
MYBPC1 | chr12 | 12q23.2 | Lethal congenital contracture syndrome 4 | 614915 |
MYBPC3 | chr11 | 11p11.2 | Cardiomyopathy hypertrophic 4 | 115197 |
MYD88 | chr3 | 3p22-p21.3 | Immunodeficiency 68 | 612260 |
MYF5 | chr12 | 12q21 | Ophthalmoplegia external with rib and vertebral anomalies | 618155 |
MYH2 | chr17 | 17p13.1 | Proximal myopathy and ophthalmoplegia | 605637 |
MYH3 | chr17 | 17p13.1 | Contractures pterygia and spondylocarpotarsal fusion syndrome 1B | 618469 |
MYH7 | chr14 | 14q12 | Myopathy myosin storage autosomal recessive | 255160 |
MYL1 | chr2 | 2q32.1-qter | Myopathy congenital with fast-twitch (type II) fiber atrophy | 618414 |
MYL3 | chr3 | 3p | Cardiomyopathy hypertrophic 8 | 608751 |
MYLK | chr3 | 3q21 | Megacystis-microcolon-intestinal hypoperistalsis syndrome | 249210 |
MYO15A | chr17 | 17p11.2 | Deafness autosomal recessive 3 | 600316 |
MYO18B | chr22 | 22q12.1 | Klippel-Feil syndrome 4 autosomal recessive with myopathy and facial dysmorphism | 616549 |
MYO1E | chr15 | 15q21-q22 | Glomerulosclerosis focal segmental 6 | 614131 |
MYO3A | chr10 | 10p11.1 | Deafness autosomal recessive 30 | 607101 |
MYO5A | chr15 | 15q21 | Griscelli syndrome type 1 | 214450 |
MYO5B | chr18 | 18q21 | Microvillus inclusion disease | 251850 |
MYO6 | chr6 | 6q13 | Deafness autosomal recessive 37 | 607821 |
MYO7A | chr11 | 11q13.5 | Deafness autosomal recessive 2 | 600060 |
MYO7A | chr11 | 11q13.5 | Usher syndrome type 1B | 276900 |
MYPN | chr10 | 10q21.1 | Nemaline myopathy 11 autosomal recessive | 617336 |
NAA10 | chrX | Xq28 | Ogden syndrome | 300855 |
NAA10 | chrX | Xq28 | Microphthalmia syndromic 1 | 309800 |
NADK2 | chr5 | 5p13.2 | 24-dienoyl-CoA reductase deficiency | 616034 |
NAGA | chr22 | 22q11 | Kanzaki disease | 609242 |
NAGA | chr22 | 22q11 | Schindler disease type I | 609241 |
NAGA | chr22 | 22q11 | Schindler disease type III | 609241 |
NAGLU | chr17 | 17q21 | Mucopolysaccharidosis type IIIB (Sanfilippo B) | 252920 |
NAGS | chr17 | 17q21.31 | N-acetylglutamate synthase deficiency | 237310 |
NALCN | chr13 | 13q33.11 | Hypotonia infantile with psychomotor retardation and characteristic facies 1 | 615419 |
NARS2 | chr11 | 11q14.1 | Deafness autosomal recessive 94 | 618434 |
NARS2 | chr11 | 11q14.1 | Combined oxidative phosphorylation deficiency 24 | 616239 |
NAT2 | chr8 | 8p23.1-p21.3 | Acetylation slow | 243400 |
NAT8L | chr4 | 4p16.3 | N-acetylaspartate deficiency | 614063 |
NBAS | chr2 | 2p24-p23 | Infantile liver failure syndrome 2 | 616483 |
NBAS | chr2 | 2p24-p23 | Short stature optic nerve atrophy and Pelger-Huet anomaly | 614800 |
NBEAL2 | chr3 | 3p22.1-p21.1 | Gray platelet syndrome | 139090 |
NBN | chr8 | 8q21 | Nijmegen breakage syndrome | 251260 |
NCAPD2 | chr12 | 12p13.31 | Microcephaly 21 primary autosomal recessive | 617983 |
NCAPG2 | chr7 | 7q36.3 | Khan-Khan-Katsanis syndrome | 618460 |
NCF1 | chr7 | 7q11.23 | Chronic granulomatous disease 1 autosomal recessive | 233700 |
NCF2 | chr1 | 1q25 | Chronic granulomatous disease due to deficiency of NCF-2 | 233710 |
NCF4 | chr22 | 22q13.1 | Chronic granulomatous disease 3 autosomal recessive | 613960 |
NDE1 | chr16 | 16p13.1 | Lissencephaly 4 (with microcephaly) | 614019 |
NDE1 | chr16 | 16p13.1 | Microhydranencephaly | 605013 |
NDP | chrX | Xp11.4 | Exudative vitreoretinopathy 2 X-linked | 305390 |
NDP | chrX | Xp11.4 | Norrie disease | 310600 |
NDRG1 | chr8 | 8q24.3 | Charcot-Marie-Tooth disease type 4D | 601455 |
NDST1 | chr5 | 5q32-q33.3 | Mental retardation autosomal recessive 46 | 616116 |
NDUFA1 | chrX | Xq24 | Mitochondrial complex I deficiency nuclear type 12 | 301020 |
NDUFA10 | chr2 | 2q37.3 | Mitochondrial complex I deficiency nuclear type 22 | 618243 |
NDUFA11 | chr19 | 19p13.3 | Mitochondrial complex I deficiency nuclear type 14 | 618236 |
NDUFA12 | chr12 | 12q22 | Mitochondrial complex I deficiency nuclear type 23 | 618244 |
NDUFA13 | chr19 | 19p13.2-p13.1 | Mitochondrial complex I deficiency nuclear type 28 | 618249 |
NDUFA2 | chr5 | 5q31.2 | Mitochondrial complex I deficiency nuclear type 13 | 618235 |
NDUFA6 | chr22 | 22q13.1 | Mitochondrial complex I deficiency nuclear type 33 | 618253 |
NDUFA9 | chr12 | 12p | Mitochondrial complex I deficiency nuclear type 26 | 618247 |
NDUFAF1 | chr15 | 15q13.3 | Mitochondrial complex I deficiency nuclear type 11 | 618234 |
NDUFAF2 | chr5 | 5q12.1 | Mitochondrial complex I deficiency nuclear type 10 | 618233 |
NDUFAF3 | chr3 | 3p21.31 | Mitochondrial complex I deficiency nuclear type 18 | 618240 |
NDUFAF4 | chr6 | 6q16.1 | Mitochondrial complex I deficiency nuclear type 15 | 618237 |
NDUFAF5 | chr20 | 20p12.1 | Mitochondrial complex I deficiency nuclear type 16 | 618238 |
NDUFAF6 | chr8 | 8q22.1 | Fanconi renotubular syndrome 5 | 618913 |
NDUFAF6 | chr8 | 8q22.1 | Mitochondrial complex I deficiency nuclear type 17 | 618239 |
NDUFB3 | chr2 | 2q31.3 | Mitochondrial complex I deficiency nuclear type 25 | 618246 |
NDUFB8 | chr10 | 10q23.2- q23.33 | Mitochondrial complex I deficiency nuclear type 32 | 618252 |
NDUFB9 | chr8 | 8q13.3 | Mitochondrial complex I deficiency nuclear type 24 | 618245 |
NDUFS1 | chr2 | 2q33-q34 | Mitochondrial complex I deficiency nuclear type 5 | 618226 |
NDUFS2 | chr1 | 1q23 | Mitochondrial complex I deficiency nuclear type 6 | 618228 |
NDUFS3 | chr11 | 11p11.11 | Mitochondrial complex I deficiency nuclear type 8 | 618230 |
NDUFS4 | chr5 | 5q11.1 | Mitochondrial complex I deficiency nuclear type 1 | 252010 |
NDUFS6 | chr5 | 5pter-p15.33 | Mitochondrial complex I deficiency nuclear type 9 | 618232 |
NDUFS7 | chr19 | 19p13 | Mitochondrial complex I deficiency nuclear type 3 | 618224 |
NDUFS8 | chr11 | 11q13 | Mitochondrial complex I deficiency nuclear type 2 | 618222 |
NDUFV1 | chr11 | 11q13 | Mitochondrial complex I deficiency nuclear type 4 | 618225 |
NDUFV2 | chr18 | 18p11.31- p11.2 | Mitochondrial complex I deficiency nuclear type 7 | 618229 |
NEB | chr2 | 2q22 | Nemaline myopathy 2 autosomal recessive | 256030 |
NECAP1 | chr12 | 12p13.31 | Epileptic encephalopathy early infantile 21 | 615833 |
NECTIN1 | chr11 | 11q23-q24 | Orofacial cleft 7 | 225060 |
NECTIN1 | chr11 | 11q23-q24 | Cleft lip/palate-ectodermal dysplasia syndrome | 225060 |
NECTIN4 | chr1 | 1q23.3 | Ectodermal dysplasia-syndactyly syndrome 1 | 613573 |
NEFH | chr22 | 22q12.2 | Charcot-Marie-Tooth disease axonal type 2CC | 616924 |
NEFH | chr22 | 22q12.2 | Amyotrophic lateral sclerosis susceptibility to | 105400 |
NEFL | chr8 | 8p21 | Charcot-Marie-Tooth disease type 1F | 607734 |
NEK1 | chr4 | 4q33 | Short-rib thoracic dysplasia 6 with or without polydactyly | 263520 |
NEK2 | chr1 | 1q32.2-q41 | Retinitis pigmentosa 67 | 615565 |
NEK8 | chr17 | 17q11.1 | Renal-hepatic-pancreatic dysplasia 2 | 615415 |
NEU1 | chr6 | 6p21.3 | Sialidosis type II | 256550 |
NEU1 | chr6 | 6p21.3 | Sialidosis type I | 256550 |
NEUROG3 | chr10 | 10q21.3 | Diarrhea 4 malabsorptive congenital | 610370 |
NFU1 | chr2 | 2p15-p13 | Multiple mitochondrial dysfunctions syndrome 1 | 605711 |
NGF | chr1 | 1p13.1 | Neuropathy hereditary sensory and autonomic type V | 608654 |
NGLY1 | chr3 | 3p24 | Congenital disorder of deglycosylation | 615273 |
NHLRC1 | chr6 | 6p22.3 | Epilepsy progressive myoclonic 2B (Lafora) | 254780 |
NHP2 | chr5 | 5q35.3 | Dyskeratosis congenita autosomal recessive 2 | 613987 |
NIN | chr14 | 14q22.1 | Seckel syndrome 7 | 614851 |
NIPAL4 | chr5 | 5q33 | Ichthyosis congenital autosomal recessive 6 | 612281 |
NKX3-2 | chr4 | 4p16.1 | Spondylo-megaepiphyseal-metaphyseal dysplasia | 613330 |
NLRP1 | chr17 | 17p13 | Autoinflammation with arthritis and dyskeratosis | 617388 |
NLRP1 | chr17 | 17p13 | Respiratory papillomatosis juvenile recurrent congenital | 618803 |
NLRP7 | chr19 | 19q13.4 | Hydatidiform mole recurrent 1 | 231090 |
NME8 | chr7 | 7p14.1 | Ciliary dyskinesia primary 6 | 610852 |
NMNAT1 | chr1 | 1p36.22 | Leber congenital amaurosis 9 | 608553 |
NNT | chr5 | 5p12 | Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency | 614736 |
NOP10 | chr15 | 15q14-q15 | Dyskeratosis congenita autosomal recessive 1 | 224230 |
NPC1 | chr18 | 18q11-q12 | Niemann-Pick disease type D | 257220 |
NPC1 | chr18 | 18q11-q12 | Niemann-Pick disease type C1 | 257220 |
NPC2 | chr14 | 14q24.3 | Niemann-pick disease type C2 | 607625 |
NPHP1 | chr2 | 2q13 | Nephronophthisis 1 juvenile | 256100 |
NPHP1 | chr2 | 2q13 | Senior-Loken syndrome-1 | 266900 |
NPHP1 | chr2 | 2q13 | Joubert syndrome 4 | 609583 |
NPHP3 | chr3 | 3q22 | Meckel syndrome 7 | 267010 |
NPHP3 | chr3 | 3q22 | Renal-hepatic-pancreatic dysplasia 1 | 208540 |
NPHP3 | chr3 | 3q22 | Nephronophthisis 3 | 604387 |
NPHP4 | chr1 | 1p36 | Nephronophthisis 4 | 606966 |
NPHP4 | chr1 | 1p36 | Senior-Loken syndrome 4 | 606996 |
NPHS1 | chr19 | 19q13.1 | Nephrotic syndrome type 1 | 256300 |
NPHS2 | chr1 | 1q25-q31 | Nephrotic syndrome type 2 | 600995 |
NPPA | chr1 | 1p36.2 | Atrial standstill 2 | 615745 |
NPR2 | chr9 | 9p21-p12 | Acromesomelic dysplasia Maroteaux type | 602875 |
NR0B1 | chrX | Xp21.3-p21.2 | Adrenal hypoplasia congenital | 300200 |
NR0B1 | chrX | Xp21.3-p21.2 | 46XY sex reversal 2 dosage-sensitive | 300018 |
NR0B2 | chr1 | 1p36.1 | Obesity mild early-onset | 601665 |
NR1H4 | chr12 | 12q23.1 | Cholestasis progressive familial intrahepatic 5 | 617049 |
NR2E3 | chr15 | 15q23 | Enhanced S-cone syndrome | 268100 |
NR2E3 | chr15 | 15q23 | Retinitis pigmentosa 37 | 611131 |
NRL | chr14 | 14q11.1-q11.2 | Retinal degeneration autosomal recessive clumped pigment type | |
NRXN1 | chr2 | 2p16.3 | Pitt-Hopkins-like syndrome 2 | 614325 |
NSDHL | chrX | Xq28 | CK syndrome | 300831 |
NSMCE3 | chr15 | 15q13.1 | Lung disease immunodeficiency and chromosome breakage syndrome | 617241 |
NSUN2 | chr5 | 5p15.31 | Mental retardation autosomal recessive 5 | 611091 |
NT5C2 | chr10 | 10q24.3 | Spastic paraplegia 45 autosomal recessive | 613162 |
NT5C3A | chr7 | 7p15-p14 | Anemia hemolytic due to UMPH1 deficiency | 266120 |
NT5E | chr6 | 6q14-q21 | Calcification of joints and arteries | 211800 |
NTHL1 | chr16 | 16p13.3-p13.2 | Familial adenomatous polyposis 3 | 616415 |
NTRK1 | chr1 | 1q21-q22 | Insensitivity to pain congenital with anhidrosis | 256800 |
NUBPL | chr14 | 14q12 | Mitochondrial complex I deficiency nuclear type 21 | 618242 |
NUP107 | chr12 | 12q15 | Galloway-Mowat syndrome 7 | 618348 |
NUP107 | chr12 | 12q15 | Ovarian dysgenesis 6 | 618078 |
NUP107 | chr12 | 12q15 | Nephrotic syndrome type 11 | 616730 |
NUP155 | chr5 | 5p13 | Atrial fibrillation 15 | 615770 |
NUP214 | chr9 | 9q34.1 | Encephalopathy acute infection-induced susceptibility to 9 | 618426 |
NUP62 | chr19 | 19q13.33 | Striatonigral degeneration infantile | 271930 |
NXN | chr17 | 17p13.3 | Robinow syndrome autosomal recessive 2 | 618529 |
NYX | chrX | Xp11.4 | Night blindness congenital stationary (complete) 1A X- linked | 310500 |
OAT | chr10 | 10q26 | Gyrate atrophy of choroid and retina with or without ornithinemia | 258870 |
OBSL1 | chr2 | 2q35 | 3-M syndrome 2 | 612921 |
OCA2 | chr15 | 15q11.2-q12 | Skin/hair/eye pigmentation 1 blue/nonblue eyes | 227220 |
OCA2 | chr15 | 15q11.2-q12 | Skin/hair/eye pigmentation 1 blond/brown hair | 227220 |
OCA2 | chr15 | 15q11.2-q12 | Albinism oculocutaneous type II | 203200 |
OCA2 | chr15 | 15q11.2-q12 | Albinism brown oculocutaneous | 203200 |
OCLN | chr5 | 5q13.1 | Pseudo-TORCH syndrome 1 | 251290 |
OCRL | chrX | Xq26.1 | Lowe syndrome | 309000 |
OCRL | chrX | Xq26.1 | Dent disease 2 | 300555 |
ODAPH | chr4 | 4q21.1 | Amelogenesis imperfecta type IIA4 | 614832 |
OFD1 | chrX | Xp22.3-p22.2 | Retinitis pigmentosa 23 | 300424 |
OFD1 | chrX | Xp22.3-p22.2 | Joubert syndrome 10 | 300804 |
OFD1 | chrX | Xp22.3-p22.2 | Simpson-Golabi-Behmel syndrome type 2 | 300209 |
OGDH | chr7 | 7p14-p13 | Alpha-ketoglutarate dehydrogenase deficiency | 203740 |
OGT | chrX | Xq13 | Mental retardation X-linked 106 | 300997 |
OPA1 | chr3 | 3q28-q29 | Behr syndrome | 210000 |
OPA1 | chr3 | 3q28-q29 | Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type) | 616896 |
OPA3 | chr19 | 19q13.2-q13.3 | 3-methylglutaconic aciduria type III | 258501 |
OPHN1 | chrX | Xq12 | Mental retardation X-linked with cerebellar hypoplasia and distinctive facial appearance | 300486 |
OPLAH | chr8 | 8q24.3 | 5-oxoprolinase deficiency | 260005 |
OPN1LW | chrX | Xq28 | Blue cone monochromacy | 303700 |
OPN1LW | chrX | Xq28 | Colorblindness protan | 303900 |
OPN1MW | chrX | Xq28 | Colorblindness deutan | 303800 |
OPN1MW | chrX | Xq28 | Blue cone monochromacy | 303700 |
ORAI1 | chr12 | 12q24 | Immunodeficiency 9 | 612782 |
ORC1 | chr1 | 1p32 | Meier-Gorlin syndrome 1 | 224690 |
ORC4 | chr2 | 2q22-q23 | Meier-Gorlin syndrome 2 | 613800 |
ORC6 | chr16 | 16q12 | Meier-Gorlin syndrome 3 | 613803 |
OSTM1 | chr6 | 6q21 | Osteopetrosis autosomal recessive 5 | 259720 |
OTC | chrX | Xp21.1 | Ornithine transcarbamylase deficiency | 311250 |
OTOA | chr16 | 16p12.2 | Deafness autosomal recessive 22 | 607039 |
OTOF | chr2 | 2p23-p22 | Auditory neuropathy autosomal recessive 1 | 601071 |
OTOF | chr2 | 2p23-p22 | Deafness autosomal recessive 9 | 601071 |
OTOG | chr11 | 11p14.3 | Deafness autosomal recessive 18B | 614945 |
OTOGL | chr12 | 12q21.31 | Deafness autosomal recessive 84B | 614944 |
P2RY12 | chr3 | 3q24-q25 | Bleeding disorder platelet-type 8 | 609821 |
P3H2 | chr3 | 3q29 | Myopia high with cataract and vitreoretinal degeneration | 614292 |
PADI6 | chr1 | 1p36.13 | Preimplantation embryonic lethality 2 | 617234 |
PAH | chr12 | 12q24.1 | Hyperphenylalaninemia non-PKU mild | 261600 |
PAH | chr12 | 12q24.1 | Phenylketonuria | 261600 |
PAK3 | chrX | Xq23 | Mental retardation X-linked 30/47 | 300558 |
PAM16 | chr16 | 16p13.3 | Spondylometaphyseal dysplasia Megarbane-Dagher- Melike type | 613320 |
PANK2 | chr20 | 20p13-p12.3 | HARP syndrome | 607236 |
PANK2 | chr20 | 20p13-p12.3 | Neurodegeneration with brain iron accumulation 1 | 234200 |
PAPSS2 | chr10 | 10q22-q24 | Brachyolmia 4 with mild epiphyseal and metaphyseal changes | 612847 |
PARK7 | chr1 | 1p36 | Parkinson disease 7 autosomal recessive early-onset | 606324 |
PARN | chr16 | 16p13.12 | Dyskeratosis congenita autosomal recessive 6 | 616353 |
PARS2 | chr1 | 1p32.2 | Epileptic encephalopathy early infantile 75 | 618437 |
PAX1 | chr20 | 20p11.2 | Otofaciocervical syndrome 2 | 615560 |
PAX3 | chr2 | 2q36.1 | Waardenburg syndrome type 3 | 148820 |
PAX4 | chr7 | 7q32 | Diabetes mellitus ketosis-prone susceptibility to | 612227 |
PAX7 | chr1 | 1p36.2-p36.12 | Myopathy congenital progressive with scoliosis | 618578 |
PC | chr11 | 11q13.4-q13.5 | Pyruvate carboxylase deficiency | 266150 |
PCBD1 | chr10 | 10q22 | Hyperphenylalaninemia BH4-deficient D | 264070 |
PCCA | chr13 | 13q32 | Propionicacidemia | 606054 |
PCCB | chr3 | 3q21-q22 | Propionicacidemia | 606054 |
PCDH15 | chr10 | 10q21-q22 | Usher syndrome type 1D/F digenic | 601067 |
PCDH15 | chr10 | 10q21-q22 | Usher syndrome type 1F | 602083 |
PCDH15 | chr10 | 10q21-q22 | Deafness autosomal recessive 23 | 609533 |
PCK1 | chr20 | 20q13.31 | Phosphoenolpyruvate carboxykinase deficiency cytosolic | 261680 |
PCK2 | chr14 | 14q11.2-q12 | PEPCK deficiency mitochondrial | 261650 |
PCLO | chr7 | 7q11.23-q21.1 | Pontocerebellar hypoplasia type 3 | 608027 |
PCNA | chr20 | 20p12 | Ataxia-telangiectasia-like disorder 2 | 615919 |
PCNT | chr21 | 21q22.3 | Microcephalic osteodysplastic primordial dwarfism type II | 210720 |
PCSK1 | chr5 | 5q15-q21 | Obesity with impaired prohormone processing | 600955 |
PCYT1A | chr3 | 3q29 | Spondylometaphyseal dysplasia with cone-rod dystrophy | 608940 |
PDE10A | chr6 | 6q27 | Dyskinesia limb and orofacial infantile-onset | 616921 |
PDE6B | chr4 | 4p16.3 | Retinitis pigmentosa-40 | 613801 |
PDE6C | chr10 | 10q24 | Cone dystrophy 4 | 613093 |
PDE6D | chr2 | 2q36-q37 | Joubert syndrome 22 | 615665 |
PDE6G | chr17 | 17q25 | Retinitis pigmentosa 57 | 613582 |
PDE6H | chr12 | 12p13 | Retinal cone dystrophy 3 | 610024 |
PDE6H | chr12 | 12p13 | Achromatopsia 6 | 610024 |
PDHX | chr11 | 11p13 | Lacticacidemia due to PDX1 deficiency | 245349 |
PDP1 | chr8 | 8q22.1 | Pyruvate dehydrogenase phosphatase deficiency | 608782 |
PDSS1 | chr10 | 10p12.1 | Coenzyme Q10 deficiency primary 2 | 614651 |
PDSS2 | chr6 | 6q21 | Coenzyme Q10 deficiency primary 3 | 614652 |
PDX1 | chr13 | 13q12.1 | Pancreatic agenesis 1 | 260370 |
PDXK | chr21 | 21q22.3 | Neuropathy hereditary motor and sensory type VIC with optic atrophy | 618511 |
PDZD7 | chr10 | 10q24.3 | Usher syndrome type IIC GPR98/PDZD7 digenic | 605472 |
PDZD7 | chr10 | 10q24.3 | Deafness autosomal recessive 57 | 618003 |
PDZD7 | chr10 | 10q24.3 | Retinal disease in Usher syndrome type IIA modifier of | 276901 |
PEPD | chr19 | 19cen-q13.11 | Prolidase deficiency | 170100 |
PET100 | chr19 | 19p13.2 | Mitochondrial complex IV deficiency | 220110 |
PEX1 | chr7 | 7q21-q22 | Heimler syndrome 1 | 234580 |
PEX1 | chr7 | 7q21-q22 | Peroxisome biogenesis disorder 1B (NALD/IRD) | 601539 |
PEX1 | chr7 | 7q21-q22 | Peroxisome biogenesis disorder 1A (Zellweger) | 214100 |
PEX10 | chr1 | 1p36.32 | Peroxisome biogenesis disorder 6B | 614871 |
PEX10 | chr1 | 1p36.32 | Peroxisome biogenesis disorder 6A (Zellweger) | 614870 |
PEX11B | chr1 | 1q21.1 | Peroxisome biogenesis disorder 14B | 614920 |
PEX12 | chr17 | 17q12 | Peroxisome biogenesis disorder 3A (Zellweger) | 614859 |
PEX12 | chr17 | 17q12 | Peroxisome biogenesis disorder 3B | 266510 |
PEX13 | chr2 | 2p15 | Peroxisome biogenesis disorder 11A (Zellweger) | 614883 |
PEX13 | chr2 | 2p15 | Peroxisome biogenesis disorder 11B | 614885 |
PEX14 | chr1 | 1p36.2 | Peroxisome biogenesis disorder 13A (Zellweger) | 614887 |
PEX16 | chr11 | 11p12-p11.2 | Peroxisome biogenesis disorder 8A (Zellweger) | 614876 |
PEX16 | chr11 | 11p12-p11.2 | Peroxisome biogenesis disorder 8B | 614877 |
PEX19 | chr1 | 1q22 | Peroxisome biogenesis disorder 12A (Zellweger) | 614886 |
PEX2 | chr8 | 8q21.1 | Peroxisome biogenesis disorder 5A (Zellweger) | 614866 |
PEX2 | chr8 | 8q21.1 | Peroxisome biogenesis disorder 5B | 614867 |
PEX26 | chr22 | 22q11.21 | Peroxisome biogenesis disorder 7A (Zellweger) | 614872 |
PEX26 | chr22 | 22q11.21 | Peroxisome biogenesis disorder 7B | 614873 |
PEX3 | chr6 | 6q24.2 | Peroxisome biogenesis disorder 10A (Zellweger) | 614882 |
PEX3 | chr6 | 6q24.2 | Peroxisome biogenesis disorder 10B | 617370 |
PEX5 | chr12 | 12p13.3 | Peroxisome biogenesis disorder 2B | 202370 |
PEX5 | chr12 | 12p13.3 | Rhizomelic chondrodysplasia punctata type 5 | 616716 |
PEX5 | chr12 | 12p13.3 | Peroxisome biogenesis disorder 2A (Zellweger) | 214110 |
PEX6 | chr6 | 6p21.1 | Peroxisome biogenesis disorder 4B | 614863 |
PEX6 | chr6 | 6p21.1 | Heimler syndrome 2 | 616617 |
PEX6 | chr6 | 6p21.1 | Peroxisome biogenesis disorder 4A (Zellweger) | 614862 |
PEX7 | chr6 | 6q23.3 | Peroxisome biogenesis disorder 9B | 614879 |
PEX7 | chr6 | 6q23.3 | Rhizomelic chondrodysplasia punctata type 1 | 215100 |
PFKM | chr12 | 12q13.3 | Glycogen storage disease VII | 232800 |
PGAM2 | chr7 | 7p13-p12.3 | Glycogen storage disease X | 261670 |
PGAP1 | chr2 | 2q33.1 | Mental retardation autosomal recessive 42 | 615802 |
PGAP2 | chr11 | 11p15.5 | Hyperphosphatasia with mental retardation syndrome 3 | 614207 |
PGAP3 | chr17 | 17q12 | Hyperphosphatasia with mental retardation syndrome 4 | 615716 |
PGK1 | chrX | Xq13 | Phosphoglycerate kinase 1 deficiency | 300653 |
PGM1 | chr1 | 1p31 | Congenital disorder of glycosylation type It | 614921 |
PGM3 | chr6 | 6q12 | Immunodeficiency 23 | 615816 |
PGR | chr11 | 11q22 | Progesterone resistance | 264080 |
PHC1 | chr12 | 12p13.31 | Microcephaly 11 primary autosomal recessive | 615414 |
PHF6 | chrX | Xq26.3 | Borjeson-Forssman-Lehmann syndrome | 301900 |
PHF8 | chrX | Xp11.2 | Mental retardation syndrome X-linked Siderius type | 300263 |
PHGDH | chr1 | 1p12 | Neu-Laxova syndrome 1 | 256520 |
PHGDH | chr1 | 1p12 | Phosphoglycerate dehydrogenase deficiency | 601815 |
PHKA1 | chrX | Xq13 | Muscle glycogenosis | 300559 |
PHKA2 | chrX | Xp22.2-p22.1 | Glycogen storage disease type IXa2 | 306000 |
PHKA2 | chrX | Xp22.2-p22.1 | Glycogen storage disease type IXa1 | 306000 |
PHKB | chr16 | 16q12-q13 | Phosphorylase kinase deficiency of liver and muscle autosomal recessive | 261750 |
PHKG2 | chr16 | 16p12.1-p11.2 | Glycogen storage disease IXc | 613027 |
PHOX2A | chr11 | 11q13.3-q13.4 | Fibrosis of extraocular muscles congenital 2 | 602078 |
PHYH | chr10 | 10pter-p11.2 | Refsum disease | 266500 |
PI4KA | chr22 | 22q11.21 | Polymicrogyria perisylvian with cerebellar hypoplasia and arthrogryposis | 616531 |
PIBF1 | chr13 | 13q21-q22 | Joubert syndrome 33 | 617767 |
PIEZO1 | chr16 | 16q24.3 | Lymphatic malformation 6 | 616843 |
PIEZO2 | chr18 | 18p11.22 | Arthrogryposis distal with impaired proprioception and touch | 617146 |
PIGA | chrX | Xp22.1 | Multiple congenital anomalies-hypotonia-seizures syndrome 2 | 300868 |
PIGL | chr17 | 17p12-p11.2 | CHIME syndrome | 280000 |
PIGM | chr1 | 1q23.2 | Glycosylphosphatidylinositol deficiency | 610293 |
PIGN | chr18 | 18q21.33 | Multiple congenital anomalies-hypotonia-seizures syndrome 1 | 614080 |
PIGO | chr9 | 9p13 | Hyperphosphatasia with mental retardation syndrome 2 | 614749 |
PIGQ | chr16 | 16p13.3 | Epileptic encephalopathy early infantile 77 | 618548 |
PIGT | chr20 | 20q13.12 | Multiple congenital anomalies-hypotonia-seizures syndrome 3 | 615398 |
PIGV | chr1 | 1p36.11 | Hyperphosphatasia with mental retardation syndrome 1 | 239300 |
PIGW | chr17 | 17q12 | Glycosylphosphatidylinositol biosynthesis defect 11 | 616025 |
PIK3R1 | chr5 | 5q13 | Agammaglobulinemia 7 autosomal recessive | 615214 |
PIK3R5 | chr17 | 17p13.1 | Ataxia-oculomotor apraxia 3 | 615217 |
PINK1 | chr1 | 1p36 | Parkinson disease 6 early onset | 605909 |
PIP5K1C | chr19 | 19p13.3 | Lethal congenital contractural syndrome 3 | 611369 |
PITX3 | chr10 | 10q25 | Cataract 11 syndromic autosomal recessive | 610623 |
PITX3 | chr10 | 10q25 | Cataract 11 multiple types | 610623 |
PJVK | chr2 | 2q31.2 | Deafness autosomal recessive 59 | 610220 |
PKD1L1 | chr7 | 7p13-p12 | Heterotaxy visceral 8 autosomal | 617205 |
PKHD1 | chr6 | 6p12.3-p12.2 | Polycystic kidney disease 4 with or without hepatic disease | 263200 |
PKLR | chr1 | 1q21 | Pyruvate kinase deficiency | 266200 |
PKP1 | chr1 | 1q32 | Ectodermal dysplasia/skin fragility syndrome | 604536 |
PLA2G4A | chr1 | 1q25 | Gastrointestinal ulceration recurrent with dysfunctional platelets | 618372 |
PLA2G5 | chr1 | 1p36-p34 | Fleck retina familial benign | 228980 |
PLA2G6 | chr22 | 22q13.1 | Infantile neuroaxonal dystrophy 1 | 256600 |
PLA2G6 | chr22 | 22q13.1 | Parkinson disease 14 autosomal recessive | 612953 |
PLA2G6 | chr22 | 22q13.1 | Neurodegeneration with brain iron accumulation 2B | 610217 |
PLA2G7 | chr6 | 6p21.2-p12 | Platelet-activating factor acetylhydrolase deficiency | 614278 |
PLCB1 | chr20 | 20p12 | Epileptic encephalopathy early infantile 12 | 613722 |
PLCB4 | chr20 | 20p12 | Auriculocondylar syndrome 2 | 614669 |
PLCD1 | chr3 | 3p22-p21.3 | Nail disorder nonsyndromic congenital 3 (leukonychia) | 151600 |
PLCE1 | chr10 | 10q23 | Nephrotic syndrome type 3 | 610725 |
PLCZ1 | chr12 | 12p12.3 | Spermatogenic failure 17 | 617214 |
PLEC | chr8 | 8q24 | Muscular dystrophy limb-girdle autosomal recessive 17 | 613723 |
PLEC | chr8 | 8q24 | Epidermolysis bullosa simplex with pyloric atresia | 612138 |
PLEC | chr8 | 8q24 | Epidermolysis bullosa simplex with muscular dystrophy | 226670 |
PLEC | chr8 | 8q24 | Epidermolysis bullosa simplex with nail dystrophy | 616487 |
PLEKHG5 | chr1 | 1p36 | Spinal muscular atrophy distal autosomal recessive 4 | 611067 |
PLEKHG5 | chr1 | 1p36 | Charcot-Marie-Tooth disease recessive intermediate C | 615376 |
PLEKHM1 | chr17 | 17q21.3 | Osteopetrosis autosomal recessive 6 | 611497 |
PLG | chr6 | 6q26 | Dysplasminogenemia | 217090 |
PLG | chr6 | 6q26 | Plasminogen deficiency type I | 217090 |
PLK4 | chr4 | 4q27-q28 | Microcephaly and chorioretinopathy autosomal recessive 2 | 616171 |
PLOD1 | chr1 | 1p36.3-p36.2 | Ehlers-Danlos syndrome kyphoscoliotic type 1 | 225400 |
PLOD2 | chr3 | 3q23-q24 | Bruck syndrome 2 | 609220 |
PLOD3 | chr7 | 7q22 | Lysyl hydroxylase 3 deficiency | 612394 |
PLP1 | chrX | Xq22 | Pelizaeus-Merzbacher disease | 312080 |
PLP1 | chrX | Xq22 | Spastic paraplegia 2 X-linked | 312920 |
PMM2 | chr16 | 16p13.3-p13.2 | Congenital disorder of glycosylation type Ia | 212065 |
PMP22 | chr17 | 17p11.2 | Dejerine-Sottas disease | 145900 |
PMPCA | chr9 | 9q34.3 | Spinocerebellar ataxia autosomal recessive 2 | 213200 |
PMS2 | chr7 | 7p22 | Mismatch repair cancer syndrome | 276300 |
PNKP | chr19 | 19q13.4 | Microcephaly seizures and developmental delay | 613402 |
PNKP | chr19 | 19q13.4 | Ataxia-oculomotor apraxia 4 | 616267 |
PNKP | chr19 | 19q13.4 | Charcot-Marie-Tooth disease type 2B2 | 605589 |
PNLIP | chr10 | 10q26.1 | Pancreatic lipase deficiency | 614338 |
PNP | chr14 | 14q13.1 | Immunodeficiency due to purine nucleoside phosphorylase deficiency | 613179 |
PNPLA1 | chr6 | 6p21.31 | Ichthyosis congenital autosomal recessive 10 | 615024 |
PNPLA2 | chr11 | 11p15.5 | Neutral lipid storage disease with myopathy | 610717 |
PNPLA6 | chr19 | 19p13.3 | Spastic paraplegia 39 autosomal recessive | 612020 |
PNPLA6 | chr19 | 19p13.3 | Boucher-Neuhauser syndrome | 215470 |
PNPLA6 | chr19 | 19p13.3 | Oliver-McFarlane syndrome | 275400 |
PNPLA6 | chr19 | 19p13.3 | Laurence-Moon syndrome | 245800 |
PNPO | chr17 | 17q21.32 | Pyridoxamine 5′-phosphate oxidase deficiency | 610090 |
PNPT1 | chr2 | 2p16.1 | Deafness autosomal recessive 70 | 614934 |
PNPT1 | chr2 | 2p16.1 | Combined oxidative phosphorylation deficiency 13 | 614932 |
POC1A | chr3 | 3p21.2 | Short stature onychodysplasia facial dysmorphism and hypotrichosis | 614813 |
POC1B | chr12 | 12q21.33 | Cone-rod dystrophy 20 | 615973 |
POF1B | chrX | Xq21 | Premature ovarian failure 2B | 300604 |
POGLUT1 | chr3 | 3q13.33 | Muscular dystrophy limb-girdle autosomal recessive 21 | 617232 |
POLA1 | chrX | Xp22.3-p21.1 | Pigmentary disorder reticulate with systemic manifestations X-linked | 301220 |
POLA1 | chrX | Xp22.3-p21.1 | Van Esch-O’Driscoll syndrome | 301030 |
POLE | chr12 | 12q24.3 | FILS syndrome | 615139 |
POLE | chr12 | 12q24.3 | IMAGE-I syndrome | 618336 |
POLG | chr15 | 15q25 | Mitochondrial DNA depletion syndrome 4B (MNGIE type) | 613662 |
POLG | chr15 | 15q25 | Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE) | 607459 |
POLG | chr15 | 15q25 | Mitochondrial DNA depletion syndrome 4A (Alpers type) | 203700 |
POLG | chr15 | 15q25 | Progressive external ophthalmoplegia autosomal recessive 1 | 258450 |
POLG2 | chr17 | 17q23-q24 | Mitochondrial DNA depletion syndrome 16 (hepatic type) | 618528 |
POLH | chr6 | 6p21.1-p12 | Xeroderma pigmentosum variant type | 278750 |
POLR1C | chr6 | 6p22.3 | Treacher Collins syndrome 3 | 248390 |
POLR1C | chr6 | 6p22.3 | Leukodystrophy hypomyelinating 11 | 616494 |
POLR1D | chr13 | 13q12.2 | Treacher Collins syndrome 2 | 613717 |
POLR3A | chr10 | 10q22.3 | Leukodystrophy hypomyelinating 7 with or without oligodontia and/or hypogonadotropic hypogonadism | 607694 |
POLR3A | chr10 | 10q22.3 | Wiedemann-Rautenstrauch syndrome | 264090 |
POLR3B | chr12 | 12q23.3 | Leukodystrophy hypomyelinating 8 with or without oligodontia and/or hypogonadotropic hypogonadism | 614381 |
POMC | chr2 | 2p23.3 | Obesity early-onset susceptibility to | 601665 |
POMC | chr2 | 2p23.3 | Obesity adrenal insufficiency and red hair due to POMC deficiency | 609734 |
POMGNT1 | chr1 | 1p34-p33 | Muscular dystrophy-dystroglycanopathy (congenital with mental retardation) type B 3 | 613151 |
POMGNT1 | chr1 | 1p34-p33 | Muscular dystrophy-dystroglycanopathy (limb-girdle) type C 3 | 613157 |
POMGNT1 | chr1 | 1p34-p33 | Retinitis pigmentosa 76 | 617123 |
POMGNT1 | chr1 | 1p34-p33 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A 3 | 253280 |
POMGNT2 | chr3 | 3p22.1 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies type A 8 | 614830 |
POMGNT2 | chr3 | 3p22.1 | Muscular dystrophy-dystroglycanopathy (limb-girdle) type C 8 | 618135 |
POMK | chr8 | 8p11 | ?Muscular dystrophy-dystroglycanopathy (limb-girdle) type C 12 | 616094 |
POMK | chr8 | 8p11 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A 12 | 615249 |
POMP | chr13 | 13q12.3 | Keratosis linearis with ichthyosis congenita and sclerosing keratoderma | 601952 |
POMT1 | chr9 | 9q34.1 | Muscular dystrophy-dystroglycanopathy (limb-girdle) type C 1 | 609308 |
POMT1 | chr9 | 9q34.1 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A 1 | 236670 |
POMT1 | chr9 | 9q34.1 | Muscular dystrophy-dystroglycanopathy (congenital with mental retardation) type B 1 | 613155 |
POMT2 | chr14 | 14q24.3 | Muscular dystrophy-dystroglycanopathy (limb-girdle) type C 2 | 613158 |
POMT2 | chr14 | 14q24.3 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A 2 | 613150 |
POMT2 | chr14 | 14q24.3 | Muscular dystrophy-dystroglycanopathy (congenital with mental retardation) type B 2 | 613156 |
POP1 | chr8 | 8q22 | Anauxetic dysplasia 2 | 617396 |
POR | chr7 | 7q11.2 | Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis | 201750 |
POU1F1 | chr3 | 3p11 | Pituitary hormone deficiency combined 1 | 613038 |
POU3F4 | chrX | Xq21.1 | Deafness X-linked 2 | 304400 |
PPARG | chr3 | 3p25 | Obesity severe | 601665 |
PPIB | chr15 | 15q21-q22 | Osteogenesis imperfecta type IX | 259440 |
PPP1R15B | chr1 | 1q32.1 | Microcephaly short stature and impaired glucose metabolism 2 | 616817 |
PPT1 | chr1 | 1p32 | Ceroid lipofuscinosis neuronal 1 | 256730 |
PQBP1 | chrX | Xp11.23 | Renpenning syndrome | 309500 |
PRDM5 | chr4 | 4q27 | Brittle cornea syndrome 2 | 614170 |
PREPL | chr2 | 2p21 | Myasthenic syndrome congenital 22 | 616224 |
PRF1 | chr10 | 10q22 | Hemophagocytic lymphohistiocytosis familial 2 | 603553 |
PRG4 | chr1 | 1q24-q25 | Camptodactyly-arthropathy-coxa vara-pericarditis syndrome | 208250 |
PRICKLE1 | chr12 | 12q12 | Epilepsy progressive myoclonic 1B | 612437 |
PRKACG | chr9 | 9q21.11 | Bleeding disorder platelet-type 19 | 616176 |
PRKCD | chr3 | 3p | Autoimmune lymphoproliferative syndrome type III | 615559 |
PRKDC | chr8 | 8q11 | Immunodeficiency 26 with or without neurologic abnormalities | 615966 |
PRKN | chr6 | 6q25.2-q27 | Parkinson disease juvenile type 2 | 600116 |
PRKRA | chr2 | 2q31.3 | Dystonia 16 | 612067 |
PRLR | chr5 | 5p13.2 | Hyperprolactinemia | 615555 |
PRMT7 | chr16 | 16q22.1 | Short stature brachydactyly intellectual developmental disability and seizures | 617157 |
PROC | chr2 | 2q13-q14 | Thrombophilia due to protein C deficiency autosomal recessive | 612304 |
PRODH | chr22 | 22q11.2 | Hyperprolinemia type I | 239500 |
PROM1 | chr4 | 4p15.3 | Retinitis pigmentosa 41 | 612095 |
PROM1 | chr4 | 4p15.3 | Cone-rod dystrophy 12 | 612657 |
PROP1 | chr5 | 5q | Pituitary hormone deficiency combined 2 | 262600 |
PROS1 | chr3 | 3q11.2 | Thrombophilia due to protein S deficiency autosomal recessive | 614514 |
PRPH | chr12 | 12q12-q13 | Amyotrophic lateral sclerosis susceptibility to | 105400 |
PRPH2 | chr6 | 6p21.1-cen | Retinitis punctata albescens | 136880 |
PRPH2 | chr6 | 6p21.1-cen | Retinitis pigmentosa 7 and digenic form | 608133 |
PRPH2 | chr6 | 6p21.1-cen | Leber congenital amaurosis 18 | 608133 |
PRPS1 | chrX | Xq22-q24 | Charcot-Marie-Tooth disease X-linked recessive 5 | 311070 |
PRPS1 | chrX | Xq22-q24 | Phosphoribosylpyrophosphate synthetase superactivity | 300661 |
PRPS1 | chrX | Xq22-q24 | Deafness X-linked 1 | 304500 |
PRPS1 | chrX | Xq22-q24 | Arts syndrome | 301835 |
PRPS1 | chrX | Xq22-q24 | Gout PRPS-related | 300661 |
PRRX1 | chr1 | 1q24 | Agnathia-otocephaly complex | 202650 |
PRSS12 | chr4 | 4q25-q26 | Mental retardation autosomal recessive 1 | 249500 |
PRSS56 | chr2 | 2q37.1 | Microphthalmia isolated 6 | 613517 |
PRX | chr19 | 19q13.1-q13.2 | Charcot-Marie-Tooth disease type 4F | 614895 |
PRX | chr19 | 19q13.1-q13.2 | Dejerine-Sottas disease | 145900 |
PSAP | chr10 | 10q22.1 | Krabbe disease atypical | 611722 |
PSAP | chr10 | 10q22.1 | Combined SAP deficiency | 611721 |
PSAP | chr10 | 10q22.1 | Metachromatic leukodystrophy due to SAP-b deficiency | 249900 |
PSAT1 | chr9 | 9q21.31 | Neu-Laxova syndrome 2 | 616038 |
PSAT1 | chr9 | 9q21.31 | Phosphoserine aminotransferase deficiency | 610992 |
PSMB8 | chr6 | 6p21.3 | Proteasome-associated autoinflammatory syndrome 1 and digenic forms | 256040 |
PSMB9 | chr6 | 6p21.3 | Proteasome-associated autoinflammatory syndrome 3 digenic | 617591 |
PSMC3IP | chr17 | 17q21.2 | Ovarian dysgenesis 3 | 614324 |
PSPH | chr7 | 7p11.2 | Phosphoserine phosphatase deficiency | 614023 |
PTCHD1 | chrX | Xp22.11 | Autism susceptibility to X-linked 4 | 300830 |
PTF1A | chr10 | 10p12.3 | Pancreatic and cerebellar agenesis | 609069 |
PTF1A | chr10 | 10p12.3 | Pancreatic agenesis 2 | 615935 |
PTGER2 | chr14 | 14q22 | Asthma aspirin-induced susceptibility to | 208550 |
PTH | chr11 | 11p15.3-p15.1 | Hypoparathyroidism familial isolated 1 | 146200 |
PTH1R | chr3 | 3p22-p21.1 | Eiken syndrome | 600002 |
PTH1R | chr3 | 3p22-p21.1 | Chondrodysplasia Blomstrand type | 215045 |
PTPN14 | chr1 | 1q32 | Choanal atresia and lymphedema | 613611 |
PTPN22 | chr1 | 1p13 | Diabetes type 1 susceptibility to | 222100 |
PTPN23 | chr3 | 3p21.3 | Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity | 618890 |
PTPRC | chr1 | 1q31-q32 | Severe combined immunodeficiency T cell-negative B- cell/natural killer-cell positive | 608971 |
PTPRF | chr1 | 1p32 | Breasts and/or nipples aplasia or hypoplasia of 2 | 616001 |
PTPRO | chr12 | 12p13-p12 | Nephrotic syndrome type 6 | 614196 |
PTPRQ | chr12 | 12q21.2 | Deafness autosomal recessive 84A | 613391 |
PTRH2 | chr17 | 17q23.1 | Infantile-onset multisystem neurologic endocrine and pancreatic disease | 616263 |
PTS | chr11 | 11q22.3-q23.3 | Hyperphenylalaninemia BH4-deficient A | 261640 |
PUS1 | chr12 | 12q24.33 | Myopathy lactic acidosis and sideroblastic anemia 1 | 600462 |
PXDN | chr2 | 2p25.3 | Anterior segment dysgenesis 7 with sclerocornea | 269400 |
PYCR1 | chr17 | 17q25.3 | Cutis laxa autosomal recessive type IIB | 612940 |
PYCR2 | chr1 | 1q42.13 | Leukodystrophy hypomyelinating 10 | 616420 |
PYGL | chr14 | 14q22.1 | Glycogen storage disease VI | 232700 |
PYGM | chr11 | 11q13 | McArdle disease | 232600 |
QDPR | chr4 | 4p15.31 | Hyperphenylalaninemia BH4-deficient C | 261630 |
RAB18 | chr10 | 10p12.1 | Warburg micro syndrome 3 | 614222 |
RAB23 | chr6 | 6p11 | Carpenter syndrome | 201000 |
RAB27A | chr15 | 15q21 | Griscelli syndrome type 2 | 607624 |
RAB28 | chr4 | 4p15.33 | Cone-rod dystrophy 18 | 615374 |
RAB33B | chr4 | 4q31.1 | Smith-McCort dysplasia 2 | 615222 |
RAB39B | chrX | Xq28 | Waisman syndrome | 311510 |
RAB39B | chrX | Xq28 | Mental retardation X-linked 72 | 300271 |
RAB3GAP1 | chr2 | 2q21.3 | Warburg micro syndrome 1 | 600118 |
RAB3GAP2 | chr1 | 1q41 | Warburg micro syndrome 2 | 614225 |
RAB3GAP2 | chr1 | 1q41 | Martsolf syndrome | 212720 |
RAD21 | chr8 | 8q24 | Mungan syndrome | 611376 |
RAD51C | chr17 | 17q22 | Fanconi anemia complementation group O | 613390 |
RAG1 | chr11 | 11p13 | Omenn syndrome | 603554 |
RAG1 | chr11 | 11p13 | Severe combined immunodeficiency B cell-negative | 601457 |
RAG1 | chr11 | 11p13 | Combined cellular and humoral immune defects with granulomas | 233650 |
RAG2 | chr11 | 11p13 | Severe combined immunodeficiency B cell-negative | 601457 |
RAG2 | chr11 | 11p13 | Combined cellular and humoral immune defects with granulomas | 233650 |
RAG2 | chr11 | 11p13 | Omenn syndrome | 603554 |
RALGAPA1 | chr14 | 14q13.2 | Neurodevelopmental disorder with hypotonia neonatal respiratory insufficiency and thermodysregulation | 618797 |
RAPSN | chr11 | 11p11.2-p11.1 | Fetal akinesia deformation sequence 2 | 618388 |
RAPSN | chr11 | 11p11.2-p11.1 | Myasthenic syndrome congenital 11 associated with acetylcholine receptor deficiency | 616326 |
RARB | chr3 | 3p24 | Microphthalmia syndromic 12 | 615524 |
RARS2 | chr6 | 6q16.1 | Pontocerebellar hypoplasia type 6 | 611523 |
RASGRP1 | chr15 | 15q15 | Immunodeficiency 64 | 618534 |
RASGRP2 | chr11 | 11q13 | Bleeding disorder platelet-type 18 | 615888 |
RAX | chr18 | 18q21.3 | Microphthalmia isolated 3 | 611038 |
RBBP8 | chr18 | 18q11.2 | Jawad syndrome | 251255 |
RBBP8 | chr18 | 18q11.2 | Seckel syndrome 2 | 606744 |
RBCK1 | chr20 | 20p13 | Polyglucosan body myopathy 1 with or without immunodeficiency | 615895 |
RBM10 | chrX | Xp11.23 | TARP syndrome | 311900 |
RBM28 | chr7 | 7q32.1 | Alopecia neurologic defects and endocrinopathy syndrome | 612079 |
RBM8A | chr1 | 1q12 | Thrombocytopenia-absent radius syndrome | 274000 |
RBP3 | chr10 | 10q11.2 | Retinitis pigmentosa 66 | 615233 |
RBP4 | chr10 | 10q24 | Retinal dystrophy iris coloboma and comedogenic acne syndrome | 615147 |
RCBTB1 | chr13 | 13q14 | Retinal dystrophy with or without extraocular anomalies | 617175 |
RD3 | chr1 | 1q32.3 | Leber congenital amaurosis 12 | 610612 |
RDH11 | chr14 | 14q23.3 | Retinal dystrophy juvenile cataracts and short stature syndrome | 616108 |
RDH12 | chr14 | 14q23.3 | Leber congenital amaurosis 13 | 612712 |
RDH5 | chr12 | 12q13-q14 | Fundus albipunctatus | 136880 |
RDX | chr11 | 11q23 | Deafness autosomal recessive 24 | 611022 |
RECQL4 | chr8 | 8q24.3 | RAPADILINO syndrome | 266280 |
RECQL4 | chr8 | 8q24.3 | Baller-Gerold syndrome | 218600 |
RECQL4 | chr8 | 8q24.3 | Rothmund-Thomson syndrome type 2 | 268400 |
REEP2 | chr5 | 5q31 | Spastic paraplegia 72 autosomal dominant | 615625 |
REEP2 | chr5 | 5q31 | Spastic paraplegia 72 autosomal recessive | 615625 |
RELN | chr7 | 7q22 | Lissencephaly 2 (Norman-Roberts type) | 257320 |
REN | chr1 | 1q32 | Renal tubular dysgenesis | 267430 |
RETREG1 | chr5 | 5p15.1 | Neuropathy hereditary sensory and autonomic type IIB | 613115 |
RFC1 | chr4 | 4p14-p13 | Cerebellar ataxia neuropathy and vestibular areflexia syndrome | 614575 |
RFT1 | chr3 | 3p21.1 | Congenital disorder of glycosylation type In | 612015 |
RFX5 | chr1 | 1q21.1-q21.3 | Bare lymphocyte syndrome type II complementation group C | 209920 |
RFX5 | chr1 | 1q21.1-q21.3 | Bare lymphocyte syndrome type II complementation group E | 209920 |
RFX6 | chr6 | 6q22.2 | Mitchell-Riley syndrome | 615710 |
RFXANK | chr19 | 19p12 | MHC class II deficiency complementation group B | 209920 |
RFXAP | chr13 | 13q14 | Bare lymphocyte syndrome type II complementation group D | 209920 |
RHO | chr3 | 3q21-q24 | Retinitis punctata albescens | 136880 |
RHO | chr3 | 3q21-q24 | Retinitis pigmentosa 4 autosomal dominant or recessive | 613731 |
RHOH | chr4 | 4p13 | Epidermodysplasia verruciformis susceptibility to 4 | 618307 |
RIC1 | chr9 | 9p24.1 | CATIFA syndrome | 618761 |
RIMS2 | chr8 | 8q22.3 | Cone-rod synaptic disorder syndrome congenital nonprogressive | 618970 |
RIN2 | chr20 | 20p11.22 | Macrocephaly alopecia cutis laxa and scoliosis | 613075 |
RINT1 | chr7 | 7q22.3 | Infantile liver failure syndrome 3 | 618641 |
RIPK4 | chr21 | 21q22.3 | Popliteal pterygium syndrome Bartsocas-Papas type | 263650 |
RIPK4 | chr21 | 21q22.3 | CHAND syndrome | 214350 |
RIPOR2 | chr6 | 6p22.3-p21.32 | Deafness autosomal recessive 104 | 616515 |
RLBP1 | chr15 | 15q26 | Retinitis punctata albescens | 136880 |
RLBP1 | chr15 | 15q26 | Bothnia retinal dystrophy | 607475 |
RLBP1 | chr15 | 15q26 | Fundus albipunctatus | 136880 |
RMND1 | chr6 | 6q25 | Combined oxidative phosphorylation deficiency 11 | 614922 |
RMRP | chr9 | 9p21-p12 | Anauxetic dysplasia 1 | 607095 |
RMRP | chr9 | 9p21-p12 | Cartilage-hair hypoplasia | 250250 |
RMRP | chr9 | 9p21-p12 | Metaphyseal dysplasia without hypotrichosis | 250460 |
RNASEH2A | chr19 | 19p13.13 | Aicardi-Goutieres syndrome 4 | 610333 |
RNASEH2B | chr13 | 13q14.1 | Aicardi-Goutieres syndrome 2 | 610181 |
RNASEH2C | chr11 | 11q13.2 | Aicardi-Goutieres syndrome 3 | 610329 |
RNASET2 | chr6 | 6q27 | Leukoencephalopathy cystic without megalencephaly | 612951 |
RNF168 | chr3 | 3q29 | RIDDLE syndrome | 611943 |
RNF216 | chr7 | 7p22 | Cerebellar ataxia and hypogonadotropic hypogonadism | 212840 |
RNU4ATAC | chr2 | 2q14.2 | Microcephalic osteodysplastic primordial dwarfism type I | 210710 |
RNU4ATAC | chr2 | 2q14.2 | Roifman syndrome | 616651 |
ROBO3 | chr11 | 11q23-q25 | Gaze palsy familial horizontal with progressive scoliosis 1 | 607313 |
ROGDI | chr16 | 16p13.3 | Kohlschutter-Tonz syndrome | 226750 |
ROM1 | chr11 | 11q13 | Retinitis pigmentosa 7 digenic form | 608133 |
ROR2 | chr9 | 9q22 | Brachydactyly type B1 | 113000 |
ROR2 | chr9 | 9q22 | Robinow syndrome autosomal recessive | 268310 |
RORC | chr1 | 1q21 | Immunodeficiency 42 | 616622 |
RP1 | chr8 | 8q11-q13 | Retinitis pigmentosa 1 | 180100 |
RP1L1 | chr8 | 8p23 | Retinitis pigmentosa 88 | 618826 |
RP1L1 | chr8 | 8p23 | Occult macular dystrophy | 613587 |
RPE65 | chr1 | 1p31 | Leber congenital amaurosis 2 | 204100 |
RPE65 | chr1 | 1p31 | Retinitis pigmentosa 87 with choroidal involvement | 618697 |
RPE65 | chr1 | 1p31 | Retinitis pigmentosa 20 | 613794 |
RPGR | chrX | Xp11.4 | Cone-rod dystrophy X-linked 1 | 304020 |
RPGR | chrX | Xp11.4 | Macular degeneration X-linked atrophic | 300834 |
RPGRIP1 | chr14 | 14q11 | Leber congenital amaurosis 6 | 613826 |
RPGRIP1L | chr16 | 16q12.2 | COACH syndrome | 216360 |
RPGRIP1L | chr16 | 16q12.2 | Meckel syndrome 5 | 611561 |
RPGRIP1L | chr16 | 16q12.2 | Joubert syndrome 7 | 611560 |
RPIA | chr2 | 2p11.2 | Ribose 5-phosphate isomerase deficiency | 608611 |
RPL10 | chrX | Xq28 | Mental retardation X-linked syndromic 35 | 300998 |
RRM2B | chr8 | 8q23.1 | Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy) | 612075 |
RRM2B | chr8 | 8q23.1 | Mitochondrial DNA depletion syndrome 8B (MNGIE type) | 612075 |
RS1 | chrX | Xp22.2-p22.1 | Retinoschisis | 312700 |
RSPH1 | chr21 | 21q22.3 | Ciliary dyskinesia primary 24 | 615481 |
RSPO1 | chr1 | 1p34.3 | Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal | 610644 |
RSPO1 | chr1 | 1p34.3 | Palmoplantar hyperkeratosis and true hermaphroditism | 610644 |
RSPO4 | chr20 | 20p13 | Anonychia congenita | 206800 |
RSRC1 | chr3 | 3q25.32 | Intellectual developmental disorder autosomal recessive 70 | 618402 |
RTEL1 | chr20 | 20q13.3 | Dyskeratosis congenita autosomal recessive 5 | 615190 |
RTEL1 | chr20 | 20q13.3 | Dyskeratosis congenita autosomal dominant 4 | 615190 |
RTTN | chr18 | 18q22.2 | Microcephaly short stature and polymicrogyria with seizures | 614833 |
RUBCN | chr3 | 3q29 | Spinocerebellar ataxia autosomal recessive 15 | 615705 |
RYR1 | chr19 | 19q13.1 | Central core disease | 117000 |
RYR1 | chr19 | 19q13.1 | Minicore myopathy with external ophthalmoplegia | 255320 |
RYR1 | chr19 | 19q13.1 | Neuromuscular disease congenital with uniform type 1 fiber | 117000 |
SACS | chr13 | 13q12 | Spastic ataxia Charlevoix-Saguenay type | 270550 |
SAG | chr2 | 2q37.1 | Oguchi disease-1 | 258100 |
SALL2 | chr14 | 14q11.1-q12 | Coloboma ocular autosomal recessive | 216820 |
SAMD9 | chr7 | 7q21 | Tumoral calcinosis familial normophosphatemic | 610455 |
SAMHD1 | chr20 | 20q11.2 | Aicardi-Goutieres syndrome 5 | 612952 |
SAR1B | chr5 | 5q31.1 | Chylomicron retention disease | 246700 |
SARDH | chr9 | 9q34.2 | Sarcosinemia | 268900 |
SARS2 | chr19 | 19q13.2 | Hyperuricemia pulmonary hypertension renal failure and alkalosis | 613845 |
SASH1 | chr6 | 6q24.3 | Cancer alopecia pigment dyscrasia onychodystrophy and keratoderma | 618373 |
SASS6 | chr1 | 1p21.2 | Microcephaly 14 primary autosomal recessive | 616402 |
SBDS | chr7 | 7q11 | Shwachman-Diamond syndrome | 260400 |
SBF1 | chr22 | 22q13.33 | Charcot-Marie-Tooth disease type 4B3 | 615284 |
SBF2 | chr11 | 11p15 | Charcot-Marie-Tooth disease type 4B2 | 604563 |
SC5D | chr11 | 11q23.3 | Lathosterolosis | 607330 |
SCAPER | chr15 | 15q24 | Intellectual developmental disorder and retinitis pigmentosa | 618195 |
SCARB2 | chr4 | 4q13-q21 | Epilepsy progressive myoclonic 4 with or without renal failure | 254900 |
SCARF2 | chr22 | 22q11 | Van den Ende-Gupta syndrome | 600920 |
SCN1B | chr19 | 19q13.1 | Epileptic encephalopathy early infantile 52 | 617350 |
SCN4A | chr17 | 17q23.1-q25.3 | Myasthenic syndrome congenital 16 | 614198 |
SCN5A | chr3 | 3p21 | Sick sinus syndrome 1 | 608567 |
SCN5A | chr3 | 3p21 | Sudden infant death syndrome susceptibility to | 272120 |
SCN9A | chr2 | 2q24 | Neuropathy hereditary sensory and autonomic type IID | 243000 |
SCN9A | chr2 | 2q24 | Insensitivity to pain congenital | 243000 |
SCNN1A | chr12 | 12p13 | Pseudohypoaldosteronism type I | 264350 |
SCNN1B | chr16 | 16p13-p12 | Pseudohypoaldosteronism type I | 264350 |
SCNN1G | chr16 | 16p13-p12 | Pseudohypoaldosteronism type I | 264350 |
SCO1 | chr17 | 17p13-p12 | Mitochondrial complex IV deficiency | 220110 |
SCO2 | chr22 | 22q13 | Cardioencephalomyopathy fatal infantile due to cytochrome c oxidase deficiency 1 | 604377 |
SCP2 | chr1 | 1p32 | Leukoencephalopathy with dystonia and motor neuropathy | 613724 |
SDC3 | chr1 | 1pter-p22.3 | Obesity association with | 601665 |
SDCCAG8 | chr1 | 1q43-q44 | Bardet-Biedl syndrome 16 | 615993 |
SDHA | chr5 | 5p15 | Cardiomyopathy dilated 1GG | 613642 |
SDHA | chr5 | 5p15 | Leigh syndrome | 256000 |
SDHA | chr5 | 5p15 | Mitochondrial respiratory chain complex II deficiency | 252011 |
SDHAF1 | chr19 | 19q12-q13.2 | Mitochondrial complex II deficiency | 252011 |
SDHD | chr11 | 11q23 | Mitochondrial complex II deficiency | 252011 |
SEC23A | chr14 | 14q21.1 | Craniolenticulosutural dysplasia | 607812 |
SEC23B | chr20 | 20p11.2 | Dyserythropoietic anemia congenital type II | 224100 |
SEC24D | chr4 | 4q26 | Cole-Carpenter syndrome 2 | 616294 |
SECISBP2 | chr9 | 9q22.2 | Thyroid hormone metabolism abnormal | 609698 |
SELENON | chr1 | 1p36-p35 | Muscular dystrophy rigid spine 1 | 602771 |
SELENON | chr1 | 1p36-p35 | Myopathy congenital with fiber-type disproportion | 255310 |
SEMA4A | chr1 | 1q22 | Cone-rod dystrophy 10 | 610283 |
SEMA4A | chr1 | 1q22 | Retinitis pigmentosa 35 | 610282 |
SEPSECS | chr4 | 4p15.2 | Pontocerebellar hypoplasia type 2D | 613811 |
SERAC1 | chr6 | 6q25.3 | 3-methylglutaconic aciduria with deafness encephalopathy and Leigh-like syndrome | 614739 |
SERPINA1 | chr14 | 14q32.1 | Hemorrhagic diathesis due to antithrombin Pittsburgh | 613490 |
SERPINA1 | chr14 | 14q32.1 | Emphysema-cirrhosis due to AAT deficiency | 613490 |
SERPINA1 | chr14 | 14q32.1 | Emphysema due to AAT deficiency | 613490 |
SERPINA6 | chr14 | 14q32.1 | Corticosteroid-binding globulin deficiency | 611489 |
SERPINB6 | chr6 | 6p25 | Deafness autosomal recessive 91 | 613453 |
SERPINB7 | chr18 | 18q21.3 | Palmoplantar keratoderma Nagashima type | 615598 |
SERPINC1 | chr1 | 1q23-q25 | Thrombophilia due to antithrombin III deficiency | 613118 |
SERPINE1 | chr7 | 7q21.3-q22 | Plasminogen activator inhibitor-1 deficiency | 613329 |
SERPINF1 | chr17 | 17p13.3 | Osteogenesis imperfecta type VI | 613982 |
SERPINF2 | chr17 | 17pter-p12 | Alpha-2-plasmin inhibitor deficiency | 262850 |
SERPING1 | chr11 | 11q11-q13.1 | Angioedema hereditary types I and II | 106100 |
SERPINH1 | chr11 | 11q13.5 | Osteogenesis imperfecta type X | 613848 |
SERPINH1 | chr11 | 11q13.5 | Preterm premature rupture of the membranes susceptibility to | 610504 |
SETX | chr9 | 9q34 | Spinocerebellar ataxia autosomal recessive with axonal neuropathy 2 | 606002 |
SFTPB | chr2 | 2p12-p11.2 | Surfactant metabolism dysfunction pulmonary 1 | 265120 |
SFXN4 | chr10 | 10q26.11 | Combined oxidative phosphorylation deficiency 18 | 615578 |
SGCA | chr17 | 17q12-q21.33 | Muscular dystrophy limb-girdle autosomal recessive 3 | 608099 |
SGCB | chr4 | 4q12 | Muscular dystrophy limb-girdle autosomal recessive 4 | 604286 |
SGCD | chr5 | 5q33 | Muscular dystrophy limb-girdle autosomal recessive 6 | 601287 |
SGCG | chr13 | 13q12 | Muscular dystrophy limb-girdle autosomal recessive 5 | 253700 |
SGO1 | chr3 | 3p24.3 | Chronic atrial and intestinal dysrhythmia | 616201 |
SGSH | chr17 | 17q25.3 | Mucopolysaccharidosis type IIIA (Sanfilippo A) | 252900 |
SH2D1A | chrX | Xq25 | Lymphoproliferative syndrome X-linked 1 | 308240 |
SH3PXD2B | chr5 | 5q35.1 | Frank-ter Haar syndrome | 249420 |
SH3TC2 | chr5 | 5q32 | Charcot-Marie-Tooth disease type 4C | 601596 |
SHOX | chrX | Xpter-p22.32 | Langer mesomelic dysplasia | 249700 |
SI | chr3 | 3q25-q26 | Sucrase-isomaltase deficiency congenital | 222900 |
SIGMAR1 | chr9 | 9p13 | Amyotrophic lateral sclerosis 16 juvenile | 614373 |
SIGMAR1 | chr9 | 9p13 | Spinal muscular atrophy distal autosomal recessive 2 | 605726 |
SIK3 | chr11 | 11q23.3 | Spondyloepimetaphyseal dysplasia Krakow type | 618162 |
SIL1 | chr5 | 5q31 | Marinesco-Sjogren syndrome | 248800 |
SIX6 | chr14 | 14q23 | Optic disc anomalies with retinal and/or macular dystrophy | 212550 |
SKIV2L | chr6 | 6p21 | Trichohepatoenteric syndrome 2 | 614602 |
SLC10A2 | chr13 | 13q33 | Bile acid malabsorption primary | 613291 |
SLC11A2 | chr12 | 12q13 | Anemia hypochromic microcytic with iron overload 1 | 206100 |
SLC12A1 | chr15 | 15q15-q21.1 | Bartter syndrome type 1 | 601678 |
SLC12A3 | chr16 | 16q13 | Gitelman syndrome | 263800 |
SLC12A5 | chr20 | 20q12-q13.1 | Epileptic encephalopathy early infantile 34 | 616645 |
SLC12A6 | chr15 | 15q13-q14 | Agenesis of the corpus callosum with peripheral neuropathy | 218000 |
SLC13A5 | chr17 | 17p13-p12 | Epileptic encephalopathy early infantile 25 | 615905 |
SLC16A1 | chr1 | 1p13.2-p12 | Monocarboxylate transporter 1 deficiency | 616095 |
SLC17A5 | chr6 | 6q14-q15 | Sialic acid storage disorder infantile | 269920 |
SLC17A5 | chr6 | 6q14-q15 | Salla disease | 604369 |
SLC19A2 | chr1 | 1q23.3 | Thiamine-responsive megaloblastic anemia syndrome | 249270 |
SLC19A3 | chr2 | 2q36.3 | Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2) | 607483 |
SLC1A1 | chr9 | 9p24 | Dicarboxylic aminoaciduria | 222730 |
SLC22A12 | chr11 | 11q13 | Hypouricemia renal | 220150 |
SLC22A5 | chr5 | 5q31.1 | Carnitine deficiency systemic primary | 212140 |
SLC24A1 | chr15 | 15q22 | Night blindness congenital stationary (complete) 1D autosomal recessive | 613830 |
SLC24A4 | chr14 | 14q32 | Skin/hair/eye pigmentation 6 blue/green eyes | 210750 |
SLC24A4 | chr14 | 14q32 | Amelogenesis imperfecta type IIA5 | 615887 |
SLC24A4 | chr14 | 14q32 | Skin/hair/eye pigmentation 6 blond/brown hair | 210750 |
SLC24A5 | chr15 | 15q21.1 | Skin/hair/eye pigmentation 4 fair/dark skin | 113750 |
SLC24A5 | chr15 | 15q21.1 | Albinism oculocutaneous type VI | 113750 |
SLC25A1 | chr22 | 22q11 | Myasthenic syndrome congenital 23 presynaptic | 618197 |
SLC25A1 | chr22 | 22q11 | Combined D-2- and L-2-hydroxyglutaric aciduria | 615182 |
SLC25A12 | chr2 | 2q24 | Epileptic encephalopathy early infantile 39 | 612949 |
SLC25A13 | chr7 | 7q21.3 | Citrullinemia adult-onset type II | 603471 |
SLC25A13 | chr7 | 7q21.3 | Citrullinemia type II neonatal-onset | 605814 |
SLC25A15 | chr13 | 13q14 | Hyperornithinemia-hyperammonemia- homocitrullinemia syndrome | 238970 |
SLC25A19 | chr17 | 17q25.3 | Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type) | 613710 |
SLC25A19 | chr17 | 17q25.3 | Microcephaly Amish type | 607196 |
SLC25A20 | chr3 | 3p21.31 | Carnitine-acylcarnitine translocase deficiency | 212138 |
SLC25A21 | chr14 | 14q11.2 | Mitochondrial DNA depletion syndrome 18 | 618811 |
SLC25A22 | chr11 | 11p15.5 | Epileptic encephalopathy early infantile 3 | 609304 |
SLC25A38 | chr3 | 3p22.1 | Anemia sideroblastic 2 pyridoxine-refractory | 205950 |
SLC25A4 | chr4 | 4q35 | Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR | 615418 |
SLC25A46 | chr5 | 5q22.1 | Neuropathy hereditary motor and sensory type VIB | 616505 |
SLC26A1 | chr4 | 4p16.3 | Nephrolithiasis calcium oxalate | 167030 |
SLC26A2 | chr5 | 5q32-q33.1 | De la Chapelle dysplasia | 256050 |
SLC26A2 | chr5 | 5q32-q33.1 | Atelosteogenesis type II | 256050 |
SLC26A2 | chr5 | 5q32-q33.1 | Diastrophic dysplasia broad bone-platyspondylic variant | 222600 |
SLC26A2 | chr5 | 5q32-q33.1 | Diastrophic dysplasia | 222600 |
SLC26A2 | chr5 | 5q32-q33.1 | Achondrogenesis Ib | 600972 |
SLC26A2 | chr5 | 5q32-q33.1 | Epiphyseal dysplasia multiple 4 | 226900 |
SLC26A3 | chr7 | 7q22-q31.1 | Diarrhea 1 secretory chloride congenital | 214700 |
SLC26A4 | chr7 | 7q31 | Deafness autosomal recessive 4 with enlarged vestibular aqueduct | 600791 |
SLC26A4 | chr7 | 7q31 | Pendred syndrome | 274600 |
SLC26A5 | chr7 | 7q22.1 | Deafness autosomal recessive 61 | 613865 |
SLC28A1 | chr15 | 15q25-q26 | Uridine-cytidineuria | 618477 |
SLC29A3 | chr10 | 10q22.1 | Histiocytosis-lymphadenopathy plus syndrome | 602782 |
SLC2A1 | chr1 | 1p34.2 | GLUT1 deficiency syndrome 1 infantile onset severe | 606777 |
SLC2A10 | chr20 | 20q13.1 | Arterial tortuosity syndrome | 208050 |
SLC2A2 | chr3 | 3q26.1-q26.3 | Fanconi-Bickel syndrome | 227810 |
SLC2A9 | chr4 | 4p16-p15.3 | Uric acid concentration serum QTL 2 | 612076 |
SLC2A9 | chr4 | 4p16-p15.3 | Hypouricemia renal 2 | 612076 |
SLC30A10 | chr1 | 1q41 | Hypermanganesemia with dystonia 1 | 613280 |
SLC33A1 | chr3 | 3q25.31 | Congenital cataracts hearing loss and neurodegeneration | 614482 |
SLC34A1 | chr5 | 5q35 | Hypercalcemia infantile 2 | 616963 |
SLC34A1 | chr5 | 5q35 | Fanconi renotubular syndrome 2 | 613388 |
SLC34A2 | chr4 | 4p15.31-p15.2 | Pulmonary alveolar microlithiasis | 265100 |
SLC34A3 | chr9 | 9q34 | Hypophosphatemic rickets with hypercalciuria | 241530 |
SLC35A1 | chr6 | 6q15 | Congenital disorder of glycosylation type IIf | 603585 |
SLC35A3 | chr1 | 1p21 | Arthrogryposis mental retardation and seizures | 615553 |
SLC35C1 | chr11 | 11p11.2 | Congenital disorder of glycosylation type IIc | 266265 |
SLC35D1 | chr1 | 1p32-p31 | Schneckenbecken dysplasia | 269250 |
SLC36A2 | chr5 | 5q33.1 | Iminoglycinuria digenic | 242600 |
SLC36A2 | chr5 | 5q33.1 | Hyperglycinuria | 138500 |
SLC37A4 | chr11 | 11q23 | Glycogen storage disease Ib | 232220 |
SLC38A8 | chr16 | 16q23.3 | Foveal hypoplasia 2 with or without optic nerve misrouting and/or anterior segment dysgenesis | 609218 |
SLC39A13 | chr11 | 11p11.2 | Ehlers-Danlos syndrome spondylodysplastic type 3 | 612350 |
SLC39A4 | chr8 | 8q24.3 | Acrodermatitis enteropathica | 201100 |
SLC3A1 | chr2 | 2p16.3 | Cystinuria | 220100 |
SLC45A2 | chr5 | 5p13.3 | Skin/hair/eye pigmentation 5 dark/fair skin | 227240 |
SLC45A2 | chr5 | 5p13.3 | Skin/hair/eye pigmentation 5 black/nonblack hair | 227240 |
SLC45A2 | chr5 | 5p13.3 | Albinism oculocutaneous type IV | 606574 |
SLC45A2 | chr5 | 5p13.3 | Skin/hair/eye pigmentation 5 dark/light eyes | 227240 |
SLC46A1 | chr17 | 17q11.1 | Folate malabsorption hereditary | 229050 |
SLC4A1 | chr17 | 17q21-q22 | Renal tubular acidosis distal AR | 611590 |
SLC4A11 | chr20 | 20p13-p12 | Corneal endothelial dystrophy autosomal recessive | 217700 |
SLC4A11 | chr20 | 20p13-p12 | Corneal endothelial dystrophy and perceptive deafness | 217400 |
SLC4A4 | chr4 | 4q21 | Renal tubular acidosis proximal with ocular abnormalities | 604278 |
SLC52A2 | chr8 | 8q24.3 | Brown-Vialetto-Van Laere syndrome 2 | 614707 |
SLC52A3 | chr20 | 20p13 | Brown-Vialetto-Van Laere syndrome 1 | 211530 |
SLC52A3 | chr20 | 20p13 | Fazio-Londe disease | 211500 |
SLC5A1 | chr22 | 22q13.1 | Glucose/galactose malabsorption | 606824 |
SLC5A2 | chr16 | 16p11.2 | Renal glucosuria | 233100 |
SLC5A5 | chr19 | 19p13.2-p12 | Thyroid dyshormonogenesis 1 | 274400 |
SLC5A7 | chr2 | 2q12.3 | Myasthenic syndrome congenital 20 presynaptic | 617143 |
SLC6A17 | chr1 | 1p13.3 | Mental retardation autosomal recessive 48 | 616269 |
SLC6A19 | chr5 | 5p15.33 | Iminoglycinuria digenic | 242600 |
SLC6A19 | chr5 | 5p15.33 | Hartnup disorder | 234500 |
SLC6A20 | chr3 | 3p21.3 | Iminoglycinuria digenic | 242600 |
SLC6A3 | chr5 | 5p15.3 | Parkinsonism-dystonia infantile 1 | 613135 |
SLC6A5 | chr11 | 11p15.2-p15.1 | Hyperekplexia 3 | 614618 |
SLC6A8 | chrX | Xq28 | Cerebral creatine deficiency syndrome 1 | 300352 |
SLC6A9 | chr1 | 1p33 | Glycine encephalopathy with normal serum glycine | 617301 |
SLC7A14 | chr3 | 3q26.2 | Retinitis pigmentosa 68 | 615725 |
SLC7A7 | chr14 | 14q11.2 | Lysinuric protein intolerance | 222700 |
SLC7A9 | chr19 | 19q13.1 | Cystinuria | 220100 |
SLC9A1 | chr1 | 1p36.1-p35 | Lichtenstein-Knorr syndrome | 616291 |
SLC9A3 | chr5 | 5p15.3 | Diarrhea 8 secretory sodium congenital | 616868 |
SLCO1B1 | chr12 | 12p12 | Hyperbilirubinemia Rotor type digenic | 237450 |
SLCO1B3 | chr12 | 12p12.2 | Hyperbilirubinemia Rotor type digenic | 237450 |
SLCO2A1 | chr3 | 3q21 | Hypertrophic osteoarthropathy primary autosomal recessive 2 | 614441 |
SLITRK6 | chr13 | 13q31 | Deafness and myopia | 221200 |
SLURP1 | chr8 | 8qter | Meleda disease | 248300 |
SLX4 | chr16 | 16p13.3 | Fanconi anemia complementation group P | 613951 |
SMARCAL1 | chr2 | 2q34-q36 | Schimke immunoosseous dysplasia | 242900 |
SMIM1 | chr1 | 1p36 | Blood group Vel system | 615264 |
SMN1 | chr5 | 5q12.2-q13.3 | Spinal muscular atrophy-2 | 253550 |
SMN1 | chr5 | 5q12.2-q13.3 | Spinal muscular atrophy-3 | 253400 |
SMN1 | chr5 | 5q12.2-q13.3 | Spinal muscular atrophy-1 | 253300 |
SMN1 | chr5 | 5q12.2-q13.3 | Spinal muscular atrophy-4 | 271150 |
SMN2 | chr5 | 5q12.2-q13.3 | Spinal muscular atrophy type III modifier of | 253400 |
SMO | chr7 | 7q31-q32 | Pallister-Hall-like syndrome | 241800 |
SMOC1 | chr14 | 14q24.1 | Microphthalmia with limb anomalies | 206920 |
SMOC2 | chr6 | 6q27 | Dentin dysplasia type I with microdontia and misshapen teeth | 125400 |
SMPD1 | chr11 | 11p15.4-p15.1 | Niemann-Pick disease type A | 257200 |
SMPD1 | chr11 | 11p15.4-p15.1 | Niemann-Pick disease type B | 607616 |
SMS | chrX | Xp22.1 | Mental retardation X-linked Snyder-Robinson type | 309583 |
SNAI2 | chr8 | 8q11 | Waardenburg syndrome type 2D | 608890 |
SNAP29 | chr22 | 22q11.2 | Cerebral dysgenesis neuropathy ichthyosis and palmoplantar keratoderma syndrome | 609528 |
SNIP1 | chr1 | 1p34.3 | Psychomotor retardation epilepsy and craniofacial dysmorphism | 614501 |
SNX10 | chr7 | 7p15.2 | Osteopetrosis autosomal recessive 8 | 615085 |
SNX14 | chr6 | 6q14.3 | Spinocerebellar ataxia autosomal recessive 20 | 616354 |
SOBP | chr6 | 6q21 | Mental retardation anterior maxillary protrusion and strabismus | 613671 |
SOD1 | chr21 | 21q22.1 | Spastic tetraplegia and axial hypotonia progressive | 618598 |
SOD1 | chr21 | 21q22.1 | Amyotrophic lateral sclerosis 1 | 105400 |
SOHLH1 | chr9 | 9q34.3 | Ovarian dysgenesis 5 | 617690 |
SORD | chr15 | 15q15.3 | Sorbitol dehydrogenase deficiency with peripheral neuropathy | 618912 |
SOST | chr17 | 17q12-q21 | Sclerosteosis 1 | 269500 |
SOST | chr17 | 17q12-q21 | Van Buchem disease | 239100 |
SOX18 | chr20 | 20q13.33 | Hypotrichosis-lymphedema-telangiectasia syndrome | 607823 |
SP110 | chr2 | 2q37.1 | Hepatic venoocclusive disease with immunodeficiency | 235550 |
SP7 | chr12 | 12q13.13 | Osteogenesis imperfecta type XII | 613849 |
SPAG1 | chr8 | 8q22 | Ciliary dyskinesia primary 28 | 615505 |
SPART | chr13 | 13q12.3 | Troyer syndrome | 275900 |
SPATA16 | chr3 | 3q26.3 | Spermatogenic failure 6 | 102530 |
SPATA7 | chr14 | 14q31.3 | Retinitis pigmentosa juvenile autosomal recessive | 604232 |
SPEF2 | chr5 | 5p13.2 | Spermatogenic failure 43 | 618751 |
SPEG | chr2 | 2q35 | Centronuclear myopathy 5 | 615959 |
SPG11 | chr15 | 15q21.1 | Charcot-Marie-Tooth disease axonal type 2X | 616668 |
SPG11 | chr15 | 15q21.1 | Spastic paraplegia 11 autosomal recessive | 604360 |
SPG11 | chr15 | 15q21.1 | Amyotrophic lateral sclerosis 5 juvenile | 602099 |
SPG21 | chr15 | 15q21-q22 | Mast syndrome | 248900 |
SPG7 | chr16 | 16q24.3 | Spastic paraplegia 7 autosomal recessive | 607259 |
SPINK1 | chr5 | 5q32 | Fibrocalculous pancreatic diabetes susceptibility to | 608189 |
SPINK1 | chr5 | 5q32 | Tropical calcific pancreatitis | 608189 |
SPINK5 | chr5 | 5q32 | Netherton syndrome | 256500 |
SPINT2 | chr19 | 19q13.1 | Diarrhea 3 secretory sodium congenital syndromic | 270420 |
SPR | chr2 | 2p14-p12 | Dystonia dopa-responsive due to sepiapterin reductase deficiency | 612716 |
SPRTN | chr1 | 1q42.2 | Ruijs-Aalfs syndrome | 616200 |
SPTA1 | chr1 | 1q21 | Pyropoikilocytosis | 266140 |
SPTA1 | chr1 | 1q21 | Spherocytosis type 3 | 270970 |
SPTBN2 | chr11 | 11q13 | Spinocerebellar ataxia autosomal recessive 14 | 615386 |
SQSTM1 | chr5 | 5q35 | Neurodegeneration with ataxia dystonia and gaze palsy childhood-onset | 617145 |
SRD5A2 | chr2 | 2p23 | Pseudovaginal perineoscrotal hypospadias | 264600 |
SRD5A3 | chr4 | 4q12 | Kahrizi syndrome | 612713 |
SRD5A3 | chr4 | 4q12 | Congenital disorder of glycosylation type Iq | 612379 |
SSR4 | chrX | Xq28 | Congenital disorder of glycosylation type Iy | 300934 |
ST14 | chr11 | 11q24-q25 | Ichthyosis congenital autosomal recessive 11 | 602400 |
ST3GAL3 | chr1 | 1p34.1 | Mental retardation autosomal recessive 12 | 611090 |
ST3GAL3 | chr1 | 1p34.1 | Epileptic encephalopathy early infantile 15 | 615006 |
ST3GAL5 | chr2 | 2p11.2 | Salt and pepper developmental regression syndrome | 609056 |
STAC3 | chr12 | 12q13.3 | Myopathy congenital Baily-Bloch | 255995 |
STAG2 | chrX | Xq25 | Mullegama-Klein-Martinez syndrome | 301022 |
STAG2 | chrX | Xq25 | Holoprosencephaly 13 X-linked | 301043 |
STAG3 | chr7 | 7q22 | Premature ovarian failure 8 | 615723 |
STAMBP | chr2 | 2p13.1 | Microcephaly-capillary malformation syndrome | 614261 |
STAR | chr8 | 8p11.2 | Lipoid adrenal hyperplasia | 201710 |
STAT1 | chr2 | 2q32.2-q32.3 | Immunodeficiency 31B mycobacterial and viral infections autosomal recessive | 613796 |
STAT2 | chr12 | 12q13.2 | Immunodeficiency 44 | 616636 |
STAT2 | chr12 | 12q13.2 | Pseudo-TORCH syndrome 3 | 618886 |
STIL | chr1 | 1p33 | Microcephaly 7 primary autosomal recessive | 612703 |
STIM1 | chr11 | 11p15.5 | Immunodeficiency 10 | 612783 |
STRA6 | chr15 | 15q24.1 | Microphthalmia isolated with coloboma 8 | 601186 |
STRA6 | chr15 | 15q24.1 | Microphthalmia syndromic 9 | 601186 |
STRADA | chr17 | 17q23.3 | Polyhydramnios megalencephaly and symptomatic epilepsy | 611087 |
STRC | chr15 | 15q15 | Deafness autosomal recessive 16 | 603720 |
STS | chrX | Xp22.32 | Ichthyosis X-linked | 308100 |
STT3A | chr11 | 11q23.3 | Congenital disorder of glycosylation type Iw | 615596 |
STT3B | chr3 | 3p23 | Congenital disorder of glycosylation type Ix | 615597 |
STUB1 | chr16 | 16p13.3 | Spinocerebellar ataxia autosomal recessive 16 | 615768 |
STX11 | chr6 | 6q24 | Hemophagocytic lymphohistiocytosis familial 4 | 603552 |
SUCLA2 | chr13 | 13q14.2 | Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria) | 612073 |
SUCLG1 | chr2 | 2p11.2 | Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria) | 245400 |
SUFU | chr10 | 10q24-q25 | Medulloblastoma desmoplastic | 155255 |
SUFU | chr10 | 10q24-q25 | Joubert syndrome 32 | 617757 |
SUGCT | chr7 | 7p14 | Glutaric aciduria III | 231690 |
SULT2B1 | chr19 | 19q13.3 | Ichthyosis congenital autosomal recessive 14 | 617571 |
SUMF1 | chr3 | 3p26 | Multiple sulfatase deficiency | 272200 |
SUOX | chr12 | Chr.12 | Sulfite oxidase deficiency | 272300 |
SURF1 | chr9 | 9q34 | Leigh syndrome due to COX IV deficiency | 256000 |
SURF1 | chr9 | 9q34 | Charcot-Marie-Tooth disease type 4K | 616684 |
SYN1 | chrX | Xp11.4-p11.2 | Epilepsy X-linked with variable learning disabilities and behavior disorders | 300491 |
SYNE1 | chr6 | 6q25 | Arthrogryposis multiplex congenita 3 myogenic type | 618484 |
SYNE1 | chr6 | 6q25 | Spinocerebellar ataxia autosomal recessive 8 | 610743 |
SYNE4 | chr19 | 19q13.12 | Deafness autosomal recessive 76 | 615540 |
SYNJ1 | chr21 | 21q22.2 | Epileptic encephalopathy early infantile 53 | 617389 |
SYNJ1 | chr21 | 21q22.2 | Parkinson disease 20 early-onset | 615530 |
SYP | chrX | Xp11.23- p11.22 | Mental retardation X-linked 96 | 300802 |
SYT14 | chr1 | 1q32.2 | Spinocerebellar ataxia autosomal recessive 11 | 614229 |
SZT2 | chr1 | 1p34.2 | Epileptic encephalopathy early infantile 18 | 615476 |
TAC3 | chr12 | 12q13-q21 | Hypogonadotropic hypogonadism 10 with or without anosmia | 614839 |
TACO1 | chr17 | 17q22-q24.2 | Mitochondrial complex IV deficiency | 220110 |
TACR3 | chr4 | 4q25 | Hypogonadotropic hypogonadism 11 with or without anosmia | 614840 |
TACSTD2 | chr1 | 1p32 | Corneal dystrophy gelatinous drop-like | 204870 |
TAF1 | chrX | Xq13 | Dystonia-Parkinsonism X-linked | 314250 |
TAF1 | chrX | Xq13 | Mental retardation X-linked syndromic 33 | 300966 |
TAF2 | chr8 | 8q24.12 | Mental retardation autosomal recessive 40 | 615599 |
TAF4B | chr18 | 18q11.2 | Spermatogenic failure 13 | 615841 |
TAF6 | chr7 | 7q22.1 | Alazami-Yuan syndrome | 617126 |
TALDO1 | chr11 | 11p15.5-p15.4 | Transaldolase deficiency | 606003 |
TAP1 | chr6 | 6p21.3 | Bare lymphocyte syndrome type I | 604571 |
TAP2 | chr6 | 6p21.3 | Bare lymphocyte syndrome type I due to TAP2 deficiency | 604571 |
TAPBP | chr6 | 6p21.3 | Bare lymphocyte syndrome type I | 604571 |
TARS2 | chr1 | 1q21.2 | Combined oxidative phosphorylation deficiency 21 | 615918 |
TAT | chr16 | 16q22.1-q22.3 | Tyrosinemia type II | 276600 |
TAZ | chrX | Xq28 | Barth syndrome | 302060 |
TBC1D20 | chr20 | 20p13 | Warburg micro syndrome 4 | 615663 |
TBC1D23 | chr3 | 3q12.1-q12.2 | Pontocerebellar hypoplasia type 11 | 617695 |
TBC1D24 | chr16 | 16p13.3 | Epilepsy rolandic with proxysmal exercise-induce dystonia and writer’s cramp | 608105 |
TBC1D24 | chr16 | 16p13.3 | DOORS syndrome | 220500 |
TBC1D24 | chr16 | 16p13.3 | Epileptic encephalopathy early infantile 16 | 615338 |
TBC1D24 | chr16 | 16p13.3 | Myoclonic epilepsy infantile familial | 605021 |
TBC1D24 | chr16 | 16p13.3 | Deafness autosomal recessive 86 | 614617 |
TBC1D7 | chr6 | 6p24.1 | Macrocephaly/megalencephaly syndrome autosomal recessive | 248000 |
TBCE | chr1 | 1q42-q43 | Kenny-Caffey syndrome type 1 | 244460 |
TBCE | chr1 | 1q42-q43 | Hypoparathyroidism-retardation-dysmorphism syndrome | 241410 |
TBCE | chr1 | 1q42-q43 | Encephalopathy progressive with amyotrophy and optic atrophy | 617207 |
TBCK | chr4 | 4q24 | Hypotonia infantile with psychomotor retardation and characteristic facies 3 | 616900 |
TBX15 | chr1 | 1p13 | Cousin syndrome | 260660 |
TBX19 | chr1 | 1q23-q24 | Adrenocorticotropic hormone deficiency | 201400 |
TBX21 | chr17 | 17q21.3 | Asthma aspirin-induced susceptibility to | 208550 |
TBX21 | chr17 | 17q21.3 | Asthma and nasal polyps | 208550 |
TBX4 | chr17 | 17q21-q22 | Amelia posterior with pelvic and pulmonary hypoplasia syndrome | 601360 |
TBX4 | chr17 | 17q21-q22 | Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension | 147891 |
TBX6 | chr16 | 16p11.2 | Spondylocostal dysostosis 5 | 122600 |
TBXAS1 | chr7 | 7q34 | Ghosal hematodiaphyseal syndrome | 231095 |
TCAP | chr17 | 17q12 | Muscular dystrophy limb-girdle autosomal recessive 7 | 601954 |
TCIRG1 | chr11 | 11q13.4-q13.5 | Osteopetrosis autosomal recessive 1 | 259700 |
TCN2 | chr22 | 22q11.2-qter | Transcobalamin II deficiency | 275350 |
TCTN1 | chr12 | 12q24.1 | Joubert syndrome 13 | 614173 |
TCTN2 | chr12 | 12q24.31 | Joubert syndrome 24 | 616654 |
TCTN2 | chr12 | 12q24.31 | Meckel syndrome 8 | 613885 |
TCTN3 | chr10 | 10q24.1 | Orofaciodigital syndrome IV | 258860 |
TCTN3 | chr10 | 10q24.1 | Joubert syndrome 18 | 614815 |
TDO2 | chr4 | 4q31-q32 | Hypertryptophanemia | 600627 |
TDP1 | chr14 | 14q31-q32 | Spinocerebellar ataxia autosomal recessive with axonal neuropathy 1 | 607250 |
TDP2 | chr6 | 6p22.3-p22.1 | Spinocerebellar ataxia autosomal recessive 23 | 616949 |
TDRD7 | chr9 | 9q22.33 | Cataract 36 | 613887 |
TECPR2 | chr14 | 14q32.31 | Spastic paraplegia 49 autosomal recessive | 615031 |
TECR | chr19 | 19p13.12 | Mental retardation autosomal recessive 14 | 614020 |
TECTA | chr11 | 11q22-q24 | Deafness autosomal recessive 21 | 603629 |
TELO2 | chr16 | 16p13.3 | You-Hoover-Fong syndrome | 616954 |
TENM3 | chr4 | 4q35.1 | Microphthalmia syndromic 15 | 615145 |
TENM3 | chr4 | 4q35.1 | Microphthalmia isolated with coloboma 9 | 615145 |
TERT | chr5 | 5p15.33 | Dyskeratosis congenita autosomal recessive 4 | 613989 |
TERT | chr5 | 5p15.33 | Dyskeratosis congenita autosomal dominant 2 | 613989 |
TEX14 | chr17 | 17q22 | Spermatogenic failure 23 | 617707 |
TF | chr3 | 3q21 | Atransferrinemia | 209300 |
TFAM | chr10 | 10q21 | Mitochondrial DNA depletion syndrome 15 (hepatocerebral type) | 617156 |
TFG | chr3 | 3q11-q12 | Spastic paraplegia 57 autosomal recessive | 615658 |
TFR2 | chr7 | 7q22 | Hemochromatosis type 3 | 604250 |
TFRC | chr3 | 3q29 | Immunodeficiency 46 | 616740 |
TG | chr8 | 8q24.2-q24.3 | Thyroid dyshormonogenesis 3 | 274700 |
TGDS | chr13 | 13q32.1 | Catel-Manzke syndrome | 616145 |
TGFB1 | chr19 | 19q13.1 | Cystic fibrosis lung disease modifier of | 219700 |
TGFB1 | chr19 | 19q13.1 | Inflammatory bowel disease immunodeficiency and encephalopathy | 618213 |
TGM1 | chr14 | 14q11.2 | Ichthyosis congenital autosomal recessive 1 | 242300 |
TGM5 | chr15 | 15q15.2 | Peeling skin syndrome 2 | 609796 |
TH | chr11 | 11p15.5 | Segawa syndrome recessive | 605407 |
THOC2 | chrX | Xq25 | Mental retardation X-linked 12/35 | 300957 |
THOC6 | chr16 | 16p13.3 | Beaulieu-Boycott-Innes syndrome | 613680 |
THRB | chr3 | 3p24.3 | Thyroid hormone resistance autosomal recessive | 274300 |
TIA1 | chr2 | 2p13 | Welander distal myopathy | 604454 |
TICAM1 | chr19 | 19p13.3 | Encephalopathy acute infection-induced (herpes- specific) susceptibility to 6 | 614850 |
TIMM8A | chrX | Xq22 | Mohr-Tranebjaerg syndrome | 304700 |
TJP2 | chr9 | 9q12-q13 | Cholestasis progressive familial intrahepatic 4 | 615878 |
TJP2 | chr9 | 9q12-q13 | Hypercholanemia familial | 607748 |
TK2 | chr16 | 16q22 | Mitochondrial DNA depletion syndrome 2 (myopathic type) | 609560 |
TK2 | chr16 | 16q22 | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive 3 | 617069 |
TLE6 | chr19 | 19p13.3 | Preimplantation embryonic lethality | 616814 |
TLR3 | chr4 | 4q35 | Encephalopathy acute infection-induced (herpes- specific) susceptibility to 2 | 613002 |
TMC1 | chr9 | 9q13-q21 | Deafness autosomal recessive 7 | 600974 |
TMC6 | chr17 | 17q25 | Epidermodysplasia verruciformis | 226400 |
TMC8 | chr17 | 17q25 | Epidermodysplasia verruciformis 2 | 618231 |
TMCO1 | chr1 | 1q24.1 | Craniofacial dysmorphism skeletal anomalies and mental retardation syndrome | 213980 |
TMEM126A | chr11 | 11q14.1-q21 | Optic atrophy 7 | 612989 |
TMEM138 | chr11 | 11q12.2 | Joubert syndrome 16 | 614465 |
TMEM165 | chr4 | 4q12 | Congenital disorder of glycosylation type IIk | 614727 |
TMEM216 | chr11 | 11q12.2 | Meckel syndrome 2 | 603194 |
TMEM216 | chr11 | 11q12.2 | Joubert syndrome 2 | 608091 |
TMEM231 | chr16 | 16q23.1 | Meckel syndrome 11 | 615397 |
TMEM231 | chr16 | 16q23.1 | Joubert syndrome 20 | 614970 |
TMEM237 | chr2 | 2q33.2 | Joubert syndrome 14 | 614424 |
TMEM67 | chr8 | 8q21.13-q22.1 | Meckel syndrome 3 | 607361 |
TMEM67 | chr8 | 8q21.13-q22.1 | RHYNS syndrome | 602152 |
TMEM67 | chr8 | 8q21.13-q22.1 | Nephronophthisis 11 | 613550 |
TMEM67 | chr8 | 8q21.13-q22.1 | Bardet-Biedl syndrome 14 modifier of | 615991 |
TMEM67 | chr8 | 8q21.13-q22.1 | COACH syndrome | 216360 |
TMEM67 | chr8 | 8q21.13-q22.1 | Joubert syndrome 6 | 610688 |
TMEM70 | chr8 | 8q21.11 | Mitochondrial complex V (ATP synthase) deficiency nuclear type 2 | 614052 |
TMIE | chr3 | 3p21 | Deafness autosomal recessive 6 | 600971 |
TMLHE | chrX | Xq28 | Autism susceptibility to X-linked 6 | 300872 |
TMPRSS15 | chr21 | 21q21 | Enterokinase deficiency | 226200 |
TMPRSS3 | chr21 | 21q22.3 | Deafness autosomal recessive 8/10 | 601072 |
TMPRSS6 | chr22 | 22q12-q13 | Iron-refractory iron deficiency anemia | 206200 |
TMTC3 | chr12 | 12q21.32 | Lissencephaly 8 | 617255 |
TNFRSF10B | chr8 | 8p22-p21 | Squamous cell carcinoma head and neck | 275355 |
TNFRSF11A | chr18 | 18q22.1 | Osteopetrosis autosomal recessive 7 | 612301 |
TNFRSF11B | chr8 | 8q24 | Paget disease of bone 5 juvenile-onset | 239000 |
TNFRSF13B | chr17 | 17p11.2 | Immunodeficiency common variable 2 | 240500 |
TNFRSF13C | chr22 | 22q13.1- q13.31 | Immunodeficiency common variable 4 | 613494 |
TNFRSF4 | chr1 | 1p36 | Immunodeficiency 16 | 615593 |
TNFSF11 | chr13 | 13q14 | Osteopetrosis autosomal recessive 2 | 259710 |
TNNI3 | chr19 | 19q13.4 | Cardiomyopathy dilated 2A | 611880 |
TNNT1 | chr19 | 19q13.4 | Nemaline myopathy 5 Amish type | 605355 |
TNXB | chr6 | 6p21.3 | Ehlers-Danlos syndrome classic-like 1 | 606408 |
TOP3A | chr17 | 17p12-p11.2 | Microcephaly growth restriction and increased sister chromatid exchange 2 | 618097 |
TOP3A | chr17 | 17p12-p11.2 | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive 5 | 618098 |
TOR1AIP1 | chr1 | 1q24 | Muscular dystrophy autosomal recessive with rigid spine and distal joint contractures | 617072 |
TP53RK | chr20 | 20q13.12 | Galloway-Mowat syndrome 4 | 617730 |
TPI1 | chr12 | 12p13 | Hemolytic anemia due to triosephosphate isomerase deficiency | 615512 |
TPK1 | chr7 | 7q34 | Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type) | 614458 |
TPM3 | chr1 | 1q22-q23 | CAP myopathy 1 | 609284 |
TPM3 | chr1 | 1q22-q23 | Nemaline myopathy 1 autosomal dominant or recessive | 609284 |
TPM3 | chr1 | 1q22-q23 | Myopathy congenital with fiber-type disproportion | 255310 |
TPMT | chr6 | 6p22.3 | Thiopurines poor metabolism of 1 | 610460 |
TPO | chr2 | 2p25 | Thyroid dyshormonogenesis 2A | 274500 |
TPP1 | chr11 | 11p15.5 | Spinocerebellar ataxia autosomal recessive 7 | 609270 |
TPP1 | chr11 | 11p15.5 | Ceroid lipofuscinosis neuronal 2 | 204500 |
TPRN | chr9 | 9q34.3 | Deafness autosomal recessive 79 | 613307 |
TRAC | chr14 | 14q11.2 | Immunodeficiency 7 TCR-alpha/beta deficient | 615387 |
TRAF3IP1 | chr2 | 2q37.3 | Senior-Loken syndrome 9 | 616629 |
TRAF3IP2 | chr6 | 6q21 | Candidiasis familial 8 | 615527 |
TRAK1 | chr3 | 3p25.3-p24.1 | Epileptic encephalopathy early infantile 68 | 618201 |
TRAPPC11 | chr4 | 4q35.1 | Muscular dystrophy limb-girdle autosomal recessive 18 | 615356 |
TRAPPC2 | chrX | Xp22.2-p22.1 | Spondyloepiphyseal dysplasia tarda | 313400 |
TRAPPC9 | chr8 | 8q24.3 | Mental retardation autosomal recessive 13 | 613192 |
TRDN | chr6 | 6q22-q23 | Ventricular tachycardia catecholaminergic polymorphic 5 with or without muscle weakness | 615441 |
TREH | chr11 | 11q23 | Trehalase deficiency | 612119 |
TREX1 | chr3 | 3p21.3-p21.2 | Systemic lupus erythematosus susceptibility to | 152700 |
TREX1 | chr3 | 3p21.3-p21.2 | Vasculopathy retinal with cerebral leukodystrophy | 192315 |
TREX1 | chr3 | 3p21.3-p21.2 | Aicardi-Goutieres syndrome 1 dominant and recessive | 225750 |
TRH | chr3 | 3q13.3-q21 | Thyrotropin-releasing hormone deficiency | 275120 |
TRHR | chr8 | 8q23 | Hypothyroidism congenital nongoitrous 7 | 618573 |
TRIM2 | chr4 | 4q31.3 | Charcot-Marie-Tooth disease type 2R | 615490 |
TRIM32 | chr9 | 9q31-q34.1 | Bardet-Biedl syndrome 11 | 615988 |
TRIM32 | chr9 | 9q31-q34.1 | Muscular dystrophy limb-girdle autosomal recessive 8 | 254110 |
TRIM37 | chr17 | 17q22-q23 | Mulibrey nanism | 253250 |
TRIOBP | chr22 | 22q13.1 | Deafness autosomal recessive 28 | 609823 |
TRIP11 | chr14 | 14q31-q32 | Osteochondrodysplasia | 184260 |
TRIP11 | chr14 | 14q31-q32 | Achondrogenesis type IA | 200600 |
TRIP13 | chr5 | 5p15.33 | Mosaic variegated aneuploidy syndrome 3 | 617598 |
TRIT1 | chr1 | 1p34.2 | Combined oxidative phosphorylation deficiency 35 | 617873 |
TRMT1 | chr19 | 19p13.3 | Mental retardation autosomal recessive 68 | 618302 |
TRMT10A | chr4 | 4q23 | Microcephaly short stature and impaired glucose metabolism 1 | 616033 |
TRMU | chr22 | 22q13 | Liver failure transient infantile | 613070 |
TRNT1 | chr3 | 3p25.1 | Sideroblastic anemia with B-cell immunodeficiency periodic fevers and developmental delay | 616084 |
TRNT1 | chr3 | 3p25.1 | Retinitis pigmentosa and erythrocytic microcytosis | 616959 |
TRPM1 | chr15 | 15q13-q14 | Night blindness congenital stationary (complete) 1C autosomal recessive | 613216 |
TRPM6 | chr9 | 9q22 | Hypomagnesemia 1 intestinal | 602014 |
TSEN15 | chr1 | 1q25 | Pontocerebellar hypoplasia type 2F | 617026 |
TSEN2 | chr3 | 3p25.1 | Pontocerebellar hypoplasia type 2B | 612389 |
TSEN34 | chr19 | 19q13.4 | Pontocerebellar hypoplasia type 2C | 612390 |
TSEN54 | chr17 | 17q25.1 | Pontocerebellar hypoplasia type 4 | 225753 |
TSEN54 | chr17 | 17q25.1 | Pontocerebellar hypoplasia type 2A | 277470 |
TSEN54 | chr17 | 17q25.1 | Pontocerebellar hypoplasia type 5 | 610204 |
TSFM | chr12 | 12q13-q14 | Combined oxidative phosphorylation deficiency 3 | 610505 |
TSHB | chr1 | 1p13 | Hypothyroidism congenital nongoitrous 4 | 275100 |
TSHR | chr14 | 14q31 | Hypothyroidism congenital nongoitrous 1 | 275200 |
TSPAN7 | chrX | Xq11 | Mental retardation X-linked 58 | 300210 |
TSPEAR | chr21 | 21q22.3 | Ectodermal dysplasia 14 hair/tooth type with or without hypohidrosis | 618180 |
TSPEAR | chr21 | 21q22.3 | Deafness autosomal recessive 98 | 614861 |
TSPYL1 | chr6 | 6q22-q23 | Sudden infant death with dysgenesis of the testes syndrome | 608800 |
TSR2 | chrX | Xp11.22 | Diamond-Blackfan anemia 14 with mandibulofacial dysostosis | 300946 |
TTC19 | chr17 | 17p12 | Mitochondrial complex III deficiency nuclear type 2 | 615157 |
TTC21B | chr2 | 2q24.3 | Nephronophthisis 12 | 613820 |
TTC21B | chr2 | 2q24.3 | Short-rib thoracic dysplasia 4 with or without polydactyly | 613819 |
TTC37 | chr5 | 5q15 | Trichohepatoenteric syndrome 1 | 222470 |
TTC7A | chr2 | 2p21 | Gastrointestinal defects and immunodeficiency syndrome | 243150 |
TTC8 | chr14 | 14q32.1 | Bardet-Biedl syndrome 8 | 615985 |
TTC8 | chr14 | 14q32.1 | Retinitis pigmentosa 51 | 613464 |
TTI2 | chr8 | 8p12 | Mental retardation autosomal recessive 39 | 615541 |
TTLL5 | chr14 | 14q24.3 | Cone-rod dystrophy 19 | 615860 |
TTN | chr2 | 2q31 | Muscular dystrophy limb-girdle autosomal recessive 10 | 608807 |
TTN | chr2 | 2q31 | Salih myopathy | 611705 |
TTPA | chr8 | 8q13.1-q13.3 | Ataxia with isolated vitamin E deficiency | 277460 |
TUB | chr11 | 11p15.4 | Retinal dystrophy and obesity | 616188 |
TUBA8 | chr22 | 22q11 | Cortical dysplasia complex with other brain malformations 8 | 613180 |
TUBGCP4 | chr15 | 15q15 | Microcephaly and chorioretinopathy autosomal recessive 3 | 616335 |
TUBGCP6 | chr22 | 22q13.33 | Microcephaly and chorioretinopathy autosomal recessive 1 | 251270 |
TUFM | chr16 | 16p11.2 | Combined oxidative phosphorylation deficiency 4 | 610678 |
TULP1 | chr6 | 6p21.3 | Retinitis pigmentosa 14 | 600132 |
TULP1 | chr6 | 6p21.3 | Leber congenital amaurosis 15 | 613843 |
TUSC3 | chr8 | 8p22 | Mental retardation autosomal recessive 7 | 611093 |
TWIST2 | chr2 | 2q37.3 | Focal facial dermal dysplasia 3 Setleis type | 227260 |
TWNK | chr10 | 10q24 | Mitochondrial DNA depletion syndrome 7 (hepatocerebral type) | 271245 |
TWNK | chr10 | 10q24 | Perrault syndrome 5 | 616138 |
TXN2 | chr22 | 22q12.3 | Combined oxidative phosphorylation deficiency 29 | 616811 |
TXNL4A | chr18 | 18q23 | Burn-McKeown syndrome | 608572 |
TXNRD2 | chr22 | 22q11.2 | Glucocorticoid deficiency 5 | 617825 |
TYK2 | chr19 | 19p13.2 | Immunodeficiency 35 | 611521 |
TYMP | chr22 | 22q13.32-qter | Mitochondrial DNA depletion syndrome 1 (MNGIE type) | 603041 |
TYR | chr11 | 11q14-q21 | Albinism oculocutaneous type IB | 606952 |
TYR | chr11 | 11q14-q21 | Albinism oculocutaneous type IA | 203100 |
TYROBP | chr19 | 19q13.1 | Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 | 221770 |
TYRP1 | chr9 | 9p23 | Albinism oculocutaneous type III | 203290 |
UBA1 | chrX | Xp11.23 | Spinal muscular atrophy X-linked 2 infantile | 301830 |
UBE2A | chrX | Xq24 | Mental retardation X-linked syndromic Nascimento- type | 300860 |
UBE2T | chr1 | 1q31 | Fanconi anemia complementation group T | 616435 |
UBE3B | chr12 | 12q24.11 | Kaufman oculocerebrofacial syndrome | 244450 |
UBR1 | chr15 | 15q15-q21.1 | Johanson-Blizzard syndrome | 243800 |
UCHL1 | chr4 | 4p14 | Spastic paraplegia 79 autosomal recessive | 615491 |
UCHL1 | chr4 | 4p14 | Parkinson disease 5 susceptibility to | 613643 |
UCP3 | chr11 | 11q13 | Obesity severe and type II diabetes | 601665 |
UGT1A1 | chr2 | 2q37 | Gilbert syndrome | 143500 |
UGT1A1 | chr2 | 2q37 | Hyperbilirubinemia familial transient neonatal | 237900 |
UGT1A1 | chr2 | 2q37 | Crigler-Najjar syndrome type I | 218800 |
UGT1A1 | chr2 | 2q37 | Crigler-Najjar syndrome type II | 606785 |
UMPS | chr3 | 3q13 | Orotic aciduria | 258900 |
UNC13D | chr17 | 17q25.1 | Hemophagocytic lymphohistiocytosis familial 3 | 608898 |
UNC80 | chr2 | 2q35 | Hypotonia infantile with psychomotor retardation and characteristic facies 2 | 616801 |
UNG | chr12 | 12q23-q24.1 | Immunodeficiency with hyper IgM type 5 | 608106 |
UPB1 | chr22 | 22q11.2 | Beta-ureidopropionase deficiency | 613161 |
UPF3B | chrX | Xq25-q26 | Mental retardation X-linked syndromic 14 | 300676 |
UQCRB | chr8 | 8q22 | Mitochondrial complex III deficiency nuclear type 3 | 615158 |
UQCRC2 | chr16 | 16p12 | Mitochondrial complex III deficiency nuclear type 5 | 615160 |
UQCRFS1 | chr19 | 19q12 | Mitochondrial complex III deficiency nuclear type 10 | 618775 |
UQCRQ | chr5 | 5q31.1 | Mitochondrial complex III deficiency nuclear type 4 | 615159 |
UROC1 | chr3 | 3q21.3 | Urocanase deficiency | 276880 |
UROD | chr1 | 1p34 | Porphyria hepatoerythropoietic | 176100 |
UROD | chr1 | 1p34 | Porphyria cutanea tarda | 176100 |
UROS | chr10 | 10q25.2-q26.3 | Porphyria congenital erythropoietic | 263700 |
USB1 | chr16 | 16q13 | Poikiloderma with neutropenia | 604173 |
USH1C | chr11 | 11p15.1 | Deafness autosomal recessive 18A | 602092 |
USH1C | chr11 | 11p15.1 | Usher syndrome type 1C | 276904 |
USH1G | chr17 | 17q24-q25 | Usher syndrome type 1G | 606943 |
USH2A | chr1 | 1q41 | Usher syndrome type 2A | 276901 |
USP27X | chrX | Xp11.2 | Mental retardation X-linked 105 | 300984 |
USP9X | chrX | Xp11.4 | Mental retardation X-linked 99 | 300919 |
USP9X | chrX | Xp11.4 | Mental retardation X-linked 99 syndromic female- restricted | 300968 |
UVSSA | chr4 | 4p16.3 | UV-sensitive syndrome 3 | 614640 |
VAMP1 | chr12 | 12p13.31 | Myasthenic syndrome congenital 25 | 618323 |
VARS2 | chr6 | 6p21.3 | Combined oxidative phosphorylation deficiency 20 | 615917 |
VAX1 | chr10 | 10q26.1 | Microphthalmia syndromic 11 | 614402 |
VDR | chr12 | 12q12-q14 | Rickets vitamin D-resistant type IIA | 277440 |
VHL | chr3 | 3p26-p25 | Erythrocytosis familial 2 | 263400 |
VIPAS39 | chr14 | 14q24.3 | Arthrogryposis renal dysfunction and cholestasis 2 | 613404 |
VLDLR | chr9 | 9p24 | Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1 | 224050 |
VMA21 | chrX | Xq28 | Myopathy X-linked with excessive autophagy | 310440 |
VPS13A | chr9 | 9q21 | Choreoacanthocytosis | 200150 |
VPS13B | chr8 | 8q22-q23 | Cohen syndrome | 216550 |
VPS33B | chr15 | 15q26.1 | Arthrogryposis renal dysfunction and cholestasis 1 | 208085 |
VPS37A | chr8 | 8p23-p21 | Spastic paraplegia 53 autosomal recessive | 614898 |
VPS45 | chr1 | 1q21-q22 | Neutropenia severe congenital 5 autosomal recessive | 615285 |
VPS53 | chr17 | 17p13.3 | Pontocerebellar hypoplasia type 2E | 615851 |
VRK1 | chr14 | 14q32 | Pontocerebellar hypoplasia type 1A | 607596 |
VWA3B | chr2 | 2q11.2 | Spinocerebellar ataxia autosomal recessive 22 | 616948 |
VWF | chr12 | 12p13.3 | von Willebrand disease type 1 | 193400 |
VWF | chr12 | 12p13.3 | von Willebrand disease types 2A 2B 2M and 2N | 613554 |
VWF | chr12 | 12p13.3 | von Willibrand disease type 3 | 277480 |
WAS | chrX | Xp11.23- p11.22 | Thrombocytopenia X-linked intermittent | 313900 |
WAS | chrX | Xp11.23- p11.22 | Thrombocytopenia X-linked | 313900 |
WAS | chrX | Xp11.23- p11.22 | Wiskott-Aldrich syndrome | 301000 |
WAS | chrX | Xp11.23- p11.22 | Neutropenia severe congenital X-linked | 300299 |
WASHC4 | chr12 | 12q23.3 | Mental retardation autosomal recessive 43 | 615817 |
WASHC5 | chr8 | 8q24.13 | Ritscher-Schinzel syndrome 1 | 220210 |
WDPCP | chr2 | 2p15 | Bardet-Biedl syndrome 15 | 615992 |
WDPCP | chr2 | 2p15 | Congenital heart defects hamartomas of tongue and polysyndactyly | 217085 |
WDR19 | chr4 | 4p14-p11 | Nephronophthisis 13 | 614377 |
WDR19 | chr4 | 4p14-p11 | Senior-Loken syndrome 8 | 616307 |
WDR19 | chr4 | 4p14-p11 | Cranioectodermal dysplasia 4 | 614378 |
WDR19 | chr4 | 4p14-p11 | Short-rib thoracic dysplasia 5 with or without polydactyly | 614376 |
WDR35 | chr2 | 2p24.1 | Short-rib thoracic dysplasia 7 with or without polydactyly | 614091 |
WDR35 | chr2 | 2p24.1 | Cranioectodermal dysplasia 2 | 613610 |
WDR4 | chr21 | 21q22.3 | Microcephaly growth deficiency seizures and brain malformations | 618346 |
WDR4 | chr21 | 21q22.3 | Galloway-Mowat syndrome 6 | 618347 |
WDR45B | chr17 | 17q25.3 | Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures | 617977 |
WDR62 | chr19 | 19q13.12 | Microcephaly 2 primary autosomal recessive with or without cortical malformations | 604317 |
WDR72 | chr15 | 15q21.3 | Amelogenesis imperfecta type IIA3 | 613211 |
WDR73 | chr15 | 15q25.2 | Galloway-Mowat syndrome 1 | 251300 |
WDR81 | chr17 | 17p13.3 | Hydrocephalus congenital 3 with brain anomalies | 617967 |
WDR81 | chr17 | 17p13.3 | Cerebellar ataxia mental retardation and dysequilibrium syndrome 2 | 610185 |
WFS1 | chr4 | 4p16.1 | Wolfram syndrome 1 | 222300 |
WHRN | chr9 | 9q32-q34 | Deafness autosomal recessive 31 | 607084 |
WHRN | chr9 | 9q32-q34 | Usher syndrome type 2D | 611383 |
WNK1 | chr12 | 12p13 | Neuropathy hereditary sensory and autonomic type II | 201300 |
WNT1 | chr12 | 12q12-q13 | Osteogenesis imperfecta type XV | 615220 |
WNT10A | chr2 | 2q35 | Schopf-Schulz-Passarge syndrome | 224750 |
WNT10A | chr2 | 2q35 | Tooth agenesis selective 4 | 150400 |
WNT10A | chr2 | 2q35 | Odontoonychodermal dysplasia | 257980 |
WNT10B | chr12 | 12q13 | Split-hand/foot malformation 6 | 225300 |
WNT3 | chr17 | 17q21 | Tetra-amelia syndrome 1 | 273395 |
WNT4 | chr1 | 1p35 | SERKAL syndrome | 611812 |
WNT7A | chr3 | 3p25 | Fuhrmann syndrome | 228930 |
WNT7A | chr3 | 3p25 | Ulna and fibula absence of with severe limb deficiency | 276820 |
WRAP53 | chr17 | 17p13 | Dyskeratosis congenita autosomal recessive 3 | 613988 |
WRN | chr8 | 8p12-p11.2 | Werner syndrome | 277700 |
WWOX | chr16 | 16q23.3-q24.1 | Spinocerebellar ataxia autosomal recessive 12 | 614322 |
WWOX | chr16 | 16q23.3-q24.1 | Epileptic encephalopathy early infantile 28 | 616211 |
XDH | chr2 | 2p23-p22 | Xanthinuria type I | 278300 |
XIAP | chrX | Xq25 | Lymphoproliferative syndrome X-linked 2 | 300635 |
XPA | chr9 | 9q22.3 | Xeroderma pigmentosum group A | 278700 |
XPC | chr3 | 3p25 | Xeroderma pigmentosum group C | 278720 |
XPNPEP3 | chr22 | 22q13.31- q13.33 | Nephronophthisis-like nephropathy 1 | 613159 |
XRCC1 | chr19 | 19q13.2 | Spinocerebellar ataxia autosomal recessive 26 | 617633 |
XRCC2 | chr7 | 7q36.1 | Fanconi anemia complementation group U | 617247 |
XRCC4 | chr5 | 5q13-q14 | Short stature microcephaly and endocrine dysfunction | 616541 |
XYLT1 | chr16 | 16p13.1 | Pseudoxanthoma elasticum modifier of severity of | 264800 |
XYLT1 | chr16 | 16p13.1 | Desbuquois dysplasia 2 | 615777 |
XYLT2 | chr17 | 17q21.3-q22 | Pseudoxanthoma elasticum modifier of severity of | 264800 |
XYLT2 | chr17 | 17q21.3-q22 | Spondyloocular syndrome | 605822 |
YARS2 | chr12 | 12p11.21 | Myopathy lactic acidosis and sideroblastic anemia 2 | 613561 |
ZAP70 | chr2 | 2q12 | Autoimmune disease multisystem infantile-onset 2 | 617006 |
ZAP70 | chr2 | 2q12 | Immunodeficiency 48 | 269840 |
ZBTB11 | chr3 | 3q12.3 | Intellectual developmental disorder autosomal recessive 69 | 618383 |
ZBTB16 | chr11 | 11q23.1 | Skeletal defects genital hypoplasia and mental retardation | 612447 |
ZBTB24 | chr6 | 6q21 | Immunodeficiency-centromeric instability-facial anomalies syndrome 2 | 614069 |
ZBTB42 | chr14 | 14q32.33 | Lethal congenital contracture syndrome 6 | 616248 |
ZC3H14 | chr14 | 14q31.3 | Mental retardation autosomal recessive 56 | 617125 |
ZC4H2 | chrX | Xq11.2 | Wieacker-Wolff syndrome | 314580 |
ZFYVE26 | chr14 | 14q24.1 | Spastic paraplegia 15 autosomal recessive | 270700 |
ZIC3 | chrX | Xq26.2 | Congenital heart defects nonsyndromic 1 X-linked | 306955 |
ZIC3 | chrX | Xq26.2 | Heterotaxy visceral 1 X-linked | 306955 |
ZIC3 | chrX | Xq26.2 | VACTERL association X-linked | 314390 |
ZMPSTE24 | chr1 | 1p34 | Restrictive dermopathy lethal | 275210 |
ZMPSTE24 | chr1 | 1p34 | Mandibuloacral dysplasia with type B lipodystrophy | 608612 |
ZMYND10 | chr3 | 3p21.3 | Ciliary dyskinesia primary 22 | 615444 |
ZMYND15 | chr17 | 17p13.2 | Spermatogenic failure 14 | 615842 |
ZNF141 | chr4 | 4p16.3 | Polydactyly postaxial type A6 | 615226 |
ZNF335 | chr20 | 20q11.2-q13.1 | Microcephaly 10 primary autosomal recessive | 615095 |
ZNF408 | chr11 | 11p11.2 | Exudative vitreoretinopathy 6 | 616468 |
ZNF408 | chr11 | 11p11.2 | Retinitis pigmentosa 72 | 616469 |
ZNF423 | chr16 | 16q12 | Nephronophthisis 14 | 614844 |
ZNF423 | chr16 | 16q12 | Joubert syndrome 19 | 614844 |
ZNF469 | chr16 | 16q24 | Brittle cornea syndrome 1 | 229200 |
ZNF513 | chr2 | 2p24.1-p22.3 | Retinitis pigmentosa 58 | 613617 |
ZP1 | chr11 | 11q12.2 | Oocyte maturation defect 1 | 615774 |
AGTR2 | chrX | Xq23 | Mental retardation, X-linked 88 | 300852 |
CASP10 | chr2 | 2q33-q34 | Autoimmune lymphoproliferative syndrome type II | 603909 |
ZNF41 | chrX | Xp22.1-cen | Mental retardation, X-linked | 314995 |
CDKL5 | chrX | Xp22 | Epileptic encephalopathy early infantile 2 | 300672 |
PTEN | chr10 | 10q23.31 | Lhermitte-Duclos syndrome | 158350 |
SFTPC | chr8 | 8p21 | Surfactant metabolism dysfunction pulmonary 2 | 610913 |
ARHGEF6 | chrX | Xq26 | X-linked non-syndromic intellectual disability | |
UBE3A | chr15 | 15q11-q13 | Angelman syndrome | 105830 |
CASK | chrX | Xp11.4 | Mental retardation with or without nystagmus | 300422 |
CASK | chrX | Xp11.4 | Mental retardation and microcephaly with pontine and cerebellar hypoplasia | 300749 |
CASK | chrX | Xp11.4 | FG syndrome 4 | 300422 |
PDHA1 | chrX | Xp22.2-p22.1 | Leigh syndrome with leukodystrophy | 312170 |
TCF4 | chr18 | 18q21.2 | Corneal dystrophy Fuchs endothelial 3 | 613267 |
SHROOM4 | chrX | Xp11.2 | Stocco dos Santos X-linked mental retardation syndrome | 300434 |
OXCT1 | chr5 | 5p13 | Succinyl CoA:3-oxoacid CoA transferase deficiency | 245050 |
GLA | chrX | Xq22 | Fabry disease | 301500 |
GLA | chrX | Xq22 | Fabry disease cardiac variant | 301500 |
NHEJ1 | chr2 | 2q35 | Cernunnos-XLF deficiency | 611291 |
ZEB2 | chr2 | 2q22 | Mowat-Wilson syndrome | 235730 |
NSD1 | chr5 | 5q35 | Sotos syndrome 1 | 117550 |
NLGN4X | chrX | Xp22.33 | Mental retardation X-linked | 300495 |
NLGN4X | chrX | Xp22.33 | Asperger syndrome susceptibility X-linked 2 | 300497 |
NLGN4X | chrX | Xp22.33 | Autism susceptibility X-linked 2 | 300495 |
BCOR | chrX | Xp11.4 | Microphthalmia syndromic 2 | 300166 |
RPS6KA3 | chrX | Xp22.2-p22.1 | Mental retardation X-linked 19 | 300844 |
RPS6KA3 | chrX | Xp22.2-p22.1 | Coffin-Lowry syndrome | 303600 |
STXBP2 | chr19 | 19p13.3-p13.2 | Hemophagocytic lymphohistiocytosis familial 5 | 613101 |
CHMP1B | chr18 | 18p11 | Spastic paraplegia | 606486 |
EFNB1 | chrX | Xq12 | Craniofrontonasal dysplasia | 304110 |
HJV | chr1 | 1q21 | Hemochromatosis type 2A | 602390 |
DCX | chrX | Xq22.3-q23 | Subcortical laminal heterotopia X-linked | 300067 |
DCX | chrX | Xq22.3-q23 | Lissencephaly X-linked | 300067 |
NXF5 | chrX | Xq22.1 | Focal segmental glomerulosclerosis | 300319 |
COL1A1 | chr17 | 17q21.31-q22 | Osteogenesis imperfecta type I | 166200 |
COL1A1 | chr17 | 17q21.31-q22 | Osteogenesis imperfecta type IV | 166220 |
COL1A1 | chr17 | 17q21.31-q22 | Osteogenesis imperfecta type II | 166210 |
COL1A1 | chr17 | 17q21.31-q22 | Bone mineral density variation QTL osteoporosis | 166710 |
COL1A1 | chr17 | 17q21.31-q22 | Caffey disease | 114000 |
COL1A1 | chr17 | 17q21.31-q22 | Ehlers-Danlos syndrome arthrochalasia type 1 | 130060 |
COL1A1 | chr17 | 17q21.31-q22 | Osteogenesis imperfecta type III | 259420 |
TUBA1A | chr12 | 12q12-q14 | Lissencephaly 3 | 611603 |
SLC16A2 | chrX | Xq13.2 | Allan-Herndon-Dudley syndrome | 300523 |
SLC9A6 | chrX | Xq26.3 | Mental retardation X-linked syndromic Christianson type | 300243 |
ZNF674 | chrX | Xp11 | X-linked mental retardation | 300573 |
FASLG | chr1 | 1q23 | Autoimmune lymphoproliferative syndrome type IB | 601859 |
HSD17B10 | chrX | Xp11.2 | HSD10 mitochondrial disease | 300438 |
NDUFA7 | chr19 | 19p13.2 | Disease associated to NDUFA7 | 602139 |
ZNF711 | chrX | Xq21.1-q21.3 | Mental retardation X-linked 97 | 300803 |
FOXG1 | chr14 | 14q13 | Rett syndrome congenital variant | 613454 |
PCDH19 | chrX | Xq22 | Epileptic encephalopathy early infantile 9 | 300088 |
ARSL | chrX | Xp22.3 | Chondrodysplasia punctata X-linked recessive | 302950 |
ACADL | chr2 | 2q34-q35 | Pulmonary surfactant dysfunction | 609576 |
HBA1 | chr16 | 16pter-p13.3 | Hemoglobin H disease nondeletional | 613978 |
HBA1 | chr16 | 16pter-p13.3 | Thalassemias alpha- | 604131 |
HBA1 | chr16 | 16pter-p13.3 | Erythrocytosis 7 | 617981 |
HBA1 | chr16 | 16pter-p13.3 | Methemoglobinemia alpha type | 617973 |
HBA1 | chr16 | 16pter-p13.3 | Heinz body anemias alpha- | 140700 |
NR5A1 | chr9 | 9q33 | Adrenocortical insufficiency | 612964 |
NR5A1 | chr9 | 9q33 | 46 XX sex reversal 4 | 617480 |
NR5A1 | chr9 | 9q33 | Premature ovarian failure 7 | 612964 |
NR5A1 | chr9 | 9q33 | Spermatogenic failure 8 | 613957 |
NR5A1 | chr9 | 9q33 | 46XY sex reversal 3 | 612965 |
HUWE1 | chrX | Xp11.2 | Mental retardation X-linked syndromic Turner type | 309590 |
ZDHHC9 | chrX | Xq26.1 | Mental retardation X-linked syndromic Raymond type | 300799 |
G6PD | chrX | Xq28 | Hemolytic anemia G6PD deficient (favism) | 300908 |
G6PD | chrX | Xq28 | Resistance to malaria due to G6PD deficiency | 611162 |
CYP11A1 | chr15 | 15q24.1 | Adrenal insufficiency congenital with 46XY sex reversal partial or complete | 613743 |
NDUFS5 | chr1 | 1p34.2-p33 | Complex I-deficiency | 603847 |
MMUT | chr6 | 6p21 | Methylmalonic aciduria mut(0) type | 251000 |
GTF2H5 | chr6 | 6q25.3 | Trichothiodystrophy 3 photosensitive | 616395 |
UNC93B1 | chr11 | 11q13 | Encephalopathy acute infection-induced (herpes- specific) susceptibility to 1 | 610551 |
NHS | chrX | Xp22.13 | Nance-Horan syndrome | 302350 |
NHS | chrX | Xp22.13 | Cataract 40 X-linked | 302200 |
SOX3 | chrX | Xq26.3 | Mental retardation X-linked with isolated growth hormone deficiency | 300123 |
SOX3 | chrX | Xq26.3 | Panhypopituitarism X-linked | 312000 |
ACSL4 | chrX | Xq22.3 | Mental retardation X-linked 63 | 300387 |
GDI1 | chrX | Xq28 | Mental retardation X-linked 41 | 300849 |
FAS | chr10 | 10q24.1 | Autoimmune lymphoproliferative syndrome type IA | 601859 |
FAS | chr10 | 10q24.1 | Autoimmune lymphoproliferative syndrome | 601859 |
COL4A5 | chrX | Xq22.3 | Alport syndrome 1 X-linked | 301050 |
Dr Belén Lledó, Scientific Director at IBBIOTECH, part of the Instituto Bernabeu group.